AgeWell New York · HPMS Approved Formulary File Submission ID 17397, Version Number 13 Il presente prontuario è aggiornato alla data 08/01/2017. Piano AgeWell New York (Medicare-Medicaid)

HPMS Approved Formulary File Submission ID 17397, Version Number 13

Il presente prontuario è aggiornato alla data 08/01/2017.

Piano AgeWell New York (Medicare-Medicaid) FIDA Prontuario 2017 (Elenco dei farmaci coperti)Un Medicare Advantage Health Maintenance Organization (HMO) offerto da AgeWell New York, LLC con contratto Medicare

Contee del Bronx, Kings (Brooklyn), Queens, Nassau e New York (Manhattan)

Per ulteriori aggiornamenti o altre richieste, contatti il reparto Servizi per i Partecipanti (Participant Services) di AgeWell New York FIDA al numero 1-866-586-8044, non udenti 1-800-662-1220, disponibile 7 giorni su 7 dalle 8:00 alle 20:00, oppure visiti il sito www.agewellnewyork.com

Parliamo la Sua linguaWelcome 환영합니다 歡迎 добро пожаловать Bienvenido Benvenuto Byenveni

H6308_001_16702v2IT Approved 09132016

2017 FIDA FORMULARY ITALIAN FINAL Approved.pdf 1 10/20/2016 2:53:27 PM

H6308_001_16702v2IT Approved 09132016

In caso di dubbi o domande, è possibile contattare AgeWell New York FIDA al numero

1-866-586-8044 (non udenti 1-800-662-1220), disponibile 7 giorni su 7, alle 8 alle 20. La chiamata è

gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. i ?

AgeWell New York FIDA 2017 Elenco dei farmaci coperti (Prontuario)

Questo è un elenco dei farmaci che i Partecipanti possono ricevere nell'ambito del piano AgeWell

New York FIDA.

AgeWell New York LLC è un piano di assistenza gestita basato su accordi sia con Medicare,

sia con il Dipartimento sanitario dello Stato di New York (Medicaid) per offrire ai Partecipanti i

vantaggi di entrambi i programmi attraverso la dimostrazione denominata FIDA (Fully

Integrated Duals Advantage).

L'Elenco dei farmaci coperti e/o le reti di fornitori e farmacie possono cambiare nel corso

dell'anno. Le invieremo un avviso prima di apportare qualsiasi cambiamento che possa influire

su di Lei.

I vantaggi possono cambiare a partire dal 1° gennaio di ogni anno.

Può consultare in qualsiasi momento l'Elenco dei farmaci aggiornato per il piano AgeWell New

York FIDA all'indirizzo agewellnewyork.com oppure tramite il nostro gestore dei vantaggi

farmaceutici, EnvisionRx per il reparto Servizi per i Partecipanti (Participant Services) di

AgeWell New York FIDA al numero 1-855-889-0046 (non udenti: 711), disponibile 24 ore su

24, 7 giorni su 7.

Potrebbero essere applicate limitazioni e restrizioni. Per ulteriori informazioni, contatti il reparto

Servizi per i Partecipanti (Participant Services) di AgeWell New York FIDA oppure legga il

Manuale del Partecipante del piano AgeWell New York FIDA. Ciò significa che deve seguire

determinate regole affinché il piano AgeWell New York FIDA paghi i Suoi servizi.

Non c'è alcun ticket da pagare per i farmaci coperti.

You can get this information for free in other languages. Call 1-866-586-8044 and TTY/TDD

1-800-662-1220; you can call us 7 days a week 8.00 am to 8.00 pm. The call is free.

Creolo haitiano

Ou ka jwenn enfòmasyon sa a gratis nan lòt lang. Rele nan 1-866-586-8044 ak nan TTY (pou

moun ki gen pwoblèm tande oswa moun ki bèbè) 1-800-662-1220 de lendi a dimanch

8:00 am - 8:00 pm. Apèl la gratis.

Spagnolo

Puede obtener esta información de manera gratuita en otros idiomas. Llame al

1-866-586-8044 y TTY 1-800-662-1220 de lunes a domingos de 8:00 am a 8:00 pm.

La llamada es gratuita.

Coreano:

이정보는 다른 언어로도 제공됩니다(무료). 월요일-일요일8:00 am – 8:00 pm 중

1-866-586-8044나 TTY 1-800-662-1220로 전화 주십시오. 통화료는 무료입니다.


http://www.agewellnewyork.com/




gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. ii

?

Cinese

您可免費取得以其他語言撰寫的資訊。請於週一至週日上午8 時至下午8時致電1-866-586-8044，

TTY 使用者：1-800-662-1220。此為免付費電話。

Russo

Данная информация доступна бесплатно на других языках. Звоните по номеру

1-866-586-8044 или 1-800-662-1220 (линия TTY) с понедельника по воскресенье

с8:00 до 20:00. Звонок бесплатный.

Italiano

È possibile ricevere gratuitamente queste informazioni in altre lingue. Contatti il numero

1-866-586-8044, non udenti 1-800-662-1220, disponibile dal lunedì alla domenica dalle ore

8:00 alle ore 20:00. Il servizio è gratuito.

È possibile ricevere gratuitamente queste informazioni in altri formati, quali ad esempio Braille,

stampa a caratteri grandi o audio. Contatti il numero 1-866-586-8044 e, per i non udenti, il

numero 1-800-662-1220, disponibile 7 giorni su 7, alle 8 alle 20. La chiamata è gratuita.

Il nostro reparto Servizi per i Partecipanti (Participant Services) inserirà la Sua richiesta nel

sistema; da quel momento tutte le comunicazioni successive verranno inoltrate nel formato e

nella lingua richiesta. Se desidera modificare la Sua richiesta in qualsiasi momento, contatti

AgeWell New York FIDA al numero 1-866-586-8044, non udenti 1-800-622-1220, e

modificheremo la Sua richiesta a sistema.

Lo Stato di New York ha creato un programma con difensori civici denominato "Independent

Consumer Advocacy Network" (ICAN) per fornire ai Partecipanti un'assistenza gratuita e

riservata su qualsiasi servizio offerto dal piano AgeWell New York FIDA. Può contattare l'ICAN

al numero verde 1-844-614-8800, oppure online all'indirizzo icannys.org. I non udenti possono

chiamare il numero 711, quindi seguire le indicazioni per selezionare il numero 1-

844-614-8800.





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. iii

?

Domande più frequenti (FAQ)

Qui può trovare le risposte alle domande riguardanti il presente Elenco dei farmaci coperti. Può

leggere tutte le FAQ per saperne di più, oppure cercare una domanda e una risposta specifiche.

1. Quali farmaci prescrivibili sono presenti nell'Elenco dei farmaci coperti?

(Da qui in poi, l'Elenco dei farmaci coperti sarà abbreviato in "Elenco dei

farmaci")

I farmaci presenti nell'Elenco dei farmaci che inizia a pagina 1 sono i farmaci coperti dal piano

AgeWell New York FIDA. Tali farmaci sono disponibili presso le farmacie incluse nella nostra

rete convenzionata. Una farmacia fa parte della nostra rete nel caso abbia accettato di lavorare

con noi e di fornirle servizi. Tali farmacie sono indicate con il termine "farmacie della rete".

Il piano AgeWell New York FIDA coprirà tutti i farmaci inclusi nell'Elenco dei farmaci se:

il Suo medico o un altro fornitore sanitario afferma che ha bisogno di tali farmaci per sentirsi meglio

o restare in salute;

il farmaco è necessario per le Sue condizioni dal punto di vista medico, e

ritira la prescrizione in una farmacia della rete convenzionata del piano AgeWell New York FIDA.

Il piano AgeWell New York FIDA può prevedere ulteriori requisiti per accedere a determinati farmaci

(consulti la domanda 5 a seguire). In alcuni casi, potrebbe essere necessaria una qualche Sua

azione prima di poter ricevere un farmaco, ad esempio provare prima altri farmaci.

Può inoltre consultare un elenco aggiornato dei farmaci da noi coperti sul nostro sito web,

all'indirizzo www.agewellnewyork.com o contattare il nostro gestore dei vantaggi farmaceutici,

EnvisionRx, al numero (855)889-0046 (i non udenti possono chiamare il numero 711),

disponibile 24 ore su 24, 7 giorni su 7.

2. L'Elenco dei farmaci è soggetto a modifiche?

Sì. Il piano AgeWell New York FIDA può aggiungere o togliere farmaci dall'Elenco dei farmaci durante

l'anno. In genere, le modifiche all'Elenco dei farmaci sono apportate soltanto se:

diventa disponibile un nuovo farmaco che funziona con la stessa efficacia di un farmaco

attualmente incluso nell'Elenco dei farmaci, oppure

scopriamo che un farmaco non è sicuro.

Potremmo anche modificare le nostre regole sui farmaci. Ad esempio, potremmo:






gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. iv

?

decidere di richiedere o meno l'approvazione preliminare per un farmaco. (Il termine approvazione

preliminare indica un permesso che deve essere rilasciato dal piano AgeWell New York FIDA o

dal Suo team interdisciplinare prima che possa ricevere un farmaco);

aggiungere o modificare la quantità di un farmaco che può ricevere (i cosiddetti "limiti quantitativi");

aggiungere o modificare le restrizioni della terapia a gradini su un farmaco. (Il termine terapia a

gradini indica una terapia in base a cui deve provare un farmaco prima che copriamo un altro

farmaco).

(Per ulteriori informazioni su queste regole per i farmaci, consulti pagina v)

Nel caso in cui un farmaco che sta assumendo venga tolto dall'Elenco dei farmaci, La informeremo

quanto prima. Le segnaleremo inoltre tutti i casi in cui modificheremo le regole per la copertura di un

farmaco. Le domande 3, 4 e 7 a seguire contengono informazioni su ciò che avviene quando l'Elenco dei

farmaci viene modificato.

Può consultare in qualsiasi momento l'Elenco dei farmaci aggiornato per il piano AgeWell New

York FIDA all'indirizzo www.agewellnewyork.com. Può inoltre contattare il nostro gestore dei

vantaggi farmaceutici, EnvisionRx, al numero 1(855)889-0046 (i non udenti possono chiamare il

numero 711), disponibile 24 ore su 24, 7 giorni su 7.

3. Cosa succede quando diventa disponibile un farmaco meno costoso

che agisce con la stessa efficacia di un farmaco attualmente incluso

nell'Elenco dei farmaci?

Se diventa disponibile un farmaco meno costoso che agisce con la stessa efficacia di un farmaco

attualmente incluso nell'Elenco dei farmaci:

Il Suo farmacista potrebbe fornirle il farmaco meno costoso in occasione della Sua prossima

prescrizione. Se Lei e il Suo fornitore sanitario decidete che il farmaco meno costoso non fa al

caso Suo, il Suo fornitore può segnalare al farmacista di continuare con il farmaco che sta

assumendo adesso.

AgeWell New York FIDA potrebbe decidere di togliere il farmaco più costoso dall'Elenco dei

farmaci. Se sta assumendo un farmaco che viene tolto dall'Elenco dei farmaci perché diventa

disponibile un farmaco meno costoso che funziona con la stessa efficacia, La avviseremo

almeno 60 giorni prima della rimozione di tale farmaco dall'elenco oppure quando chiede un

rinnovo. A quel punto può ottenere una fornitura del farmaco per 60 giorni prima che venga

apportata la modifica all'Elenco dei farmaci. Invieremo una comunicazione via posta per

segnalare il cambiamento.






gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. v

?

4. Cosa succede se si scopre che un farmaco non è sicuro?

Qualora la Food and Drug Administration (FDA) affermi che un farmaco che sta assumendo non è

sicuro, toglieremo immediatamente tale farmaco dall'Elenco dei farmaci. Oltre a contattarla

telefonicamente, Le invieremo inoltre una lettera per avvisarla che il farmaco non sicuro è stato rimosso

dall'Elenco dei farmaci. Se riceve una comunicazione postale o telefonica relativa all'esclusione di un

farmaco che assume dall'Elenco dei farmaci, è tenuto a contattare tempestivamente il medico che l'ha

prescritto.

5. Vi sono restrizioni o limitazioni alla copertura dei farmaci? Oppure vi

sono azioni necessarie da intraprendere per ricevere determinati

farmaci?

Sì, alcuni farmaci presentano regole sulla loro copertura o limitazioni sulla quantità che può ricevere. In

alcuni casi, Lei, il Suo medico o chi esegue le prescrizioni deve fare qualcosa prima di poter ricevere il

farmaco. Ad esempio:

Approvazione preliminare (o autorizzazione preliminare): Per alcuni farmaci Lei, il Suo medico

o chi esegue le prescrizioni è tenuto a ottenere un'approvazione da parte di AgeWell New York

FIDA o del Suo team interdisciplinare (IDT) prima che venga compilata la prescrizione. Qualora

non ricevesse tale approvazione, AgeWell New York FIDA potrebbe non coprire il farmaco.

Limiti quantitativi: Talvolta, AgeWell New York FIDA limita la quantità di farmaco che può

ricevere.

Terapia a gradini: A volte AgeWell New York FIDA obbliga a seguire una terapia a gradini. Ciò

significa che dovrà provare i farmaci in un determinato ordine per le Sue condizioni mediche.

Potrebbe dover provare un farmaco prima che copriamo un altro farmaco. Se il Suo medico ritiene

che il primo farmaco non faccia al caso Suo, allora copriremo il secondo.

Può scoprire se il Suo farmaco presenta requisiti o limiti aggiuntivi consultando le tabelle a pagina 1. Può

inoltre reperire ulteriori informazioni visitando il nostro sito, all'indirizzo www.agewellnewyork.com.

Abbiamo pubblicato online alcuni documenti che spiegano come funziona la nostra autorizzazione

preliminare e le restrizioni della terapia a gradini. Può inoltre chiederci di inviarle una copia.

Può chiedere una "eccezione" a tali limiti. Consulti la domanda 11 per ulteriori informazioni sulle eccezioni.

Se si trova in una casa di riposo o in un'altra struttura per cure a lungo termine e Le servisse un

farmaco che non è incluso nell'Elenco dei farmaci, oppure se non potesse procurarsi con facilità il

farmaco che Le serve, possiamo aiutarla. Copriremo una fornitura d'emergenza del farmaco che

Le serve per 31 giorni (a meno che la Sua prescrizione non indichi un numero minore di giorni),






gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. vi

?

che Lei sia o meno un nuovo Partecipante di AgeWell New York FIDA. Ciò Le darà il tempo di

parlare con il Suo medico o altra persona che esegue le prescrizioni, che potrà aiutarla a

decidere se esiste, nell'Elenco dei farmaci, un farmaco simile che può assumere al posto di

quello attuale oppure se richiedere o meno un'eccezione. Consulti la domanda 11 per ulteriori

informazioni sulle eccezioni.

6. Come può scoprire se il farmaco da Lei desiderato presenta delle

limitazioni oppure se è necessario intraprendere determinate azioni

per ricevere tale farmaco?

L'Elenco dei farmaci a pagina 1 presenta una colonna denominata "Azioni necessarie, restrizioni o

limitazioni all'uso".

7. Cosa succede se modifichiamo le regole sul modo in cui copriamo

determinati farmaci? Ad esempio, se aggiungiamo l'autorizzazione

(approvazione) preliminare, limiti quantitativi e/o restrizioni alla

terapia a gradini su un farmaco.

Se aggiungiamo l'approvazione preliminare, limiti quantitativi e/o restrizioni alla terapia a gradini su un

farmaco, La avviseremo almeno 60 giorni prima che la restrizione venga aggiunta oppure quando chiede

il prossimo rinnovo. A quel punto può ottenere una fornitura del farmaco per 60 giorni prima che venga

apportata la modifica all'Elenco dei farmaci. Ciò Le darà il tempo di parlare con il Suo medico o con chi

esegue le prescrizioni) per decidere cosa fare in seguito.

8. Come posso trovare un farmaco nell'Elenco dei farmaci?

Esistono due modi per trovare un farmaco:

Può cercarlo in ordine alfabetico (se sa come si scrive il nome del farmaco), oppure

può cercarlo in base alla patologia medica.

Per cercarlo in ordine alfabetico, consulti la sezione Elenco alfabetico a pagina 150. In seguito cerchi il

nome del Suo farmaco nell'elenco.

Per eseguire ricerche in base alla condizione medica, trovi la sezione denominata "Elenco dei farmaci

in base alla condizione medica" a pagina xii. I farmaci in questa sezione sono raggruppati in categorie in

base al tipo di patologia medica per cui vengono utilizzati come trattamento. Ad esempio, se soffre di

disturbi cardiaci, deve cercare in quella categoria, ossia Agenti cardiovascolari. Lì troverà i farmaci che

curano i disturbi cardiaci.





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. vii

?

9. Cosa succede se il farmaco da Lei desiderato non è incluso

nell'Elenco dei farmaci?

Se non trova il Suo farmaco nell'Elenco dei farmaci, contatti il nostro gestore dei vantaggi

farmaceutici, EnvisionRx, al numero 1(855)889-0046 (i non udenti possono chiamare il numero

711), disponibile 24 ore su 24, 7 giorni su 7, e chieda spiegazioni. Se scopre che AgeWell New

York FIDA non coprirà il farmaco, può decidere di fare quanto segue:

Chiedere al reparto Servizi per i Partecipanti (Participant Services) un elenco di farmaci simili a

quello che desidera assumere, quindi mostrare l'elenco al Suo medico o altra persona che esegue

le prescrizioni che potrà prescrivere un farmaco, presente nell'Elenco dei farmaci, simile a quello

che desidera assumere. Oppure

Chiedere al piano o al Suo team interdisciplinare (IDT) di fare un'eccezione per coprire il Suo

farmaco. Consulti la domanda 11 per ulteriori informazioni sulle eccezioni.

10. Cosa succede se è un nuovo Partecipante al piano AgeWell New

York FIDA e non riesce a trovare il Suo farmaco nell'Elenco dei

farmaci oppure ha problemi nell'ottenere il Suo farmaco?

Possiamo aiutarla. Abbiamo l'obbligo di coprire fino a 90 giorni di forniture temporanee del Suo farmaco,

secondo necessità, durante i Suoi primi 90 giorni di partecipazione al piano AgeWell New York FIDA. Ciò

Le darà il tempo di parlare con il Suo medico o altra persona che esegue le prescrizioni, che potrà

aiutarla a decidere se esiste, nell'Elenco dei farmaci, un farmaco simile che può assumere al posto di

quello attuale oppure se richiedere o meno un'eccezione.

Copriremo fino a 90 giorni di forniture temporanee del Suo farmaco se:

sta assumendo un farmaco che non è incluso nel nostro Elenco dei farmaci; oppure

le regole del piano sanitario non Le permettono di ricevere la quantità ordinata da chi esegue le

prescrizioni; oppure

il farmaco richiede un'approvazione preliminare da parte di AgeWell New York FIDA oppure del

Suo team interdisciplinare (IDT); oppure

sta assumendo un farmaco che fa parte di una restrizione alla terapia a gradini.

Se risiede in una casa di riposo o in un'altra struttura per cure a lungo termine, può rinnovare la Sua

prescrizione fino a 91 giorni, con possibile estensione a 98 giorni. Può farsi erogare il farmaco diverse

volte durante i primi 90 giorni dall'iscrizione al piano. Ciò dà il tempo a chi esegue le prescrizioni di

cambiare i Suoi farmaci e passare a quelli presenti nell'Elenco dei farmaci, oppure di chiedere

un'eccezione.





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. viii

?

Agli attuali partecipanti soggetti a cambiamenti nel proprio livello di cura (ossia, dimissione

ospedaliera) AgeWell New York FIDA garantirà una fornitura del farmaco per 31 giorni.

11. Può chiedere un'eccezione per coprire il Suo farmaco?

Sì. Può chiedere ad AgeWell New York FIDA oppure al Suo team interdisciplinare (IDT) di fare

un'eccezione per coprire un farmaco che non è incluso nell'Elenco dei farmaci.

Può inoltre chiedere ad AgeWell New York FIDA o al Suo team interdisciplinare di modificare le regole

sul Suo farmaco.

Ad esempio, AgeWell New York FIDA potrebbe limitare la quantità di farmaco che copriremo. Se il

Suo farmaco presenta un limite, può chiederci, oppure chiedere al Suo team interdisciplinare, di

modificare il limite e coprirne una quantità maggiore.

Altri esempi: Può chiederci, oppure chiedere al Suo team interdisciplinare, di ridurre le restrizioni

alla terapia a gradini o i requisiti per l'approvazione preliminare.

12. Quanto tempo serve per ricevere un'eccezione?

Per prima cosa, AgeWell New York FIDA o il Suo team interdisciplinare (IDT) devono ricevere una

dichiarazione da parte di chi esegue le prescrizioni a supporto della Sua richiesta di eccezione. Dopo che

avremo ricevuto la dichiarazione, riceverà una decisione sulla Sua richiesta di eccezione entro 72 ore.

Se Lei o chi esegue le prescrizioni ritiene che la Sua salute potrebbe essere pregiudicata nel caso

dovesse attendere 72 ore per una decisione, può richiedere un'eccezione urgente. Si tratta di una

decisione più rapida. Se chi esegue le prescrizioni supporta la Sua richiesta, riceverà una decisione entro

24 ore dal ricevimento della dichiarazione di supporto.

13. Come può chiedere un'eccezione?

Per chiedere un'eccezione, contatti il Suo gestore delle cure. Il Suo gestore delle cure lavorerà con Lei e

con il Suo fornitore sanitario per aiutarla a chiedere un'eccezione.

14. Che cosa sono i farmaci equivalenti?

I farmaci equivalenti (detti anche generici) sono composti dagli stessi ingredienti dei farmaci di marca. In

genere, costano meno dei farmaci di marca corrispondenti e non hanno nomi conosciuti. I farmaci

equivalenti sono approvati dalla Food and Drug Administration (FDA).





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. ix

?

AgeWell New York FIDA copre sia farmaci di marca, sia farmaci equivalenti.

15. Che cosa sono i farmaci da banco?

La sigla inglese OTC indica i farmaci "da banco". AgeWell New York FIDA copre alcuni farmaci da banco

quando vengono prescritti dal Suo fornitore.

Può consultare l'Elenco dei farmaci di AgeWell New York FIDA per verificare quali farmaci da banco

sono coperti.

16. AgeWell New York copre prodotti "da banco" diversi dai farmaci?

AgeWell New York FIDA copre alcuni prodotti da banco diversi dai farmaci quando vengono prescritti dal

Suo fornitore (ad es. aspirina, crema clotrimazolo 1%, tamponi imbevuti di alcool).

Può consultare l'Elenco dei farmaci di AgeWell New York FIDA per verificare quali prodotti da banco

sono coperti.

17. Quanto deve pagare di ticket?

Non Le verrà addebitato alcun ticket per i farmaci inclusi nell'Elenco dei farmaci.

18. Cosa sono le classi di farmaci?

Le classi sono gruppi di farmaci inclusi nel nostro Elenco dei farmaci. Nessuna delle classi prevede il

ticket.

Classe 1 Include i farmaci equivalenti Medicare Part D.

Questa è la classe più bassa.

Classe 2 Include i farmaci di marca Medicare Part D

Classe 3 Include i farmaci coperti da Medicaid dello Stato di New York: I

farmaci da banco (OTC) equivalenti e di marca come concesso ai

sensi del programma Medicaid nello Stato di New York.

Prodotti e farmaci da banco (OTC)

Questa è la classe più alta.





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. x

?

Elenco dei farmaci coperti

L'Elenco dei farmaci coperti riportato di seguito Le fornisce informazioni sui farmaci coperti dal

piano AgeWell New York FIDA. Qualora avesse problemi a reperire il Suo farmaco nell'elenco,

faccia riferimento all'Indice che inizia a pagina 150.

La prima colonna della tabella elenca il nome del farmaco. I farmaci di marca sono scritti in lettere

maiuscole (ad es. JAKAFI) mentre i farmaci equivalenti sono scritti in lettere minuscole e in corsivo

(ad es. amoxicillina).

Le informazioni nella colonna Azioni necessarie, restrizioni o limitazioni all'uso indicano se il piano

AgeWell New York FIDA presenta eventuali regole per la copertura del farmaco.

Di seguito sono riportate le definizioni dei codici utilizzati nella colonna "Azioni necessarie,

restrizioni o limitazioni all'uso":

QL - Limiti quantitativi: esiste una limitazione alla quantità di farmaco coperta per ciascuna

prescrizione o in un determinato lasso di tempo.

PA - Autorizzazione preliminare: prima di ritirare la prescrizione per questo farmaco, Lei (o

il Suo medico) è tenuto ad ottenere l'autorizzazione preliminare. In assenza di

autorizzazione preliminare, non copriremo il farmaco.

ST - Terapia a gradini: in alcuni casi Le sarà chiesto di provare determinati farmaci per

trattare la Sua condizione medica prima di coprirne un altro per tale condizione medica.

LA - Accesso limitato: Il farmaco prescrivibile è disponibile solo in determinate farmacie.

HR - Farmaci ad alto rischio: I Centri per i Servizi Medicare e Medicaid (CMS) hanno

identificato i farmaci elencati come fattori di maggiore rischio per i pazienti, soprattutto

quelli anziani (PA obbligatoria per chi ha almeno 65 anni).

MO – Farmaco per corrispondenza: può ricevere il farmaco tramite il nostro programma di

fornitura per corrispondenza da 90 giorni.

BD - Parte B rispetto a Parte D: il farmaco prescrivibile potrebbe essere coperto tramite

Medicare Parte B o Parte D, a seconda delle circostanze.

* - Farmaci non di Parte D o articoli da banco coperti da Medicaid.

Nota: L'asterisco (*) accanto al farmaco indica che lo stesso non è un "farmaco di Parte D".

Questi farmaci presentano regole differenti per i ricorsi. Il ricorso è un modo formale con cui

chiedere il riesame e l'eventuale modifica di una decisione sulla copertura, qualora ritenesse che





gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com. xi

?

si sia verificato un errore. Ad esempio, AgeWell New York FIDA o il Suo team interdisciplinare

(IDT) potrebbero decidere che un farmaco da Lei desiderato non è coperto o non è più coperto da

Medicare o Medicaid. Se Lei, il Suo medico o chi esegue le prescrizioni non è d'accordo con la

decisione, può presentare ricorso. Per ricevere istruzioni su come presentare un ricorso, contatti il

nostro gestore dei vantaggi farmaceutici, EnvisionRx, al numero (855)889-0046 (i non udenti

possono chiamare il numero 711), disponibile 24 ore su 24, 7 giorni su 7, oppure l'ICAN

(Independent Consumer Advocacy Network) al numero 1-844-614-8800. I non udenti possono

chiamare il numero 711, quindi seguire le indicazioni per selezionare il numero 844-614-8800. Per

sapere come ricorrere contro una decisione può inoltre leggere il Manuale del Partecipante.




1-866-586-8044 (non udenti 1-800-662-1220), disponibile dal lunedì alla domenica, alle 8 alle 20. La

chiamata è gratuita. Per ulteriori informazioni, visitare il sito www.agewellnewyork.com xii

?

Elenco dei farmaci per patologia medica

I farmaci in questa sezione sono raggruppati in categorie in base al tipo di patologia medica per

cui vengono utilizzati come trattamento. Ad esempio, se soffre di disturbi cardiaci, deve cercare

in quella categoria, ossia Agenti cardiovascolari. Lì troverà i farmaci che curano i disturbi

cardiaci.



Formulary ID 17397 Ver.13; Updated: 08/01/2017

You can find information on what symbols and abbreviations on this table mean by going to the introduction

pages of this document.

If you have questions, please call AgeWell New York FIDA at 1-866-586-8044 and TTY/TDD 1-800-662-1220;

you can call us 7 days a week 8:00 am to 8:00 pm The call is free. For more information, visit

www.agewellnewyork.com

1

?

Drug Drug Tier Requirements/Limits

BLOOD DISORDER

ABNORMAL INCREASE IN ABILITY

OF BLOOD TO CLOT

ADEMPAS ORAL TABLET 0.5 MG, 1 MG, 1.5

MG, 2 MG, 2.5 MG 2 MO

anagrelide hcl oral capsule 0.5 mg 1 MO

ARGATROBAN INTRAVENOUS SOLUTION

125 MG/125ML 2 BD

aspirin ec tablet delayed release 325 mg oral 325

mg 3 QL (60 EA per 30 days)

ASPIRIN-DIPYRIDAMOLE ER ORAL

CAPSULE EXTENDED RELEASE 12 HOUR

25-200 MG

2 MO

BRILINTA ORAL TABLET 60 MG, 90 MG 2 MO

ELIQUIS ORAL TABLET 2.5 MG, 5 MG 2 MO

enoxaparin sodium injection solution 300 mg/3ml 1

enoxaparin sodium subcutaneous solution 100

mg/ml, 120 mg/0.8ml, 150 mg/ml, 30 mg/0.3ml,

40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1

fondaparinux sodium subcutaneous solution 10

mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1

FRAGMIN SUBCUTANEOUS SOLUTION

10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500

UNIT/0.3ML, 95000 UNIT/3.8ML

2

goodsense aspirin tablet 325 mg oral 325 mg 3 QL (60 EA per 30 days)

heparin (porcine) in d5w intravenous solution 40-

5 unit/ml-%, 50-5 unit/ml-% 1

heparin sod (porcine) in d5w intravenous solution

100 unit/ml 1

heparin sodium (porcine) injection solution 1000

unit/ml, 10000 unit/ml, 20000 unit/ml, 5000

unit/ml

1








2

?


jantoven oral tablet 1 mg, 10 mg, 2 mg, 2.5 mg, 3

mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO

PRADAXA ORAL CAPSULE 110 MG, 150

MG, 75 MG 2 MO; QL (60 EA per 30 days)

warfarin sodium oral tablet 1 mg, 10 mg, 2 mg,

2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO

XARELTO ORAL TABLET 10 MG, 15 MG, 20

MG 2 MO

XARELTO STARTER PACK ORAL TABLET

THERAPY PACK 15 & 20 MG 2

ABNORMAL RED BLOOD CELLS

ANADROL-50 ORAL TABLET 50 MG 2

ATGAM INTRAVENOUS INJECTABLE 50

MG/ML 2 BD

ferrous gluconate tablet 324 (38 fe) mg oral 324

(38 fe) mg 3

ferrous sulfate tablet delayed release 325 (65 fe)

mg oral 325 (65 fe) mg 3

folic acid tablet 1 mg oral (otc) 1 mg 3 MO

folic acid tablet 400 mcg oral 400 mcg 3

JAKAFI ORAL TABLET 10 MG, 15 MG, 20

MG, 25 MG, 5 MG 2

kp ferrous sulfate tablet 325 (65 fe) mg oral 325

(65 fe) mg 3

LUPRON DEPOT (1-MONTH)

INTRAMUSCULAR KIT 3.75 MG 2



MIRCERA INJECTION SOLUTION

PREFILLED SYRINGE 100 MCG/0.3ML, 50

MCG/0.3ML, 75 MCG/0.3ML

2 BD

NU-IRON CAPSULE 150 MG ORAL 150 MG 3

PROCRIT INJECTION SOLUTION 10000

UNIT/ML, 20000 UNIT/ML, 4000 UNIT/ML 2 PA; QL (12 ML per 28 days)








3

?



UNIT/ML 2 PA; QL (23 ML per 30 days)





PROMACTA ORAL TABLET 12.5 MG, 25 MG,

50 MG, 75 MG 2 MO

BLOOD CLOTTING DISORDER


MG, 2 MG, 2.5 MG 2 MO



125 MG/125ML 2 BD





25-200 MG

2 MO


CARIMUNE NF INTRAVENOUS SOLUTION

RECONSTITUTED 6 GM 2 BD

dipyridamole oral tablet 25 mg, 50 mg, 75 mg 1 PA; HR; MO





40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1


mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1








4

?



10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2

GAMMAGARD S/D LESS IGA

INTRAVENOUS SOLUTION

RECONSTITUTED 10 GM, 5 GM

2 BD

GAMMAKED INJECTION SOLUTION 1

GM/10ML 2 BD

GAMMAPLEX INTRAVENOUS SOLUTION

10 GM/100ML, 20 GM/200ML, 5 GM/50ML 2 BD


10 GM/200ML 2 BD

GAMUNEX-C INJECTION SOLUTION 1

GM/10ML 2 BD





100 unit/ml 1



unit/ml

1


mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO

MEPHYTON TABLET 5 MG ORAL 5 MG 3



PRIVIGEN INTRAVENOUS SOLUTION 20

GM/200ML 2 BD


50 MG, 75 MG 2 MO

vitamin k1 injection solution 10 mg/ml 3








5

?



2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO


MG 2 MO



CHRONIC GRANULOMATOUS

DISEASE

ACTIMMUNE SUBCUTANEOUS SOLUTION

2000000 UNIT/0.5ML 2 LA; MO

DECREASED FUNCTION OF BONE

MARROW

ANADROL-50 ORAL TABLET 50 MG 2


125 MG/125ML 2 BD


MG/ML 2 BD






2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD

LEUCOVORIN CALCIUM INJECTION

SOLUTION RECONSTITUTED 100 MG 2 BD

leucovorin calcium injection solution

reconstituted 350 mg 1 BD

leucovorin calcium oral tablet 10 mg, 15 mg, 25

mg, 5 mg 1








6

?


LEVOLEUCOVORIN CALCIUM

INTRAVENOUS SOLUTION 175 MG/17.5ML 2 BD



RECONSTITUTED 50 MG

2 BD

NEUPOGEN INJECTION SOLUTION 300

MCG/ML, 480 MCG/1.6ML 2

NEUPOGEN INJECTION SOLUTION


MCG/0.8ML

2


GM/200ML 2 BD


50 MG, 75 MG 2 MO

ZARXIO INJECTION SOLUTION PREFILLED

SYRINGE 300 MCG/0.5ML, 480 MCG/0.8ML 2

DECREASED WHITE BLOOD

CELLS





MCG/0.8ML

2



INCREASED RISK OF BLEEDING


MG, 2 MG, 2.5 MG 2 MO



125 MG/125ML 2 BD










7

?




25-200 MG

2 MO









40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1


mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1


10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2




2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD





100 unit/ml 1








8

?




unit/ml

1


mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO

MEPHYTON TABLET 5 MG ORAL 5 MG 3




GM/200ML 2 BD


50 MG, 75 MG 2 MO

vitamin k1 injection solution 10 mg/ml 3


2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO


MG 2 MO



MALIGNANCY OF BONE MARROW

CELLS

cladribine intravenous solution 10 mg/10ml 1 BD

DARZALEX INTRAVENOUS SOLUTION 100

MG/5ML 2 LA

ERWINAZE INJECTION SOLUTION

RECONSTITUTED 10000 UNIT 2 PA

FARYDAK ORAL CAPSULE 10 MG, 15 MG,

20 MG 2 PA

IMBRUVICA ORAL CAPSULE 140 MG 2 PA


MG, 25 MG, 5 MG 2

KYPROLIS INTRAVENOUS SOLUTION

RECONSTITUTED 30 MG, 60 MG 2 BD

LEUKERAN ORAL TABLET 2 MG 2








9

?


mitoxantrone hcl intravenous concentrate 25

mg/12.5ml 1

MOZOBIL SUBCUTANEOUS SOLUTION 24

MG/1.2ML 2

NINLARO ORAL CAPSULE 2.3 MG, 3 MG, 4

MG 2

POMALYST ORAL CAPSULE 1 MG, 2 MG, 3

MG, 4 MG 2 LA

SYNRIBO SUBCUTANEOUS SOLUTION

RECONSTITUTED 3.5 MG 2

TABLOID ORAL TABLET 40 MG 2

THALOMID ORAL CAPSULE 100 MG, 150

MG, 200 MG, 50 MG 2 MO

TRISENOX INTRAVENOUS SOLUTION 10

MG/10ML 2 BD

VENCLEXTA ORAL TABLET 10 MG, 100

MG, 50 MG 2 PA; LA

VENCLEXTA STARTING PACK ORAL

TABLET THERAPY PACK 10 & 50 & 100 MG 2 PA; LA

XATMEP ORAL SOLUTION 2.5 MG/ML 2 BD



zoledronic acid intravenous concentrate 4 mg/5ml 1 BD

ZOMETA INTRAVENOUS SOLUTION 4

MG/100ML 2 BD

ZYDELIG ORAL TABLET 100 MG, 150 MG 2

MYELOFIBROSIS


MG, 25 MG, 5 MG 2

MYELOPROLIFERATIVE

NEOPLASM









10

?


PROBLEM WITH PLATELET

BLOOD CELLS



125 MG/125ML 2 BD







2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD


GM/200ML 2 BD


50 MG, 75 MG 2 MO

CHRONIC LUNG OR BREATHING

PASSAGE PROBLEM

BRONCHOSPASM

ADVAIR DISKUS INHALATION AEROSOL

POWDER BREATH ACTIVATED 100-50

MCG/DOSE, 250-50 MCG/DOSE, 500-50

MCG/DOSE

2 MO

ADVAIR HFA INHALATION AEROSOL 115-

21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO

albuterol sulfate er oral tablet extended release

12 hour 4 mg, 8 mg 1 MO








11

?


albuterol sulfate inhalation nebulization solution

(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO

albuterol sulfate oral syrup 2 mg/5ml 1 MO

albuterol sulfate oral tablet 2 mg, 4 mg 1 MO

aminophylline intravenous solution 25 mg/ml 1

ATROVENT HFA INHALATION AEROSOL

SOLUTION 17 MCG/ACT 2 MO

BREO ELLIPTA INHALATION AEROSOL


MCG/INH, 200-25 MCG/INH

2 MO

COMBIVENT RESPIMAT INHALATION

AEROSOL SOLUTION 20-100 MCG/ACT 2 MO

CROMOLYN SODIUM INHALATION

NEBULIZATION SOLUTION 20 MG/2ML 2 BD; MO

FLOVENT DISKUS INHALATION AEROSOL

POWDER BREATH ACTIVATED 100

MCG/BLIST, 250 MCG/BLIST, 50 MCG/BLIST

2 MO

FLOVENT HFA INHALATION AEROSOL 110

MCG/ACT, 220 MCG/ACT, 44 MCG/ACT 2 MO

FLUTICASONE-SALMETEROL

INHALATION AEROSOL POWDER BREATH

ACTIVATED 113-14 MCG/ACT, 232-14

MCG/ACT, 55-14 MCG/ACT

2 MO

ipratropium bromide inhalation solution 0.02 % 1 BD; MO

ipratropium-albuterol inhalation solution 0.5-2.5

(3) mg/3ml 1 BD; MO

LEVALBUTEROL HCL INHALATION

NEBULIZATION SOLUTION 1.25 MG/0.5ML 2 BD; MO

montelukast sodium oral packet 4 mg 1 MO

montelukast sodium oral tablet 10 mg 1 MO

montelukast sodium oral tablet chewable 4 mg, 5

mg 1 MO

NUCALA SUBCUTANEOUS SOLUTION

RECONSTITUTED 100 MG 2 PA; MO








12

?


PULMICORT FLEXHALER INHALATION

AEROSOL POWDER BREATH ACTIVATED

180 MCG/ACT, 90 MCG/ACT

2 MO

PULMICORT INHALATION SUSPENSION

0.25 MG/2ML, 0.5 MG/2ML, 1 MG/2ML 2 BD; MO

SEREVENT DISKUS INHALATION


50 MCG/DOSE

2 MO

SPIRIVA HANDIHALER INHALATION

CAPSULE 18 MCG 2 MO

SPIRIVA RESPIMAT INHALATION

AEROSOL SOLUTION 1.25 MCG/ACT, 2.5

MCG/ACT

2 MO

STIOLTO RESPIMAT INHALATION

AEROSOL SOLUTION 2.5-2.5 MCG/ACT 2 MO

theophylline er oral tablet extended release 12

hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO

VENTOLIN HFA INHALATION AEROSOL

SOLUTION 108 (90 BASE) MCG/ACT 2 MO

XOLAIR SUBCUTANEOUS SOLUTION

RECONSTITUTED 150 MG 2 LA

zafirlukast oral tablet 10 mg, 20 mg 1 MO

ZILEUTON ER ORAL TABLET EXTENDED

RELEASE 12 HOUR 600 MG 2 MO

ZYFLO CR ORAL TABLET EXTENDED


ZYFLO ORAL TABLET 600 MG 2 MO

CHRONIC BRONCHITIS



MCG/DOSE

2 MO

DALIRESP ORAL TABLET 500 MCG 2 MO








13

?




50 MCG/DOSE

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO

CHRONIC INFLAMMATION OF

THE NOSE NOT DUE TO

ALLERGIES

fluticasone propionate nasal suspension 50

mcg/act 1

ipratropium bromide nasal solution 0.03 %, 0.06

% 1 MO

CHRONIC LUNG DISEASE

ADCIRCA ORAL TABLET 20 MG 2 PA; MO


MG, 2 MG, 2.5 MG 2 MO




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO






2 MO

CAYSTON INHALATION SOLUTION

RECONSTITUTED 75 MG 2








14

?







ESBRIET ORAL CAPSULE 267 MG 2 PA; MO

ESBRIET ORAL TABLET 267 MG, 801 MG 2 PA; MO




2 MO







2 MO



(3) mg/3ml 1 BD; MO

KALYDECO ORAL PACKET 50 MG, 75 MG 2 PA; MO

KALYDECO ORAL TABLET 150 MG 2 PA; MO

LETAIRIS ORAL TABLET 10 MG, 5 MG 2 MO




mg 1 MO

NEBUPENT INHALATION SOLUTION

RECONSTITUTED 300 MG 2 BD



OFEV ORAL CAPSULE 100 MG 2 MO

OPSUMIT ORAL TABLET 10 MG 2 MO

ORKAMBI ORAL TABLET 100-125 MG, 200-

125 MG 2 PA; MO








15

?


PENTAM INJECTION SOLUTION


PROLASTIN-C INTRAVENOUS SOLUTION





2 MO



PULMOZYME INHALATION SOLUTION 1

MG/ML 2 BD; MO



50 MCG/DOSE

2 MO

sildenafil citrate intravenous solution 10

mg/12.5ml 1 PA

sildenafil citrate oral tablet 20 mg 1 PA; MO


CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO

tobramycin inhalation nebulization solution 300

mg/5ml 1 BD

TRACLEER ORAL TABLET 125 MG, 62.5 MG 2 LA; MO

VENTAVIS INHALATION SOLUTION 10

MCG/ML, 20 MCG/ML 2 BD; MO










16

?








CHRONIC OBSTRUCTIVE LUNG

DISEASE





MCG/INH

2 MO





(3) mg/3ml 1 BD; MO





50 MCG/DOSE

2 MO


CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO








17

?


SEASONAL RUNNY NOSE

azelastine hcl nasal solution 0.1 %, 0.15 % 1

COLD SYMPTOMS

COLD SYMPTOMS

all day allergy-d tablet extended release 12 hour

5-120 mg oral 5-120 mg 3

APRODINE TABLET 2.5-60 MG ORAL 2.5-60

MG 3

brotapp dm oral liquid 15-1-5 mg/5ml 3

childrens cold & allergy elixir 1-2.5 mg/5ml oral

1-2.5 mg/5ml 3

cold/cough childrens elixir 2.5-1-5 mg/5ml oral

2.5-1-5 mg/5ml 3

CONGESTAC TABLET 60-400 MG ORAL 60-

400 MG 3

cough & cold tablet 4-30 mg oral 4-30 mg 3

ENDACOF-DM LIQUID 2.5-1-5 MG/5ML

ORAL 2.5-1-5 MG/5ML 3

kidkare cough/cold liquid 15-1-5 mg/5ml oral 15-

1-5 mg/5ml 3

loratadine-d 24hr tablet extended release 24 hour

10-240 mg oral 10-240 mg 3

mucus relief cough childrens liquid 5-100 mg/5ml

oral 5-100 mg/5ml 3

mucus relief pe tablet 10-400 mg oral 10-400 mg 3

phenylhistine dh oral liquid 30-2-10 mg/5ml 3

SUDOGEST SINUS/ALLERGY TABLET 4-60

MG ORAL 4-60 MG 3

WAL-PHED PE SINUS/ALLERGY TABLET 4-

10 MG ORAL 4-10 MG 3

COUGH

benzonatate capsule 100 mg oral 100 mg 3









18

?




oral 5-100 mg/5ml 3

mucus relief er tablet extended release 12 hour

600 mg oral 600 mg 3

mucus relief tablet 400 mg oral 400 mg 3


ROBITUSSIN MUCUS+CHEST CONGEST

LIQUID 100 MG/5ML ORAL 100 MG/5ML 3

tussin mucus+chest congestion syrup 100 mg/5ml

oral 100 mg/5ml 3

INFLAMMATION OF THE NOSE


5-120 mg oral 5-120 mg 3

aller-ease tablet 60 mg oral 60 mg 3

allergy tablet 4 mg oral 4 mg 3


MG 3


cetirizine hcl oral syrup 1 mg/ml 1


1-2.5 mg/5ml 3


cyproheptadine hcl oral tablet 4 mg 1 PA; HR

desloratadine oral tablet 5 mg 1

desloratadine oral tablet dispersible 2.5 mg, 5 mg 1

ed chlorped jr syrup 2 mg/5ml oral 2 mg/5ml 3

flunisolide nasal solution 25 mcg/act (0.025%) 1


mcg/act 1


% 1 MO








19

?


KLS ALLER-TEC TABLET 10 MG ORAL 10

MG 3

kp fexofenadine hcl tablet 180 mg oral 180 mg 3

loratadine tablet 10 mg oral 10 mg 3


10-240 mg oral 10-240 mg 3

mometasone furoate nasal suspension 50 mcg/act 1




mg 1 MO


MG ORAL 4-60 MG 3

WAL-ITIN SYRUP 5 MG/5ML ORAL 5

MG/5ML 3



RUNNY NOSE




% 1 MO


STUFFY NOSE


5-120 mg oral 5-120 mg 3


MG 3


1-2.5 mg/5ml 3

DRISTAN SPRAY SOLUTION 0.05 % NASAL

0.05 % 3

gnp suphedrin liquid 15 mg/5ml oral 15 mg/5ml 3








20

?



10-240 mg oral 10-240 mg 3

nasal decongestant liquid 30 mg/5ml oral 30

mg/5ml 3

nasal decongestant pe max st tablet 10 mg oral 10

mg 3

OCEAN NASAL SPRAY NASAL SOLUTION

0.65 % 3


MG ORAL 4-60 MG 3

SUDOGEST TABLET 30 MG ORAL 30 MG 3



COLLAGEN VASCULAR DISEASE

RHEUMATIC DISEASE CAUSING

PAIN & STIFFNESS IN BACKBONE

COSENTYX SENSOREADY PEN

SUBCUTANEOUS SOLUTION AUTO-

INJECTOR 150 MG/ML

2 ST; MO

COSENTYX SUBCUTANEOUS SOLUTION

PREFILLED SYRINGE 150 MG/ML 2 ST; MO

ENBREL SUBCUTANEOUS SOLUTION

PREFILLED SYRINGE 25 MG/0.5ML, 50

MG/ML

2 MO


RECONSTITUTED 25 MG 2 MO

ENBREL SURECLICK SUBCUTANEOUS

SOLUTION AUTO-INJECTOR 50 MG/ML 2 MO

SIMPONI SUBCUTANEOUS SOLUTION

AUTO-INJECTOR 100 MG/ML, 50 MG/0.5ML 2 ST; MO


PREFILLED SYRINGE 100 MG/ML, 50

MG/0.5ML

2 ST; MO

RHEUMATOID ARTHRITIS








21

?


ACTEMRA INTRAVENOUS SOLUTION 200

MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST

ACTEMRA SUBCUTANEOUS SOLUTION

PREFILLED SYRINGE 162 MG/0.9ML 2 ST; MO

AZASAN ORAL TABLET 100 MG, 75 MG 2 BD; MO

azathioprine oral tablet 50 mg 1 BD; MO

AZATHIOPRINE SODIUM INJECTION


celecoxib oral capsule 100 mg, 200 mg, 400 mg,

50 mg 1 MO

CIMZIA PREFILLED SUBCUTANEOUS KIT 2

X 200 MG/ML 2 ST; MO

CIMZIA SUBCUTANEOUS KIT 2 X 200 MG 2 ST

diclofenac sodium er oral tablet extended release

24 hour 100 mg 1 MO



MG/ML

2 MO





etodolac er oral tablet extended release 24 hour

400 mg, 500 mg, 600 mg 1 MO

flurbiprofen oral tablet 100 mg, 50 mg 1 MO

HUMIRA PEDIATRIC CROHNS START

SUBCUTANEOUS PREFILLED SYRINGE KIT

40 MG/0.8ML

2 MO

HUMIRA PEN SUBCUTANEOUS PEN-

INJECTOR KIT 40 MG/0.8ML 2 MO

HUMIRA PEN-CROHNS STARTER

SUBCUTANEOUS PEN-INJECTOR KIT 40

MG/0.8ML

2 MO








22

?


HUMIRA PEN-PSORIASIS STARTER


MG/0.8ML

2 MO

HUMIRA SUBCUTANEOUS PREFILLED

SYRINGE KIT 10 MG/0.2ML, 20 MG/0.4ML,

40 MG/0.8ML

2 MO

hydroxychloroquine sulfate oral tablet 200 mg 1 MO

ketoprofen er oral capsule extended release 24

hour 200 mg 1 MO

KINERET SUBCUTANEOUS SOLUTION


leflunomide oral tablet 10 mg, 20 mg 1 MO

meloxicam oral tablet 15 mg, 7.5 mg 1 MO

methotrexate oral tablet 2.5 mg 1 BD

nabumetone oral tablet 500 mg, 750 mg 1 MO

ORENCIA CLICKJECT SUBCUTANEOUS

SOLUTION AUTO-INJECTOR 125 MG/ML 2 ST; MO

ORENCIA INTRAVENOUS SOLUTION

RECONSTITUTED 250 MG 2 ST; MO

ORENCIA SUBCUTANEOUS SOLUTION


oxaprozin oral tablet 600 mg 1 MO

piroxicam oral capsule 10 mg, 20 mg 1 MO

RITUXAN INTRAVENOUS SOLUTION 500

MG/50ML 2

SIMPONI ARIA INTRAVENOUS SOLUTION

50 MG/4ML 2 ST; MO





MG/0.5ML

2 ST; MO

sulfasalazine oral tablet delayed release 500 mg 1 MO

tolmetin sodium oral capsule 400 mg 1 MO








23

?


tolmetin sodium oral tablet 600 mg 1 MO

TREXALL ORAL TABLET 10 MG, 15 MG, 5

MG, 7.5 MG 2 BD

XELJANZ ORAL TABLET 5 MG 2 ST; MO

SJOGREN'S SYNDROME; CAUSES

DRY EYES & MOUTH AND

ARTHRITIS

pilocarpine hcl oral tablet 5 mg, 7.5 mg 1 MO

SYSTEMIC LUPUS

ERYTHEMATOSUS

BENLYSTA INTRAVENOUS SOLUTION





TUMOR OF SOFT/CONNECTIVE

TISSUE THAT IS USUALLY

MALIGNANT

LARTRUVO INTRAVENOUS SOLUTION 500

MG/50ML 2 PA

PANRETIN EXTERNAL GEL 0.1 % 2

YONDELIS INTRAVENOUS SOLUTION

RECONSTITUTED 1 MG 2 PA

CONDITION RESULTING FROM A

DEFECTIVE IMMUNE SYSTEM

CHRONIC GRANULOMATOUS

DISEASE


2000000 UNIT/0.5ML 2 LA; MO

CHRONIC INFLAMMATORY

DEMYELINATING

POLYNEUROPATHY








24

?


GAMMAGARD INJECTION SOLUTION 2.5

GM/25ML 2 BD

CRYOPYRIN-ASSOCIATED

PERIODIC SYNDROME

ARCALYST SUBCUTANEOUS SOLUTION

RECONSTITUTED 220 MG 2 BD; MO

ILARIS SUBCUTANEOUS SOLUTION




DECREASED WHITE BLOOD

CELLS





MCG/0.8ML

2



DISEASE IN WHICH BODY HAS

IMMUNE RESPONSE AGAINST

ITSELF


MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST






125 MG/125ML 2 BD












25

?









50 mg 1 MO






INJECTOR 150 MG/ML

2 ST; MO




24 hour 100 mg 1 MO



MG/ML

2 MO






400 mg, 500 mg, 600 mg 1 MO





2 BD


GM/10ML 2 BD








26

?



10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD

GUANIDINE HCL ORAL TABLET 125 MG 2



40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO

hydrocortisone oral tablet 10 mg, 5 mg 1





hour 200 mg 1 MO




MG/50ML 2 PA



MESTINON ORAL SYRUP 60 MG/5ML 2









27

?


methylprednisolone acetate injection suspension

40 mg/ml, 80 mg/ml 1

methylprednisolone oral tablet 16 mg, 32 mg, 4

mg, 8 mg 1

methylprednisolone oral tablet therapy pack 4 mg 1

methylprednisolone sodium succ injection

solution reconstituted 1000 mg, 125 mg, 40 mg 1












prednisolone sodium phosphate oral solution 15

mg/5ml, 25 mg/5ml, 6.7 (5 base) mg/5ml 1

prednisolone sodium phosphate oral tablet

dispersible 10 mg, 15 mg, 30 mg 1


GM/200ML 2 BD


50 MG, 75 MG 2 MO

pyridostigmine bromide oral tablet 60 mg 1


MG/50ML 2


50 MG/4ML 2 ST; MO










28

?




MG/0.5ML

2 ST; MO





MG, 7.5 MG 2 BD




HEREDITARY PERIODIC FEVER







HIV

abacavir sulfate oral tablet 300 mg 1 MO

ABACAVIR SULFATE-LAMIVUDINE ORAL

TABLET 600-300 MG 2 MO

abacavir-lamivudine-zidovudine oral tablet 300-

150-300 mg 1 MO

APTIVUS ORAL CAPSULE 250 MG 2 MO

APTIVUS ORAL SOLUTION 100 MG/ML 2 MO

ATRIPLA ORAL TABLET 600-200-300 MG 2 MO

COMPLERA ORAL TABLET 200-25-300 MG 2 MO

CRIXIVAN ORAL CAPSULE 200 MG, 400 MG 2 MO

DARAPRIM ORAL TABLET 25 MG 2

DESCOVY ORAL TABLET 200-25 MG 2 MO

didanosine oral capsule delayed release 125 mg,

200 mg, 250 mg, 400 mg 1 MO








29

?


dronabinol oral capsule 10 mg, 2.5 mg, 5 mg 1 BD; QL (60 EA per 30 days)

EDURANT ORAL TABLET 25 MG 2 MO

EMTRIVA ORAL CAPSULE 200 MG 2 MO

EMTRIVA ORAL SOLUTION 10 MG/ML 2 MO

EVOTAZ ORAL TABLET 300-150 MG 2 MO

FUZEON SUBCUTANEOUS SOLUTION


ganciclovir sodium intravenous solution


GENVOYA ORAL TABLET 150-150-200-10

MG 2 MO

INTELENCE ORAL TABLET 100 MG, 200

MG, 25 MG 2 MO

INVIRASE ORAL CAPSULE 200 MG 2 MO

INVIRASE ORAL TABLET 500 MG 2 MO

ISENTRESS ORAL PACKET 100 MG 2 MO

ISENTRESS ORAL TABLET 400 MG 2 MO

ISENTRESS ORAL TABLET CHEWABLE 100

MG, 25 MG 2 MO

KALETRA ORAL TABLET 100-25 MG, 200-50

MG 2 MO

lamivudine oral solution 10 mg/ml 1 MO

lamivudine oral tablet 150 mg, 300 mg 1 MO

lamivudine-zidovudine oral tablet 150-300 mg 1 MO

LEXIVA ORAL SUSPENSION 50 MG/ML 2 MO

LEXIVA ORAL TABLET 700 MG 2 MO

LOPINAVIR-RITONAVIR ORAL SOLUTION

400-100 MG/5ML 2 MO

MEGACE ES ORAL SUSPENSION 625

MG/5ML 2 PA; HR; MO

megestrol acetate oral suspension 40 mg/ml 1 PA; HR

megestrol acetate oral suspension 625 mg/5ml 1 PA; HR; MO








30

?


MYTESI ORAL TABLET DELAYED

RELEASE 125 MG 2 MO

nevirapine er oral tablet extended release 24 hour

100 mg, 400 mg 1 MO

NEVIRAPINE ORAL SUSPENSION 50

MG/5ML 2 MO

nevirapine oral tablet 200 mg 1 MO

NORDITROPIN FLEXPRO SUBCUTANEOUS

SOLUTION 10 MG/1.5ML, 15 MG/1.5ML, 30

MG/3ML, 5 MG/1.5ML

2 PA; MO

NORVIR ORAL CAPSULE 100 MG 2 MO

NORVIR ORAL SOLUTION 80 MG/ML 2 MO

NORVIR ORAL TABLET 100 MG 2 MO

NUTROPIN AQ NUSPIN 10 SUBCUTANEOUS

SOLUTION 10 MG/2ML 2 PA; MO



ODEFSEY ORAL TABLET 200-25-25 MG 2 MO

PREZCOBIX ORAL TABLET 800-150 MG 2 MO

PREZISTA ORAL SUSPENSION 100 MG/ML 2 MO

PREZISTA ORAL TABLET 150 MG, 600 MG,

75 MG, 800 MG 2 MO

RESCRIPTOR ORAL TABLET 100 MG, 200

MG 2 MO

RETROVIR INTRAVENOUS SOLUTION 10

MG/ML 2

REYATAZ ORAL CAPSULE 150 MG, 200 MG,

300 MG 2 MO

REYATAZ ORAL PACKET 50 MG 2 MO

SELZENTRY ORAL TABLET 150 MG, 25 MG,

300 MG, 75 MG 2 MO

stavudine oral capsule 15 mg, 20 mg, 30 mg, 40

mg 1 MO








31

?


STRIBILD ORAL TABLET 150-150-200-300

MG 2 MO

SUSTIVA ORAL CAPSULE 200 MG, 50 MG 2 MO

SUSTIVA ORAL TABLET 600 MG 2 MO

TIVICAY ORAL TABLET 10 MG, 25 MG, 50

MG 2 MO

TRIUMEQ ORAL TABLET 600-50-300 MG 2 MO

TRUVADA ORAL TABLET 100-150 MG, 133-

200 MG, 167-250 MG, 200-300 MG 2 MO

TYBOST ORAL TABLET 150 MG 2 MO

VIDEX ORAL SOLUTION RECONSTITUTED

2 GM 2 MO

VIRACEPT ORAL TABLET 250 MG, 625 MG 2 MO

VIREAD ORAL POWDER 40 MG/GM 2 MO

VIREAD ORAL TABLET 150 MG, 200 MG,

250 MG, 300 MG 2 MO

ZERIT ORAL SOLUTION RECONSTITUTED

1 MG/ML 2 MO

ZIAGEN ORAL SOLUTION 20 MG/ML 2 MO

zidovudine oral capsule 100 mg 1 MO

zidovudine oral syrup 50 mg/5ml 1 MO

zidovudine oral tablet 300 mg 1 MO

INHERITED DISORDER OF

CONTINUING EPISODES OF

SWELLING

FIRAZYR SUBCUTANEOUS SOLUTION 30

MG/3ML 2

LACK OF THE ENZYME

ADENOSINE DEAMINASE

ADAGEN INTRAMUSCULAR SOLUTION 250

UNIT/ML 2 LA

PATIENT WITH WEAKENED

IMMUNE FUNCTION








32

?


ASTAGRAF XL ORAL CAPSULE EXTENDED

RELEASE 24 HOUR 0.5 MG, 1 MG, 5 MG 2 BD; MO


MG/ML 2 BD





BUSULFAN INTRAVENOUS SOLUTION 6

MG/ML 2 BD

BUSULFEX INTRAVENOUS SOLUTION 6

MG/ML 2 BD

cyclosporine intravenous solution 50 mg/ml 1 BD

cyclosporine modified oral capsule 100 mg, 25

mg, 50 mg 1 BD; MO

cyclosporine modified oral solution 100 mg/ml 1 BD; MO

cyclosporine oral capsule 100 mg, 25 mg 1 BD; MO

ENVARSUS XR ORAL TABLET EXTENDED




gengraf oral capsule 100 mg, 25 mg 1 BD; MO

gengraf oral capsule 50 mg 1 MO

gengraf oral solution 100 mg/ml 1 BD; MO

mycophenolate mofetil hcl intravenous solution


mycophenolate mofetil oral capsule 250 mg 1 BD; MO

mycophenolate mofetil oral suspension

reconstituted 200 mg/ml 1 BD; MO

mycophenolate mofetil oral tablet 500 mg 1 BD; MO

mycophenolate sodium oral tablet delayed release

180 mg, 360 mg 1 BD; MO

NOXAFIL ORAL SUSPENSION 40 MG/ML 2 MO








33

?


NOXAFIL ORAL TABLET DELAYED

RELEASE 100 MG 2 MO

NULOJIX INTRAVENOUS SOLUTION


PROGRAF INTRAVENOUS SOLUTION 5

MG/ML 2 BD

RAPAMUNE ORAL SOLUTION 1 MG/ML 2 BD; MO

SANDIMMUNE ORAL CAPSULE 100 MG, 25

MG 2 BD; MO

SANDIMMUNE ORAL SOLUTION 100

MG/ML 2 BD; MO

SIMULECT INTRAVENOUS SOLUTION


sirolimus oral tablet 0.5 mg, 1 mg, 2 mg 1 BD; MO

tacrolimus oral capsule 0.5 mg, 1 mg, 5 mg 1 BD; MO

THYMOGLOBULIN INTRAVENOUS


ZORTRESS ORAL TABLET 0.25 MG, 0.5 MG,

0.75 MG 2 BD; MO

PERIPHERAL BLOOD STEM CELL

THERAPY


MG/1.2ML 2

PNEUMOCYSTIS JIROVECI

PNEUMONIA PREVENTION



PRIMARY IMMUNE DEFICIENCY

DISORDER

BIVIGAM INTRAVENOUS SOLUTION 10

GM/100ML 2 BD










34

?


FLEBOGAMMA DIF INTRAVENOUS

SOLUTION 5 GM/50ML 2 BD


GM/25ML 2 BD




2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD


GM/200ML 2 BD

DISEASE AFFECTING THE BODY'S

METABOLISM

A DISORDER OF THE BODY'S USE

OF CALCIUM

allopurinol oral tablet 100 mg, 300 mg 1 MO

calcitriol intravenous solution 1 mcg/ml 1

calcitriol oral capsule 0.25 mcg, 0.5 mcg 1 MO

calcitriol oral solution 1 mcg/ml 1 MO

calcium 600 tablet 600 mg oral 600 mg 3

calcium acetate (phos binder) oral capsule 667

mg 1 MO

calcium acetate (phos binder) oral tablet 667 mg 1 MO

calcium carbonate suspension 1250 (500 ca)

mg/5ml oral 1250 (500 ca) mg/5ml 3

calcium carbonate tablet 1250 (500 ca) mg oral

1250 (500 ca) mg 3

calcium-vitamin d tablet 600-200 mg-unit oral

600-200 mg-unit 3








35

?


kp calcium 600+d tablet 600-400 mg-unit oral

600-400 mg-unit 3

NATPARA SUBCUTANEOUS CARTRIDGE

25 MCG 2 MO

OS-CAL EXTRA D3 ORAL TABLET 500-600

MG-UNIT 3

OYSCO 500+D TABLET 500-200 MG-UNIT

ORAL 500-200 MG-UNIT 3

pamidronate disodium intravenous solution 30

mg/10ml, 6 mg/ml, 90 mg/10ml 1

RENVELA ORAL PACKET 0.8 GM, 2.4 GM 2 MO

RENVELA ORAL TABLET 800 MG 2 MO

sm oyster shell calcium/vit d3 tablet 500-400 mg-

unit oral 500-400 mg-unit 3

XGEVA SUBCUTANEOUS SOLUTION 120

MG/1.7ML 2



MG/100ML 2 BD

ABNORMAL METABOLISM OF

FATS AND CHOLESTEROL

amlodipine-atorvastatin oral tablet 10-10 mg, 10-

20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO

atorvastatin calcium oral tablet 10 mg, 20 mg, 40

mg, 80 mg 1 MO

CEREZYME INTRAVENOUS SOLUTION

RECONSTITUTED 400 UNIT 2 BD; LA

cholestyramine light oral packet 4 gm 1 MO

cholestyramine light oral powder 4 gm/dose 1 MO

colestipol hcl oral granules 5 gm 1 MO

colestipol hcl oral tablet 1 gm 1 MO

EZETIMIBE ORAL TABLET 10 MG 2 MO








36

?


FABRAZYME INTRAVENOUS SOLUTION

RECONSTITUTED 35 MG 2 BD; LA

fenofibrate micronized oral capsule 134 mg, 200

mg, 67 mg 1 MO

fenofibrate oral capsule 150 mg, 50 mg 1 MO

fenofibrate oral tablet 145 mg, 160 mg, 48 mg, 54

mg 1 MO

FENOFIBRATE ORAL TABLET 40 MG 2 MO

FENOFIBRIC ACID ORAL TABLET 105 MG,

35 MG 2 MO

fluvastatin sodium er oral tablet extended release

24 hour 80 mg 1 MO

fluvastatin sodium oral capsule 20 mg, 40 mg 1 MO

gemfibrozil oral tablet 600 mg 1 MO

JUXTAPID ORAL CAPSULE 10 MG, 20 MG, 5

MG 2 PA; MO

KANUMA INTRAVENOUS SOLUTION 20

MG/10ML 2 PA

KYNAMRO SUBCUTANEOUS SOLUTION

PREFILLED SYRINGE 200 MG/ML 2 PA; MO

LIVALO ORAL TABLET 1 MG, 2 MG, 4 MG 2 MO

lovastatin oral tablet 10 mg, 20 mg, 40 mg 1 MO

niacin er (antihyperlipidemic) oral tablet

extended release 1000 mg, 500 mg, 750 mg 1 MO

niacin er tablet extended release 500 mg oral 500

mg 3

NIACOR ORAL TABLET 500 MG 2

omega-3-acid ethyl esters oral capsule 1 gm 1 MO

PRALUENT SUBCUTANEOUS SOLUTION

PEN-INJECTOR 150 MG/ML, 75 MG/ML 2 PA; MO

pravastatin sodium oral tablet 10 mg, 20 mg, 40

mg, 80 mg 1 MO








37

?


REPATHA PUSHTRONEX SYSTEM

SUBCUTANEOUS SOLUTION CARTRIDGE

420 MG/3.5ML

2 PA; MO

REPATHA SUBCUTANEOUS SOLUTION


REPATHA SURECLICK SUBCUTANEOUS

SOLUTION AUTO-INJECTOR 140 MG/ML 2 PA; MO

rosuvastatin calcium oral tablet 10 mg, 20 mg, 40

mg, 5 mg 1 MO

simvastatin oral tablet 10 mg, 20 mg, 40 mg, 5

mg, 80 mg 1 MO

VPRIV INTRAVENOUS SOLUTION

RECONSTITUTED 400 UNIT 2

ZAVESCA ORAL CAPSULE 100 MG 2 MO

ACCUMULATION OF A AMYLOID

PROTEIN IN ORGANS AND TISSUES





CHANGE IN APPETITE



MG/5ML 2 PA; HR; MO



CYSTIC FIBROSIS






125 MG 2 PA; MO








38

?



MG/ML 2 BD; MO


mg/5ml 1 BD

DIABETES INSIPIDUS

desmopressin ace rhinal tube nasal solution 0.01

% 1 MO

desmopressin ace spray refrig nasal solution 0.01

% 1 MO

desmopressin acetate injection solution 4 mcg/ml 1

desmopressin acetate oral tablet 0.1 mg, 0.2 mg 1 MO

EXCESSIVE COPPER DEPOSITS IN

THE LIVER AND BRAIN

DEPEN TITRATABS ORAL TABLET 250 MG 2

SYPRINE ORAL CAPSULE 250 MG 2

GOUT

COLCHICINE ORAL CAPSULE 0.6 MG 2

COLCHICINE ORAL TABLET 0.6 MG 2

indomethacin er oral capsule extended release 75

mg 1 PA; HR; MO

indomethacin oral capsule 25 mg, 50 mg 1 PA; HR; MO

probenecid oral tablet 500 mg 1 MO

ULORIC ORAL TABLET 40 MG, 80 MG 2 ST; MO

HIGH AMOUNT OF

PHENYLALANINE IN THE BLOOD

KUVAN ORAL PACKET 100 MG, 500 MG 2 MO

KUVAN ORAL TABLET SOLUBLE 100 MG 2 LA; MO

HIGH AMOUNT OF PHOSPHATE IN

THE BLOOD


mg 1 MO









39

?




HIGH AMOUNT OF URIC ACID IN

THE BLOOD




ELITEK INTRAVENOUS SOLUTION

RECONSTITUTED 1.5 MG, 7.5 MG 2 BD


mg 1 PA; HR; MO




HIGH BLOOD SUGAR

acarbose oral tablet 100 mg, 25 mg, 50 mg 1 MO

AVANDIA ORAL TABLET 2 MG, 4 MG 2 MO

BYDUREON SUBCUTANEOUS PEN-

INJECTOR 2 MG 2 MO

BYDUREON SUBCUTANEOUS SUSPENSION

RECONSTITUTED ER 2 MG 2 MO

BYETTA 10 MCG PEN SUBCUTANEOUS

SOLUTION PEN-INJECTOR 10 MCG/0.04ML 2 MO



captopril oral tablet 100 mg, 12.5 mg, 25 mg, 50

mg 1 MO

chlorpropamide oral tablet 100 mg, 250 mg 1 PA; HR; MO

CYCLOSET ORAL TABLET 0.8 MG 2 MO

glimepiride oral tablet 1 mg, 2 mg, 4 mg 1 MO

glipizide er oral tablet extended release 24 hour

10 mg, 2.5 mg, 5 mg 1 MO








40

?


glipizide oral tablet 10 mg, 5 mg 1 MO

glipizide-metformin hcl oral tablet 2.5-250 mg,

2.5-500 mg, 5-500 mg 1 MO

glyburide micronized oral tablet 1.5 mg, 3 mg, 6

mg 1 PA; HR; MO

glyburide oral tablet 1.25 mg, 2.5 mg, 5 mg 1 PA; HR; MO

glyburide-metformin oral tablet 1.25-250 mg, 2.5-

500 mg, 5-500 mg 1 PA; HR; MO

INVOKAMET ORAL TABLET 150-1000 MG,

150-500 MG, 50-1000 MG, 50-500 MG 2 MO

INVOKAMET XR ORAL TABLET

EXTENDED RELEASE 24 HOUR 150-1000

MG, 150-500 MG, 50-1000 MG, 50-500 MG

2 MO

INVOKANA ORAL TABLET 100 MG, 300 MG 2 MO

JANUMET ORAL TABLET 50-1000 MG, 50-

500 MG 2 MO

JANUMET XR ORAL TABLET EXTENDED

RELEASE 24 HOUR 100-1000 MG, 50-1000

MG, 50-500 MG

2 MO

JANUVIA ORAL TABLET 100 MG, 25 MG, 50

MG 2 MO

JARDIANCE ORAL TABLET 10 MG, 25 MG 2 MO

JENTADUETO ORAL TABLET 2.5-1000 MG,

2.5-500 MG, 2.5-850 MG 2 MO

JENTADUETO XR ORAL TABLET

EXTENDED RELEASE 24 HOUR 2.5-1000

MG, 5-1000 MG

2 MO

KORLYM ORAL TABLET 300 MG 2 PA; LA; MO

LYRICA ORAL CAPSULE 100 MG, 150 MG,

200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO

LYRICA ORAL SOLUTION 20 MG/ML 2 MO

metformin hcl er (osm) oral tablet extended

release 24 hour 1000 mg, 500 mg 1 MO








41

?


metformin hcl er oral tablet extended release 24

hour 500 mg, 750 mg 1 MO

metformin hcl oral tablet 1000 mg, 500 mg, 850

mg 1 MO

metoclopramide hcl oral solution 5 mg/5ml 1

metoclopramide hcl oral tablet 10 mg 1 MO

metoclopramide hcl oral tablet 5 mg 1

miglitol oral tablet 100 mg, 25 mg, 50 mg 1 MO

nateglinide oral tablet 120 mg, 60 mg 1 MO

pioglitazone hcl oral tablet 15 mg, 30 mg, 45 mg 1 MO

pioglitazone hcl-glimepiride oral tablet 30-2 mg,

30-4 mg 1 MO

pioglitazone hcl-metformin hcl oral tablet 15-500

mg, 15-850 mg 1 MO

REGRANEX EXTERNAL GEL 0.01 % 2 PA

repaglinide oral tablet 0.5 mg, 1 mg, 2 mg 1 MO

repaglinide-metformin hcl oral tablet 1-500 mg,

2-500 mg 1 MO

RIOMET ORAL SOLUTION 500 MG/5ML 2 MO

SYMLINPEN 120 SUBCUTANEOUS




SYNJARDY ORAL TABLET 12.5-1000 MG,

12.5-500 MG, 5-1000 MG, 5-500 MG 2 MO

tolazamide oral tablet 250 mg, 500 mg 1 MO

tolbutamide oral tablet 500 mg 1 MO

TRADJENTA ORAL TABLET 5 MG 2 MO

VICTOZA SUBCUTANEOUS SOLUTION

PEN-INJECTOR 18 MG/3ML 2 MO

HUNTER SYNDROME

ELAPRASE INTRAVENOUS SOLUTION 6

MG/3ML 2 BD








42

?


IMBALANCE IN BODY SALTS LIKE

POTASSIUM AND SODIUM


calcitriol intravenous solution 1 mcg/ml 1

calcitriol oral capsule 0.25 mcg, 0.5 mcg 1 MO

calcitriol oral solution 1 mcg/ml 1 MO



mg 1 MO


calcium carbonate suspension 1250 (500 ca)

mg/5ml oral 1250 (500 ca) mg/5ml 3


1250 (500 ca) mg 3


600-200 mg-unit 3

kcl in dextrose-nacl intravenous solution 10-5-

0.45 meq/l-%-%, 20-5-0.2 meq/l-%-%, 20-5-

0.225 meq/l-%-%, 20-5-0.33 meq/l-%-%, 20-5-

0.45 meq/l-%-%, 30-5-0.45 meq/l-%-%, 40-5-

0.45 meq/l-%-%

1

kcl-lactated ringers-d5w intravenous solution 20

meq/l 1

kionex oral powder 1

klor-con 10 oral tablet extended release 10 meq 1 MO

klor-con m10 oral tablet extended release 10 meq 1 MO

klor-con m20 oral tablet extended release 20 meq 1 MO


600-400 mg-unit 3

magnesium sulfate injection solution 50 % 1


25 MCG 2 MO


MG-UNIT 3








43

?






potassium chloride crys er oral tablet extended

release 10 meq, 20 meq 1 MO

potassium chloride er oral capsule extended

release 10 meq, 8 meq 1 MO

potassium chloride er oral tablet extended release

10 meq, 20 meq, 8 meq 1 MO

potassium chloride in dextrose intravenous

solution 20-5 meq/l-%, 40-5 meq/l-% 1

potassium chloride in nacl intravenous solution

20-0.45 meq/l-%, 20-0.9 meq/l-% 1

POTASSIUM CHLORIDE INTRAVENOUS

SOLUTION 10 MEQ/100ML, 40 MEQ/100ML 2

potassium chloride intravenous solution 2

meq/ml, 20 meq/100ml 1

potassium chloride oral solution 20 meq/15ml

(10%), 40 meq/15ml (20%) 1 MO



SAMSCA ORAL TABLET 15 MG, 30 MG 2 PA



sodium chloride injection solution 2.5 meq/ml 1

sodium polystyrene sulfonate oral suspension 15

gm/60ml 1

sps oral suspension 15 gm/60ml 1


MG/1.7ML 2



MG/100ML 2 BD








44

?


IMBALANCE OF BODY FLUIDS

acetazolamide oral tablet 125 mg, 250 mg 1 MO


amiloride hcl oral tablet 5 mg 1 MO

bumetanide injection solution 0.25 mg/ml 1


chlorothiazide oral tablet 250 mg, 500 mg 1 MO

chlorthalidone oral tablet 25 mg, 50 mg 1 MO

CINRYZE INTRAVENOUS SOLUTION

RECONSTITUTED 500 UNIT 2

danazol oral capsule 100 mg, 200 mg, 50 mg 1


MG/3ML 2

furosemide injection solution 10 mg/ml 1

furosemide oral tablet 20 mg, 40 mg, 80 mg 1 MO

indapamide oral tablet 1.25 mg, 2.5 mg 1 MO


MG 3



methyclothiazide oral tablet 5 mg 1 MO

metolazone oral tablet 10 mg, 2.5 mg, 5 mg 1 MO

MURO 128 OPHTHALMIC OINTMENT 5 % 3

MURO 128 SOLUTION 5 % OPHTHALMIC 5

% 3

spironolactone oral tablet 100 mg, 25 mg, 50 mg 1 MO

spironolactone-hctz oral tablet 25-25 mg 1 MO

torsemide oral tablet 100 mg, 20 mg 1 MO

triamterene-hctz oral capsule 50-25 mg 1 MO

triamterene-hctz oral tablet 37.5-25 mg, 75-50 mg 1 MO


MG/5ML 3








45

?




IMPAIRED BRAIN FUNCTION DUE

TO LIVER DISEASE

enulose oral solution 10 gm/15ml 1 MO

generlac oral solution 10 gm/15ml 1 MO

lactulose oral solution 10 gm/15ml 1 MO

XIFAXAN ORAL TABLET 550 MG 2 MO

INBORN ERROR OF AMINO ACID

METABOLISM

CARBAGLU ORAL TABLET 200 MG 2 MO

CYSTADANE ORAL POWDER 2 MO

CYSTAGON ORAL CAPSULE 150 MG, 50 MG 2 MO

CYSTARAN OPHTHALMIC SOLUTION 0.44

% 2 PA; MO; QL (60 ML per 30 days)

KUVAN ORAL PACKET 100 MG, 500 MG 2 MO

KUVAN ORAL TABLET SOLUBLE 100 MG 2 LA; MO

ORFADIN ORAL CAPSULE 10 MG, 2 MG, 5

MG 2 MO

ORFADIN ORAL SUSPENSION 4 MG/ML 2 LA; MO

RAVICTI ORAL LIQUID 1.1 GM/ML 2 MO

LACK IN MINERALS


(38 fe) mg 3




(65 fe) mg 3


LACK OF THE ENZYME

ADENOSINE DEAMINASE








46

?


ADAGEN INTRAMUSCULAR SOLUTION 250

UNIT/ML 2 LA

LOW BLOOD SUGAR

GLUCAGEN HYPOKIT INJECTION

SOLUTION RECONSTITUTED 1 MG 2

GLUCAGON EMERGENCY INJECTION KIT 1

MG 2

PROGLYCEM ORAL SUSPENSION 50

MG/ML 2 MO

MAROTEAUX-LAMY SYNDROME

NAGLAZYME INTRAVENOUS SOLUTION 1

MG/ML 2 BD

METABOLIC BONE DISEASE

alendronate sodium oral tablet 40 mg 1


mg 1 MO


octreotide acetate injection solution 100 mcg/ml,

1000 mcg/ml, 200 mcg/ml, 50 mcg/ml, 500

mcg/ml

1 MO



risedronate sodium oral tablet 30 mg 1

SANDOSTATIN LAR DEPOT

INTRAMUSCULAR KIT 10 MG, 20 MG, 30

MG

2

SOMATULINE DEPOT SUBCUTANEOUS


MG/0.3ML

2

SOMAVERT SUBCUTANEOUS SOLUTION

RECONSTITUTED 10 MG, 15 MG, 20 MG 2 LA; MO

METABOLIC PROCESS WHICH

BREAKS DOWN SUBSTANCES IN

THE BODY








47

?


oxandrolone oral tablet 10 mg, 2.5 mg 1

MUCOPOLYSACCHARIDOSIS TYPE

I

ALDURAZYME INTRAVENOUS SOLUTION

2.9 MG/5ML 2 BD; LA

POMPE DISEASE

LUMIZYME INTRAVENOUS SOLUTION


PULMONARY EMPHYSEMA

ASSOCIATED WITH ALPHA-1-

PROTEINASE INHIBITOR

DEFICIENCY



WEIGHT LOSS


MG/5ML 2 PA; HR; MO





MG/3ML, 5 MG/1.5ML

2 PA; MO





DISEASE OF THE HEART AND

BLOOD VESSELS

BLOOD VESSEL DISEASE

acebutolol hcl oral capsule 200 mg, 400 mg 1 MO



MG, 2 MG, 2.5 MG 2 MO








48

?


afeditab cr oral tablet extended release 24 hour

30 mg, 60 mg 1 MO

amiloride-hydrochlorothiazide oral tablet 5-50

mg 1 MO

amlodipine besy-benazepril hcl oral capsule 10-

20 mg, 10-40 mg, 2.5-10 mg, 5-10 mg, 5-20 mg,

5-40 mg

1 MO

amlodipine besylate oral tablet 10 mg, 2.5 mg, 5

mg 1 MO

amlodipine besylate-valsartan oral tablet 10-160

mg, 10-320 mg, 5-160 mg, 5-320 mg 1 MO


20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO

amlodipine-olmesartan oral tablet 10-20 mg, 10-

40 mg, 5-20 mg, 5-40 mg 1 MO

amlodipine-valsartan-hctz oral tablet 10-160-12.5

mg, 10-160-25 mg, 10-320-25 mg, 5-160-12.5 mg,

5-160-25 mg

1 MO


125 MG/125ML 2 BD



aspirin suppository 300 mg rectal 300 mg 3 QL (60 EA per 30 days)




25-200 MG

2 MO

ASPIR-LOW TABLET DELAYED RELEASE

81 MG ORAL 81 MG 3 QL (60 EA per 30 days)

atenolol oral tablet 100 mg, 25 mg, 50 mg 1 MO

atenolol-chlorthalidone oral tablet 100-25 mg,

50-25 mg 1 MO








49

?


benazepril hcl oral tablet 10 mg, 20 mg, 40 mg, 5

mg 1 MO

benazepril-hydrochlorothiazide oral tablet 10-

12.5 mg, 20-12.5 mg, 20-25 mg, 5-6.25 mg 1 MO

betaxolol hcl oral tablet 10 mg, 20 mg 1 MO

bisoprolol fumarate oral tablet 10 mg, 5 mg 1 MO

bisoprolol-hydrochlorothiazide oral tablet 10-

6.25 mg, 2.5-6.25 mg, 5-6.25 mg 1 MO


candesartan cilexetil oral tablet 16 mg, 32 mg, 4

mg, 8 mg 1 MO

candesartan cilexetil-hctz oral tablet 16-12.5 mg,

32-12.5 mg, 32-25 mg 1 MO


mg 1 MO

captopril-hydrochlorothiazide oral tablet 25-15

mg, 25-25 mg, 50-15 mg, 50-25 mg 1 MO



cartia xt oral capsule extended release 24 hour

120 mg, 180 mg, 240 mg, 300 mg 1 MO

carvedilol oral tablet 12.5 mg, 25 mg, 3.125 mg,

6.25 mg 1 MO

cilostazol oral tablet 100 mg, 50 mg 1 MO

clonidine hcl oral tablet 0.1 mg, 0.2 mg, 0.3 mg 1 MO

clonidine hcl transdermal patch weekly 0.1

mg/24hr, 0.2 mg/24hr, 0.3 mg/24hr 1 MO

clopidogrel bisulfate oral tablet 300 mg 1

clopidogrel bisulfate oral tablet 75 mg 1 MO

DEMSER ORAL CAPSULE 250 MG 2

dihydroergotamine mesylate injection solution 1

mg/ml 1

diltiazem hcl er beads oral capsule extended

release 24 hour 180 mg, 360 mg, 420 mg 1 MO








50

?


diltiazem hcl er coated beads oral capsule

extended release 24 hour 120 mg, 240 mg, 300

mg

1 MO

diltiazem hcl er oral capsule extended release 12

hour 120 mg, 60 mg, 90 mg 1 MO

diltiazem hcl oral tablet 120 mg, 30 mg, 60 mg,

90 mg 1 MO

dilt-xr oral capsule extended release 24 hour 120

mg, 180 mg, 240 mg 1 MO

divalproex sodium er oral tablet extended release

24 hour 250 mg, 500 mg 1 MO

divalproex sodium oral capsule delayed release

sprinkle 125 mg 1 MO

divalproex sodium oral tablet delayed release 125

mg, 250 mg, 500 mg 1 MO

doxazosin mesylate oral tablet 1 mg, 2 mg, 4 mg,

8 mg 1 MO


enalapril maleate oral tablet 10 mg, 2.5 mg, 20

mg, 5 mg 1 MO

enalapril-hydrochlorothiazide oral tablet 10-25

mg, 5-12.5 mg 1 MO




40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1

eplerenone oral tablet 25 mg, 50 mg 1 MO

eprosartan mesylate oral tablet 600 mg 1 MO

ergotamine-caffeine oral tablet 1-100 mg 1 QL (40 EA per 28 days)

ESOMEPRAZOLE SODIUM INTRAVENOUS


felodipine er oral tablet extended release 24 hour

10 mg, 2.5 mg, 5 mg 1 MO

fosinopril sodium oral tablet 10 mg, 20 mg, 40 mg 1 MO








51

?


fosinopril sodium-hctz oral tablet 10-12.5 mg, 20-

12.5 mg 1 MO


10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2

frovatriptan succinate oral tablet 2.5 mg 1 QL (18 EA per 30 days)




2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD


hydralazine hcl injection solution 20 mg/ml 1

hydralazine hcl oral tablet 10 mg, 100 mg, 25 mg,

50 mg 1 MO

hydrochlorothiazide oral capsule 12.5 mg 1 MO

hydrochlorothiazide oral tablet 12.5 mg, 25 mg,

50 mg 1 MO

hydroxyprogesterone caproate intramuscular

solution 1.25 gm/5ml 1 PA


irbesartan oral tablet 150 mg, 300 mg, 75 mg 1 MO

irbesartan-hydrochlorothiazide oral tablet 150-

12.5 mg, 300-12.5 mg 1 MO

isosorbide dinitrate er oral tablet extended

release 40 mg 1 MO

isosorbide dinitrate oral tablet 10 mg, 20 mg, 30

mg, 5 mg 1 MO








52

?


isosorbide mononitrate er oral tablet extended


isosorbide mononitrate oral tablet 10 mg, 20 mg 1 MO

isradipine oral capsule 2.5 mg, 5 mg 1 MO


mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO

labetalol hcl intravenous solution 5 mg/ml 1

labetalol hcl oral tablet 100 mg, 200 mg, 300 mg 1 MO


lisinopril oral tablet 10 mg, 2.5 mg, 20 mg, 30

mg, 40 mg, 5 mg 1 MO

lisinopril-hydrochlorothiazide oral tablet 10-12.5

mg, 20-12.5 mg, 20-25 mg 1 MO

losartan potassium oral tablet 100 mg, 25 mg, 50

mg 1 MO

losartan potassium-hctz oral tablet 100-12.5 mg,

100-25 mg, 50-12.5 mg 1 MO





meclizine hcl oral tablet 12.5 mg, 25 mg 1

meclizine hcl tablet chewable 25 mg oral 25 mg 3

medroxyprogesterone acetate oral tablet 10 mg,

2.5 mg, 5 mg 1 MO

mesna intravenous solution 100 mg/ml 1 BD

MESNEX ORAL TABLET 400 MG 2

methyldopa oral tablet 250 mg, 500 mg 1 PA; HR; MO

methyldopa-hydrochlorothiazide oral tablet 250-

15 mg, 250-25 mg 1 PA; HR; MO

methyldopate hcl intravenous solution 250

mg/5ml 1 PA; HR

metoprolol succinate er oral tablet extended

release 24 hour 100 mg, 200 mg, 25 mg, 50 mg 1 MO








53

?


metoprolol tartrate intravenous solution 5 mg/5ml 1

metoprolol tartrate intravenous solution cartridge

5 mg/5ml 1 BD

metoprolol tartrate oral tablet 100 mg, 25 mg, 50

mg 1 MO

metoprolol-hydrochlorothiazide oral tablet 100-

25 mg, 100-50 mg, 50-25 mg 1 MO

midodrine hcl oral tablet 10 mg, 2.5 mg, 5 mg 1

minitran transdermal patch 24 hour 0.1 mg/hr,

0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr 1 MO

minoxidil oral tablet 10 mg, 2.5 mg 1 MO

moexipril hcl oral tablet 15 mg, 7.5 mg 1 MO

moexipril-hydrochlorothiazide oral tablet 15-12.5

mg, 15-25 mg, 7.5-12.5 mg 1 MO

nadolol oral tablet 20 mg, 40 mg, 80 mg 1 MO

nadolol-bendroflumethiazide oral tablet 40-5 mg,

80-5 mg 1 MO

nicardipine hcl oral capsule 20 mg, 30 mg 1 MO

nifedipine er oral tablet extended release 24 hour

30 mg, 60 mg, 90 mg 1 MO

nifedipine er osmotic release oral tablet extended


nifedipine oral capsule 10 mg, 20 mg 1 PA; HR; MO

nimodipine oral capsule 30 mg 1 MO

nisoldipine er oral tablet extended release 24


nitroglycerin intravenous solution 5 mg/ml 1

nitroglycerin sublingual tablet sublingual 0.3 mg,

0.4 mg, 0.6 mg 1 MO

nitroglycerin transdermal patch 24 hour 0.1

mg/hr, 0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr 1 MO

NITROGLYCERIN TRANSLINGUAL

SOLUTION 0.4 MG/SPRAY 2 MO

norethindrone acetate oral tablet 5 mg 1 MO








54

?


NORTHERA ORAL CAPSULE 100 MG, 200

MG, 300 MG 2 PA

OLMESARTAN MEDOXOMIL ORAL

TABLET 20 MG, 40 MG, 5 MG 2 MO

OLMESARTAN MEDOXOMIL-HCTZ ORAL

TABLET 20-12.5 MG, 40-12.5 MG, 40-25 MG 2 MO

OLMESARTAN-AMLODIPINE-HCTZ ORAL

TABLET 20-5-12.5 MG, 40-10-12.5 MG, 40-10-

25 MG, 40-5-12.5 MG, 40-5-25 MG

2 MO


pentoxifylline er oral tablet extended release 400

mg 1 MO

perindopril erbumine oral tablet 2 mg, 4 mg, 8

mg 1 MO

pindolol oral tablet 10 mg, 5 mg 1 MO



PRALUENT SUBCUTANEOUS SOLUTION

PEN-INJECTOR 150 MG/ML, 75 MG/ML 2 PA; MO

prazosin hcl oral capsule 1 mg, 2 mg, 5 mg 1 MO

PREMARIN INJECTION SOLUTION



GM/200ML 2 BD


50 MG, 75 MG 2 MO

propranolol hcl er oral capsule extended release

24 hour 120 mg, 160 mg, 60 mg, 80 mg 1 MO

propranolol hcl oral solution 40 mg/5ml 1 MO

propranolol hcl oral tablet 10 mg, 20 mg, 40 mg,

60 mg, 80 mg 1 MO

propranolol-hctz oral tablet 40-25 mg, 80-25 mg 1 MO

quinapril hcl oral tablet 10 mg, 20 mg, 40 mg, 5

mg 1 MO








55

?


quinapril-hydrochlorothiazide oral tablet 10-12.5

mg, 20-12.5 mg, 20-25 mg 1 MO

ramipril oral capsule 1.25 mg, 10 mg, 2.5 mg, 5

mg 1 MO

RANEXA ORAL TABLET EXTENDED

RELEASE 12 HOUR 1000 MG, 500 MG 2 MO

ranitidine hcl injection solution 50 mg/2ml 1

ranitidine hcl oral capsule 150 mg, 300 mg 1 MO

ranitidine hcl oral syrup 15 mg/ml 1 MO

ranitidine hcl oral tablet 150 mg, 300 mg 1 MO

RELPAX ORAL TABLET 20 MG, 40 MG 2 QL (9 EA per 30 days)

REPATHA PUSHTRONEX SYSTEM

SUBCUTANEOUS SOLUTION CARTRIDGE

420 MG/3.5ML

2 PA; MO

REPATHA SUBCUTANEOUS SOLUTION


REPATHA SURECLICK SUBCUTANEOUS

SOLUTION AUTO-INJECTOR 140 MG/ML 2 PA; MO


mg/12.5ml 1 PA


sumatriptan succinate oral tablet 100 mg, 25 mg,

50 mg 1 QL (9 EA per 30 days)

sumatriptan succinate subcutaneous solution 6

mg/0.5ml 1 QL (10 ML per 30 days)

sumatriptan succinate subcutaneous solution

auto-injector 4 mg/0.5ml 1 QL (4.5 ML per 30 days)


prefilled syringe 6 mg/0.5ml 1 QL (4.5 ML per 30 days)

taztia xt oral capsule extended release 24 hour

120 mg, 180 mg, 240 mg, 300 mg, 360 mg 1 MO

telmisartan oral tablet 20 mg, 40 mg, 80 mg 1 MO

telmisartan-amlodipine oral tablet 40-10 mg, 40-

5 mg, 80-10 mg, 80-5 mg 1 MO








56

?


telmisartan-hctz oral tablet 40-12.5 mg, 80-12.5

mg, 80-25 mg 1 MO

terazosin hcl oral capsule 1 mg, 10 mg, 2 mg, 5

mg 1 MO

timolol maleate oral tablet 10 mg, 20 mg, 5 mg 1 MO

TOPIRAMATE ER ORAL CAPSULE ER 24

HOUR SPRINKLE 100 MG, 150 MG, 200 MG,

25 MG, 50 MG

2 MO

topiramate oral capsule sprinkle 15 mg, 25 mg 1 MO

topiramate oral tablet 100 mg, 200 mg, 25 mg, 50

mg 1 MO



trandolapril oral tablet 1 mg, 2 mg, 4 mg 1 MO

trandolapril-verapamil hcl er oral tablet extended

release 1-240 mg, 2-180 mg, 2-240 mg, 4-240 mg 1 MO

tranexamic acid oral tablet 650 mg 1



TROKENDI XR ORAL CAPSULE EXTENDED

RELEASE 24 HOUR 100 MG, 200 MG, 25 MG,

50 MG

2 MO

valsartan oral tablet 160 mg, 320 mg, 40 mg, 80

mg 1 MO

valsartan-hydrochlorothiazide oral tablet 160-

12.5 mg, 160-25 mg, 320-12.5 mg, 320-25 mg,

80-12.5 mg

1 MO



verapamil hcl er oral capsule extended release 24

hour 100 mg, 120 mg, 180 mg, 200 mg, 240 mg,

300 mg, 360 mg

1 MO

verapamil hcl er oral tablet extended release 120

mg, 180 mg, 240 mg 1 MO








57

?


verapamil hcl oral tablet 120 mg, 40 mg, 80 mg 1 MO

WAL-ZAN 150 MAXIMUM STRENGTH

TABLET 150 MG ORAL 150 MG 3 MO


2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg 1 MO


MG 2 MO



CHANGES IN BLOOD PRESSURE

acebutolol hcl oral capsule 200 mg, 400 mg 1 MO


30 mg, 60 mg 1 MO

amiloride-hydrochlorothiazide oral tablet 5-50

mg 1 MO

amlodipine besy-benazepril hcl oral capsule 10-

20 mg, 10-40 mg, 2.5-10 mg, 5-10 mg, 5-20 mg,

5-40 mg

1 MO


mg 1 MO


mg, 10-320 mg, 5-160 mg, 5-320 mg 1 MO


20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO


40 mg, 5-20 mg, 5-40 mg 1 MO


mg, 10-160-25 mg, 10-320-25 mg, 5-160-12.5 mg,

5-160-25 mg

1 MO


atenolol-chlorthalidone oral tablet 100-25 mg,

50-25 mg 1 MO








58

?


benazepril hcl oral tablet 10 mg, 20 mg, 40 mg, 5

mg 1 MO

benazepril-hydrochlorothiazide oral tablet 10-

12.5 mg, 20-12.5 mg, 20-25 mg, 5-6.25 mg 1 MO

betaxolol hcl oral tablet 10 mg, 20 mg 1 MO

bisoprolol fumarate oral tablet 10 mg, 5 mg 1 MO

bisoprolol-hydrochlorothiazide oral tablet 10-

6.25 mg, 2.5-6.25 mg, 5-6.25 mg 1 MO


mg, 8 mg 1 MO

candesartan cilexetil-hctz oral tablet 16-12.5 mg,

32-12.5 mg, 32-25 mg 1 MO


mg 1 MO

captopril-hydrochlorothiazide oral tablet 25-15

mg, 25-25 mg, 50-15 mg, 50-25 mg 1 MO


120 mg, 180 mg, 240 mg, 300 mg 1 MO


6.25 mg 1 MO

clonidine hcl oral tablet 0.1 mg, 0.2 mg, 0.3 mg 1 MO

clonidine hcl transdermal patch weekly 0.1

mg/24hr, 0.2 mg/24hr, 0.3 mg/24hr 1 MO






mg

1 MO




mg, 180 mg, 240 mg 1 MO


8 mg 1 MO








59

?



mg, 5 mg 1 MO

enalapril-hydrochlorothiazide oral tablet 10-25

mg, 5-12.5 mg 1 MO

eprosartan mesylate oral tablet 600 mg 1 MO

felodipine er oral tablet extended release 24 hour

10 mg, 2.5 mg, 5 mg 1 MO


fosinopril sodium-hctz oral tablet 10-12.5 mg, 20-

12.5 mg 1 MO

hydralazine hcl injection solution 20 mg/ml 1

hydralazine hcl oral tablet 10 mg, 100 mg, 25 mg,

50 mg 1 MO

hydrochlorothiazide oral capsule 12.5 mg 1 MO

hydrochlorothiazide oral tablet 12.5 mg, 25 mg,

50 mg 1 MO


irbesartan oral tablet 150 mg, 300 mg, 75 mg 1 MO

irbesartan-hydrochlorothiazide oral tablet 150-

12.5 mg, 300-12.5 mg 1 MO

isradipine oral capsule 2.5 mg, 5 mg 1 MO

labetalol hcl intravenous solution 5 mg/ml 1

labetalol hcl oral tablet 100 mg, 200 mg, 300 mg 1 MO



lisinopril-hydrochlorothiazide oral tablet 10-12.5

mg, 20-12.5 mg, 20-25 mg 1 MO

losartan potassium oral tablet 100 mg, 25 mg, 50

mg 1 MO

losartan potassium-hctz oral tablet 100-12.5 mg,

100-25 mg, 50-12.5 mg 1 MO










60

?


methyldopa oral tablet 250 mg, 500 mg 1 PA; HR; MO

methyldopa-hydrochlorothiazide oral tablet 250-

15 mg, 250-25 mg 1 PA; HR; MO

methyldopate hcl intravenous solution 250

mg/5ml 1 PA; HR




mg 1 MO

metoprolol-hydrochlorothiazide oral tablet 100-

25 mg, 100-50 mg, 50-25 mg 1 MO

midodrine hcl oral tablet 10 mg, 2.5 mg, 5 mg 1

minoxidil oral tablet 10 mg, 2.5 mg 1 MO

moexipril hcl oral tablet 15 mg, 7.5 mg 1 MO

moexipril-hydrochlorothiazide oral tablet 15-12.5

mg, 15-25 mg, 7.5-12.5 mg 1 MO


nadolol-bendroflumethiazide oral tablet 40-5 mg,

80-5 mg 1 MO



30 mg, 60 mg, 90 mg 1 MO



nisoldipine er oral tablet extended release 24



NORTHERA ORAL CAPSULE 100 MG, 200

MG, 300 MG 2 PA




TABLET 20-12.5 MG, 40-12.5 MG, 40-25 MG 2 MO








61

?



TABLET 20-5-12.5 MG, 40-10-12.5 MG, 40-10-

25 MG, 40-5-12.5 MG, 40-5-25 MG

2 MO


mg 1 MO

pindolol oral tablet 10 mg, 5 mg 1 MO

prazosin hcl oral capsule 1 mg, 2 mg, 5 mg 1 MO



60 mg, 80 mg 1 MO

propranolol-hctz oral tablet 40-25 mg, 80-25 mg 1 MO


mg 1 MO

quinapril-hydrochlorothiazide oral tablet 10-12.5

mg, 20-12.5 mg, 20-25 mg 1 MO

ramipril oral capsule 1.25 mg, 10 mg, 2.5 mg, 5

mg 1 MO


120 mg, 180 mg, 240 mg, 300 mg, 360 mg 1 MO



5 mg, 80-10 mg, 80-5 mg 1 MO


mg, 80-25 mg 1 MO


mg 1 MO




trandolapril-verapamil hcl er oral tablet extended

release 1-240 mg, 2-180 mg, 2-240 mg, 4-240 mg 1 MO










62

?



mg 1 MO

valsartan-hydrochlorothiazide oral tablet 160-

12.5 mg, 160-25 mg, 320-12.5 mg, 320-25 mg,

80-12.5 mg

1 MO

verapamil hcl er oral capsule extended release 24

hour 100 mg, 120 mg, 180 mg, 200 mg, 240 mg,

300 mg, 360 mg

1 MO

verapamil hcl er oral tablet extended release 120

mg, 180 mg, 240 mg 1 MO


CORONARY ARTERY DISEASE


30 mg, 60 mg 1 MO


mg 1 MO


125 MG/125ML 2 BD










120 mg, 180 mg, 240 mg, 300 mg 1 MO












63

?




mg

1 MO




90 mg 1 MO


mg, 180 mg, 240 mg 1 MO




40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1



10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2



release 40 mg 1 MO


mg, 5 mg 1 MO








5 mg/5ml 1 BD


mg 1 MO








64

?



0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr 1 MO




30 mg, 60 mg, 90 mg 1 MO






0.4 mg, 0.6 mg 1 MO






mg 1 MO




120 mg, 180 mg, 240 mg, 300 mg, 360 mg 1 MO





HEART DISEASE


30 mg, 60 mg 1 MO

amiloride hcl oral tablet 5 mg 1 MO

amiodarone hcl intravenous solution 150 mg/3ml 1

amiodarone hcl oral tablet 100 mg, 200 mg, 400

mg 1 MO








65

?



mg 1 MO


125 MG/125ML 2 BD








atropine sulfate injection solution prefilled

syringe 0.25 mg/5ml 1


bumetanide injection solution 0.25 mg/ml 1


mg, 8 mg 1 MO


mg 1 MO


120 mg, 180 mg, 240 mg, 300 mg 1 MO


6.25 mg 1 MO



dexrazoxane intravenous solution reconstituted

250 mg 1 BD

digitek oral tablet 125 mcg 1 MO

digitek oral tablet 250 mcg 1 PA; HR; MO

digoxin injection solution 0.25 mg/ml 1

digoxin oral solution 0.05 mg/ml 1 MO

digoxin oral tablet 125 mcg 1 MO; QL (30 EA per 30 days)

digoxin oral tablet 250 mcg 1 MO








66

?






mg

1 MO



diltiazem hcl intravenous solution 50 mg/10ml 1

diltiazem hcl intravenous solution reconstituted

100 mg 1


90 mg 1 MO


mg, 180 mg, 240 mg 1 MO

disopyramide phosphate oral capsule 100 mg,

150 mg 1 PA; HR; MO

dofetilide oral capsule 125 mcg, 250 mcg, 500

mcg 1 MO



mg, 5 mg 1 MO




40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1


flecainide acetate oral tablet 100 mg, 150 mg, 50

mg 1 MO



10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2

furosemide oral tablet 20 mg, 40 mg, 80 mg 1 MO








67

?




release 40 mg 1 MO


mg, 5 mg 1 MO












5 mg/5ml 1 BD


mg 1 MO

mexiletine hcl oral capsule 150 mg, 200 mg, 250

mg 1 MO


0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr 1 MO

MULTAQ ORAL TABLET 400 MG 2 MO




30 mg, 60 mg, 90 mg 1 MO






0.4 mg, 0.6 mg 1 MO








68

?






pacerone oral tablet 100 mg, 200 mg 1 MO


mg 1 MO



procainamide hcl injection solution 100 mg/ml 1

propafenone hcl oral tablet 150 mg, 225 mg, 300

mg 1 MO

propranolol hcl intravenous solution 1 mg/ml 1


mg 1 MO

quinidine gluconate er oral tablet extended

release 324 mg 1 MO

quinidine sulfate oral tablet 200 mg, 300 mg 1 MO



sotalol hcl (af) oral tablet 120 mg 1 MO

sotalol hcl oral tablet 160 mg, 240 mg, 80 mg 1 MO


spironolactone-hctz oral tablet 25-25 mg 1 MO


120 mg, 180 mg, 240 mg, 300 mg, 360 mg 1 MO





mg 1 MO

verapamil hcl intravenous solution 2.5 mg/ml 1









69

?



MG 2 MO



INFLAMMATORY DISORDER OF

CARDIOVASCULAR SYSTEM




2 BD

DISEASE OF THE URINARY TRACT

BLADDER DISORDER

darifenacin hydrobromide er oral tablet extended

release 24 hour 15 mg, 7.5 mg 1 MO

ELMIRON ORAL CAPSULE 100 MG 2



MYRBETRIQ ORAL TABLET EXTENDED

RELEASE 24 HOUR 25 MG, 50 MG 2 ST; MO

oxybutynin chloride er oral tablet extended


oxybutynin chloride oral syrup 5 mg/5ml 1 MO

oxybutynin chloride oral tablet 5 mg 1 MO

tolterodine tartrate oral tablet 1 mg, 2 mg 1 MO

VESICARE ORAL TABLET 10 MG, 5 MG 2 MO

BLEEDING FROM THE

GENITOURINARY SYSTEM




2.5 mg, 5 mg 1 MO











70

?





CANCER OF THE URINARY TRACT

AFINITOR ORAL TABLET 10 MG, 2.5 MG, 5

MG, 7.5 MG 2

AVASTIN INTRAVENOUS SOLUTION 100

MG/4ML, 400 MG/16ML 2

DEPO-PROVERA INTRAMUSCULAR

SUSPENSION 400 MG/ML 2 BD

ELIGARD SUBCUTANEOUS KIT 22.5 MG, 30

MG, 45 MG, 7.5 MG 2 BD

EMCYT ORAL CAPSULE 140 MG 2

leuprolide acetate injection kit 1 mg/0.2ml 1






INTRAMUSCULAR KIT 30 MG 2




mg/12.5ml 1

TORISEL INTRAVENOUS SOLUTION 25

MG/ML 2 BD

TRELSTAR MIXJECT INTRAMUSCULAR

SUSPENSION RECONSTITUTED 11.25 MG,

22.5 MG, 3.75 MG

2 BD

DISORDER OF KIDNEY


MG, 7.5 MG 2









71

?





MG/ML 2 BD


MG/4ML, 400 MG/16ML 2






mg 1 MO



mg 1 MO



mg, 50 mg 1 BD; MO












lidocaine hcl external gel 2 % 1





2 BD








72

?









180 mg, 360 mg 1 BD; MO



PARICALCITOL INTRAVENOUS SOLUTION

2 MCG/ML 2


5 MCG/ML 2 BD

paricalcitol oral capsule 1 mcg, 2 mcg, 4 mcg 1 BD; MO










MG/ML 2 BD





MG 2 BD; MO


MG/ML 2 BD; MO

SENSIPAR ORAL TABLET 30 MG, 60 MG, 90

MG 2 MO








73

?









MG/ML 2 BD


0.75 MG 2 BD; MO

DISORDER OF PROSTATE


8 mg 1 MO

dutasteride oral capsule 0.5 mg 1 MO

dutasteride-tamsulosin hcl oral capsule 0.5-0.4

mg 1 MO


MG, 45 MG, 7.5 MG 2 BD


finasteride oral tablet 5 mg 1 MO











mg/12.5ml 1

RAPAFLO ORAL CAPSULE 4 MG, 8 MG 2 MO

tamsulosin hcl oral capsule 0.4 mg 1 MO








74

?



mg 1 MO



22.5 MG, 3.75 MG

2 BD

FREQUENT URINATION



INFLAMMATION OF THE TUBE

THAT BRINGS URINE FROM

BLADDER




clindamycin phosphate vaginal cream 2 % 1

clotrimazole cream 1 % vaginal 1 % 3

metronidazole vaginal gel 0.75 % 1

miconazole 3 vaginal suppository 200 mg 1

miconazole 7 cream 2 % vaginal 2 % 3

miconazole 7 suppository 100 mg vaginal 100 mg 3

PREMARIN VAGINAL CREAM 0.625 MG/GM 2 MO

PREMPHASE ORAL TABLET 0.625-5 MG 2 PA; HR; MO

PREMPRO ORAL TABLET 0.3-1.5 MG, 0.45-

1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO

terconazole vaginal cream 0.4 % 1

terconazole vaginal suppository 80 mg 1

YUVAFEM VAGINAL TABLET 10 MCG 2 MO

KIDNEY DISEASE WITH

REDUCTION IN KIDNEY

FUNCTION


MG, 7.5 MG 2








75

?






MG/ML 2 BD


MG/4ML, 400 MG/16ML 2






mg 1 MO



mg 1 MO



mg, 50 mg 1 BD; MO





















76

?





2 BD








180 mg, 360 mg 1 BD; MO




2 MCG/ML 2


5 MCG/ML 2 BD











MG/ML 2 BD





MG 2 BD; MO








77

?



MG/ML 2 BD; MO


MG 2 MO








MG/ML 2 BD


0.75 MG 2 BD; MO

NEEDING TO URINATE

IMMEDIATELY










OBSTRUCTION OF ANY PART OF

THE URINARY TRACT


8 mg 1 MO



mg 1 MO









78

?





mg 1 MO

PROBLEMS WITH BLADDER

CONTROL




imipramine hcl oral tablet 10 mg, 25 mg, 50 mg 1 PA; HR; MO








STONES IN THE URINARY TRACT


THE APPEARANCE OF CRYSTALS

IN THE URINE


URETERAL SPASM


URINARY TRACT INFECTION

neomycin-polymyxin b gu irrigation solution 40-

200000 1

trimethoprim oral tablet 100 mg 1

URINARY TRACT SURGERY










79

?



MG/ML 2 BD







mg, 50 mg 1 BD; MO















180 mg, 360 mg 1 BD; MO




MG/ML 2 BD



MG 2 BD; MO


MG/ML 2 BD; MO








80

?









0.75 MG 2 BD; MO

DISORDER OF NERVE

DEMYELINATING DISEASE

AMPYRA ORAL TABLET EXTENDED

RELEASE 12 HOUR 10 MG 2 PA; MO

AVONEX INTRAMUSCULAR KIT 30 MCG 2 PA; MO

AVONEX PEN INTRAMUSCULAR AUTO-

INJECTOR KIT 30 MCG/0.5ML 2 PA; MO

AVONEX PREFILLED INTRAMUSCULAR

PREFILLED SYRINGE KIT 30 MCG/0.5ML 2 PA; MO

BETASERON SUBCUTANEOUS KIT 0.3 MG 2 PA; MO

COPAXONE SUBCUTANEOUS SOLUTION

PREFILLED SYRINGE 20 MG/ML, 40 MG/ML 2 PA; MO


GM/25ML 2 BD

GILENYA ORAL CAPSULE 0.5 MG 2 PA; MO


mg/12.5ml 1

PLEGRIDY STARTER PACK

SUBCUTANEOUS SOLUTION PEN-

INJECTOR 63 & 94 MCG/0.5ML

2 PA

PLEGRIDY SUBCUTANEOUS SOLUTION

PEN-INJECTOR 125 MCG/0.5ML 2 PA; MO


PREFILLED SYRINGE 125 MCG/0.5ML 2 PA; MO

REBIF SUBCUTANEOUS SOLUTION









81

?


TECFIDERA ORAL 120 & 240 MG 2 PA

TECFIDERA ORAL CAPSULE DELAYED

RELEASE 120 MG, 240 MG 2 PA; MO

TYSABRI INTRAVENOUS CONCENTRATE

300 MG/15ML 2 PA

DISEASE OF THE BRAIN AND-OR

SPINAL CORD

AFINITOR DISPERZ ORAL TABLET

SOLUBLE 2 MG, 3 MG, 5 MG 2

amantadine hcl oral capsule 100 mg 1 MO

amantadine hcl oral syrup 50 mg/5ml 1 MO

amantadine hcl oral tablet 100 mg 1 MO


20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO

amphetamine-dextroamphetamine oral tablet 10

mg, 12.5 mg, 15 mg, 20 mg, 30 mg, 5 mg, 7.5 mg 1 MO



APOKYN SUBCUTANEOUS SOLUTION

CARTRIDGE 30 MG/3ML 2 LA

APTIOM ORAL TABLET 200 MG, 400 MG,

600 MG, 800 MG 2 MO





25-200 MG

2 MO













82

?


baclofen oral tablet 10 mg, 20 mg 1 MO

benztropine mesylate injection solution 1 mg/ml 1

benztropine mesylate oral tablet 0.5 mg, 1 mg, 2

mg 1 PA; HR; MO


BRIVIACT INTRAVENOUS SOLUTION 50

MG/5ML 2 PA

BRIVIACT ORAL SOLUTION 10 MG/ML 2 PA; MO

BRIVIACT ORAL TABLET 10 MG, 100 MG,

25 MG, 50 MG, 75 MG 2 PA; MO

bromocriptine mesylate oral capsule 5 mg 1 MO

bromocriptine mesylate oral tablet 2.5 mg 1 MO

BUTISOL SODIUM ORAL TABLET 30 MG 2 PA; HR

carbamazepine er oral capsule extended release

12 hour 100 mg, 200 mg, 300 mg 1 MO

carbamazepine er oral tablet extended release 12

hour 100 mg, 200 mg, 400 mg 1 MO

carbamazepine oral suspension 100 mg/5ml 1 MO

carbamazepine oral tablet 200 mg 1 MO

carbamazepine oral tablet chewable 100 mg 1 MO

carbidopa-levodopa er oral tablet extended

release 25-100 mg, 50-200 mg 1 MO

carbidopa-levodopa oral tablet 10-100 mg, 25-

100 mg, 25-250 mg 1 MO

carbidopa-levodopa oral tablet dispersible 10-

100 mg, 25-100 mg, 25-250 mg 1 MO

CELONTIN ORAL CAPSULE 300 MG 2 MO

CEREBYX INJECTION SOLUTION 500 MG

PE/10ML 2

chlordiazepoxide hcl oral capsule 10 mg, 25 mg,


clonazepam oral tablet 0.5 mg, 1 mg, 2 mg 1 MO








83

?


clonazepam oral tablet dispersible 0.125 mg, 0.25

mg, 0.5 mg, 1 mg, 2 mg 1 MO

clorazepate dipotassium oral tablet 15 mg, 3.75

mg, 7.5 mg 1 QL (180 EA per 30 days)





DEXMETHYLPHENIDATE HCL ER ORAL


25 MG, 35 MG

2 MO

dextroamphetamine sulfate er oral capsule

extended release 24 hour 10 mg, 15 mg, 5 mg 1 MO

dextroamphetamine sulfate oral tablet 10 mg, 5

mg 1 MO

diazepam intensol oral concentrate 5 mg/ml 1 QL (240 ML per 30 days)

DIAZEPAM ORAL SOLUTION 1 MG/ML 2 QL (1200 ML per 30 days)

diazepam oral tablet 10 mg 1 QL (120 EA per 30 days)



diazepam rectal gel 10 mg, 2.5 mg, 20 mg 1


mg/ml 1

DILANTIN ORAL CAPSULE 30 MG 2 MO

diphenhydramine hcl capsule 25 mg oral (otc) 25

mg 3

diphenhydramine hcl injection solution 50 mg/ml 1


24 hour 250 mg, 500 mg 1 MO




mg, 250 mg, 500 mg 1 MO

donepezil hcl oral tablet 10 mg, 23 mg, 5 mg 1 MO








84

?


donepezil hcl oral tablet dispersible 10 mg, 5 mg 1 MO

entacapone oral tablet 200 mg 1 MO


epitol oral tablet 200 mg 1 MO

EQUETRO ORAL CAPSULE EXTENDED

RELEASE 12 HOUR 100 MG, 200 MG, 300 MG 2 MO

ergoloid mesylates oral tablet 1 mg 1 PA; HR; MO


estazolam oral tablet 1 mg 1 QL (60 EA per 30 days)


ethosuximide oral capsule 250 mg 1 MO

ethosuximide oral solution 250 mg/5ml 1 MO

flurazepam hcl oral capsule 15 mg 1 QL (60 EA per 30 days)


fosphenytoin sodium injection solution 100 mg

pe/2ml 1


FYCOMPA ORAL SUSPENSION 0.5 MG/ML 2 MO

FYCOMPA ORAL TABLET 10 MG, 12 MG, 2

MG, 4 MG, 6 MG, 8 MG 2 MO

gabapentin oral capsule 100 mg, 300 mg, 400 mg 1 MO

gabapentin oral solution 250 mg/5ml 1 MO

gabapentin oral tablet 600 mg, 800 mg 1 MO

GABITRIL ORAL TABLET 12 MG, 16 MG 2 MO

galantamine hydrobromide er oral capsule


GALANTAMINE HYDROBROMIDE ORAL

SOLUTION 4 MG/ML 2 MO

galantamine hydrobromide oral tablet 12 mg, 4

mg, 8 mg 1 MO










85

?



guanfacine hcl er oral tablet extended release 24

hour 1 mg, 2 mg, 3 mg, 4 mg 1 PA; HR; MO

HETLIOZ ORAL CAPSULE 20 MG 2 MO

hydroxyzine hcl oral syrup 10 mg/5ml 1 PA; HR

hydroxyzine hcl oral tablet 10 mg, 25 mg, 50 mg 1 PA; HR

hydroxyzine pamoate oral capsule 100 mg, 25

mg, 50 mg 1 PA; HR

HYPERRAB S/D INTRAMUSCULAR

INJECTABLE 150 UNIT/ML 2

IMOVAX RABIES INTRAMUSCULAR

INJECTABLE 2.5 UNIT/ML 2 BD

INCRELEX SUBCUTANEOUS SOLUTION 40

MG/4ML 2 LA; MO

IXIARO INTRAMUSCULAR SUSPENSION 2


LAMICTAL STARTER ORAL KIT 25 (35) MG,

25 (42)-100 (7) MG, 25 (84)-100(14) MG 2

LAMICTAL XR ORAL KIT 25 & 50 & 100 MG,

25 (21)-50 (7) MG, 50 & 100 & 200 MG 2

lamotrigine er oral tablet extended release 24

hour 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, 50

mg

1 MO

lamotrigine oral tablet 100 mg, 150 mg, 200 mg,

25 mg 1 MO

lamotrigine oral tablet chewable 25 mg, 5 mg 1 MO

lamotrigine oral tablet dispersible 100 mg, 200

mg, 25 mg, 50 mg 1 MO

levetiracetam er oral tablet extended release 24


LEVETIRACETAM IN NACL INTRAVENOUS

SOLUTION 1000 MG/100ML, 1500

MG/100ML, 500 MG/100ML

2

levetiracetam intravenous solution 500 mg/5ml 1








86

?


levetiracetam oral solution 100 mg/ml 1 MO

levetiracetam oral tablet 1000 mg, 250 mg, 500

mg, 750 mg 1 MO


200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO




memantine hcl oral solution 2 mg/ml 1 MO

memantine hcl oral tablet 10 mg, 5 mg 1 MO

memantine hcl oral tablet 5 (28)-10 (21) mg 1

methylphenidate hcl er (cd) oral capsule extended

release 10 mg, 20 mg, 40 mg 1 MO

methylphenidate hcl er (la) oral capsule extended

release 24 hour 60 mg 1 MO

methylphenidate hcl er oral tablet extended

release 20 mg 1 MO

METHYLPHENIDATE HCL ER ORAL

TABLET EXTENDED RELEASE 24 HOUR 27

MG

2 PA; HR; MO

methylphenidate hcl oral solution 10 mg/5ml, 5

mg/5ml 1 MO

methylphenidate hcl oral tablet 10 mg, 20 mg, 5

mg 1 MO

methylphenidate hcl oral tablet chewable 10 mg,

2.5 mg, 5 mg 1 MO


mg/12.5ml 1

modafinil oral tablet 100 mg, 200 mg 1 PA; MO

NAMENDA XR ORAL CAPSULE EXTENDED

RELEASE 24 HOUR 14 MG, 21 MG, 28 MG, 7

MG

2 MO








87

?


NAMENDA XR TITRATION PACK ORAL

CAPSULE EXTENDED RELEASE 24 HOUR 7

& 14 & 21 &28 MG

2

NAMZARIC ORAL CAPSULE ER 24 HOUR

THERAPY PACK 7 & 14 & 21 &28 -10 MG 2

NAMZARIC ORAL CAPSULE EXTENDED

RELEASE 24 HOUR 14-10 MG, 28-10 MG 2 MO; QL (30 EA per 30 days)


RELEASE 24 HOUR 21-10 MG, 7-10 MG 2 MO

NEUPRO TRANSDERMAL PATCH 24 HOUR

1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4

MG/24HR, 6 MG/24HR, 8 MG/24HR

2 MO


NUPLAZID ORAL TABLET 17 MG 2 PA; MO



mcg/ml

1 MO

ONFI ORAL SUSPENSION 2.5 MG/ML 2 MO

ONFI ORAL TABLET 10 MG, 20 MG 2 MO

oxazepam oral capsule 10 mg, 15 mg, 30 mg 1 QL (120 EA per 30 days)

oxcarbazepine oral suspension 300 mg/5ml 1 MO

oxcarbazepine oral tablet 150 mg, 300 mg, 600

mg 1 MO

OXTELLAR XR ORAL TABLET EXTENDED


PEGANONE ORAL TABLET 250 MG 2 MO

phenytoin oral suspension 125 mg/5ml 1 MO

phenytoin oral tablet chewable 50 mg 1 MO

phenytoin sodium extended oral capsule 100 mg,

200 mg, 300 mg 1 MO

phenytoin sodium injection solution 50 mg/ml 1

pimozide oral tablet 1 mg, 2 mg 1 MO








88

?





2 PA





POTIGA ORAL TABLET 200 MG, 300 MG,

400 MG, 50 MG 2 MO

pramipexole dihydrochloride er oral tablet

extended release 24 hour 2.25 mg, 3.75 mg 1 MO

pramipexole dihydrochloride oral tablet 0.125

mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg 1 MO


24 hour 120 mg, 160 mg, 60 mg, 80 mg 1 MO

propranolol hcl oral solution 20 mg/5ml, 40

mg/5ml 1 MO


60 mg, 80 mg 1 MO

RABAVERT INTRAMUSCULAR

SUSPENSION RECONSTITUTED 2 BD

RASAGILINE MESYLATE ORAL TABLET 0.5

MG, 1 MG 2 MO




RESTORIL ORAL CAPSULE 15 MG, 22.5 MG 2 QL (30 EA per 30 days)

RESTORIL ORAL CAPSULE 7.5 MG 2 QL (120 EA per 30 days)

rivastigmine tartrate oral capsule 1.5 mg, 3 mg,

4.5 mg, 6 mg 1 MO

RIVASTIGMINE TRANSDERMAL PATCH 24

HOUR 13.3 MG/24HR, 4.6 MG/24HR, 9.5

MG/24HR

2 MO

ropinirole hcl oral tablet 0.25 mg, 0.5 mg, 1 mg, 2

mg, 3 mg, 4 mg, 5 mg 1 MO








89

?


roweepra oral tablet 1000 mg, 500 mg, 750 mg 1 MO

ROZEREM ORAL TABLET 8 MG 2 MO

SABRIL ORAL PACKET 500 MG 2 MO

SABRIL ORAL TABLET 500 MG 2 MO



MG

2

selegiline hcl oral capsule 5 mg 1 MO

selegiline hcl oral tablet 5 mg 1 MO



MG/0.3ML

2



SPRITAM ORAL TABLET DISINTEGRATING

SOLUBLE 1000 MG 2 MO; QL (90 EA per 30 days)


SOLUBLE 250 MG, 500 MG, 750 MG 2 MO; QL (120 EA per 30 days)

STRATTERA ORAL CAPSULE 10 MG, 100

MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO













TEGRETOL-XR ORAL TABLET EXTENDED









90

?


temazepam oral capsule 15 mg, 22.5 mg, 30 mg 1 QL (30 EA per 30 days)

temazepam oral capsule 7.5 mg 1 QL (120 EA per 30 days)

tetrabenazine oral tablet 12.5 mg, 25 mg 1 MO

thiamine hcl solution 100 mg/ml injection 100

mg/ml 3

tiagabine hcl oral tablet 2 mg, 4 mg 1 MO



25 MG, 50 MG

2 MO



mg 1 MO

triazolam oral tablet 0.125 mg 1 QL (30 EA per 30 days)


trihexyphenidyl hcl oral elixir 0.4 mg/ml 1 PA; HR; MO

trihexyphenidyl hcl oral tablet 2 mg, 5 mg 1 PA; HR; MO



50 MG

2 MO


300 MG/15ML 2 PA

valproate sodium intravenous solution 500

mg/5ml 1

valproate sodium oral solution 250 mg/5ml 1 MO

valproic acid oral capsule 250 mg 1 MO

VIMPAT INTRAVENOUS SOLUTION 200

MG/20ML 2

VIMPAT ORAL SOLUTION 10 MG/ML 2 MO

VIMPAT ORAL TABLET 100 MG, 150 MG,

200 MG, 50 MG 2 MO

vitamin b-1 oral tablet 100 mg 3


XYREM ORAL SOLUTION 500 MG/ML 2 LA








91

?


zaleplon oral capsule 10 mg, 5 mg 1 PA; HR

zolpidem tartrate oral tablet 10 mg, 5 mg 1 PA; HR

zolpidem tartrate sublingual tablet sublingual

1.75 mg, 3.5 mg 1 PA; HR; QL (30 EA per 30 days)

zonisamide oral capsule 100 mg, 25 mg, 50 mg 1 MO

EXTREME DISCOMFORT IN

CALVES WHEN SITTING OR LYING

DOWN


1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4


2 MO


mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg 1 MO



PARALYSIS

atropine sulfate ophthalmic solution 1 % 1 MO

PERIPHERAL NEUROPATHY







25 MG, 35 MG

2 MO




mg 1 MO











92

?



GM/25ML 2 BD




lidocaine external patch 5 % 1 PA; QL (90 EA per 30 days)


200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO








release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO



riluzole oral tablet 50 mg 1 MO


MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO

DISORDER OF NERVOUS SYSTEM

DEMYELINATING DISEASE








93

?













GM/25ML 2 BD



mg/12.5ml 1




2 PA











300 MG/15ML 2 PA

DISEASE OF THE BRAIN AND-OR

SPINAL CORD











94

?





20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO








600 MG, 800 MG 2 MO





25-200 MG

2 MO









mg 1 PA; HR; MO



MG/5ML 2 PA



25 MG, 50 MG, 75 MG 2 PA; MO








95

?






12 hour 100 mg, 200 mg, 300 mg 1 MO


hour 100 mg, 200 mg, 400 mg 1 MO





release 25-100 mg, 50-200 mg 1 MO


100 mg, 25-250 mg 1 MO


100 mg, 25-100 mg, 25-250 mg 1 MO



PE/10ML 2





mg, 0.5 mg, 1 mg, 2 mg 1 MO









25 MG, 35 MG

2 MO








96

?





mg 1 MO








mg/ml 1



mg 3



24 hour 250 mg, 500 mg 1 MO




mg, 250 mg, 500 mg 1 MO



















97

?







pe/2ml 1














mg, 8 mg 1 MO










mg, 50 mg 1 PA; HR










98

?





MG/4ML 2 LA; MO




25 (42)-100 (7) MG, 25 (84)-100(14) MG 2


25 (21)-50 (7) MG, 50 & 100 & 200 MG 2


hour 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, 50

mg

1 MO


25 mg 1 MO



mg, 25 mg, 50 mg 1 MO





MG/100ML, 500 MG/100ML

2




mg, 750 mg 1 MO


200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO












99

?









release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO


mg/12.5ml 1




MG

2 MO



& 14 & 21 &28 MG

2


THERAPY PACK 7 & 14 & 21 &28 -10 MG 2






1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4


2 MO








100

?






mcg/ml

1 MO






mg 1 MO







200 mg, 300 mg 1 MO






2 PA






400 MG, 50 MG 2 MO




mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg 1 MO








101

?



24 hour 120 mg, 160 mg, 60 mg, 80 mg 1 MO


mg/5ml 1 MO


60 mg, 80 mg 1 MO




MG, 1 MG 2 MO







4.5 mg, 6 mg 1 MO


HOUR 13.3 MG/24HR, 4.6 MG/24HR, 9.5

MG/24HR

2 MO









MG

2





MG/0.3ML

2








102

?









MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO



















mg/ml 3




25 MG, 50 MG

2 MO



mg 1 MO








103

?








50 MG

2 MO


300 MG/15ML 2 PA


mg/5ml 1




MG/20ML 2



200 MG, 50 MG 2 MO









DISORDER OF NERVE













104

?



20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20

mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80

mg

1 MO








600 MG, 800 MG 2 MO





25-200 MG

2 MO












mg 1 PA; HR; MO



MG/5ML 2 PA



25 MG, 50 MG, 75 MG 2 PA; MO








105

?






12 hour 100 mg, 200 mg, 300 mg 1 MO


hour 100 mg, 200 mg, 400 mg 1 MO





release 25-100 mg, 50-200 mg 1 MO


100 mg, 25-250 mg 1 MO


100 mg, 25-100 mg, 25-250 mg 1 MO



PE/10ML 2





mg, 0.5 mg, 1 mg, 2 mg 1 MO









25 MG, 35 MG

2 MO








106

?





mg 1 MO








mg/ml 1



mg 3



24 hour 250 mg, 500 mg 1 MO




mg, 250 mg, 500 mg 1 MO



















107

?







pe/2ml 1














mg, 8 mg 1 MO


GM/25ML 2 BD











mg, 50 mg 1 PA; HR








108

?







MG/4ML 2 LA; MO




25 (42)-100 (7) MG, 25 (84)-100(14) MG 2


25 (21)-50 (7) MG, 50 & 100 & 200 MG 2


hour 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, 50

mg

1 MO


25 mg 1 MO



mg, 25 mg, 50 mg 1 MO





MG/100ML, 500 MG/100ML

2




mg, 750 mg 1 MO



200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO









109

?













release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO


mg/12.5ml 1




MG

2 MO



& 14 & 21 &28 MG

2


THERAPY PACK 7 & 14 & 21 &28 -10 MG 2










110

?





1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4


2 MO





mcg/ml

1 MO






mg 1 MO







200 mg, 300 mg 1 MO






2 PA






400 MG, 50 MG 2 MO








111

?





mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg 1 MO


24 hour 120 mg, 160 mg, 60 mg, 80 mg 1 MO


mg/5ml 1 MO


60 mg, 80 mg 1 MO





MG, 1 MG 2 MO









4.5 mg, 6 mg 1 MO


HOUR 13.3 MG/24HR, 4.6 MG/24HR, 9.5

MG/24HR

2 MO














112

?




MG

2





MG/0.3ML

2








MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO

























113

?



mg/ml 3




25 MG, 50 MG

2 MO



mg 1 MO







50 MG

2 MO


300 MG/15ML 2 PA


mg/5ml 1




MG/20ML 2



200 MG, 50 MG 2 MO













114

?





EXTREME DISCOMFORT IN

CALVES WHEN SITTING OR LYING

DOWN


1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4


2 MO


mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg 1 MO




THE NERVOUS SYSTEM



GM/25ML 2 BD








PARALYSIS


DISORDER OF REPRODUCTIVE

SYSTEM

"CHANGE OF LIFE" SIGNS

BRISDELLE ORAL CAPSULE 7.5 MG 2 MO

estradiol oral tablet 0.5 mg, 1 mg, 2 mg 1 PA; HR; MO

fyavolv oral tablet 0.5-2.5 mg-mcg, 1-5 mg-mcg 1 PA; HR; MO








115

?


PREMARIN ORAL TABLET 0.3 MG, 0.45 MG,

0.625 MG, 0.9 MG, 1.25 MG 2 PA; HR; MO



1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO

ABNORMAL BLEEDING FROM THE

UTERUS




2.5 mg, 5 mg 1 MO





BIRTH CONTROL

alyacen 1/35 oral tablet 1-35 mg-mcg 1 MO

bekyree oral tablet 0.15-0.02/0.01 mg (21/5) 1 MO

blisovi 24 fe oral tablet 1-20 mg-mcg(24) 1 MO

blisovi fe 1.5/30 oral tablet 1.5-30 mg-mcg 1 MO

blisovi fe 1/20 oral tablet 1-20 mg-mcg 1 MO

caziant oral tablet 0.1/0.125/0.15 -0.025 mg 1 MO

drospirenone-ethinyl estradiol oral tablet 3-0.02

mg 1 MO

ECONTRA EZ TABLET 1.5 MG ORAL 1.5 MG 3

ethynodiol diac-eth estradiol oral tablet 1-50 mg-

mcg 1 MO

femynor oral tablet 0.25-35 mg-mcg 1 MO

juleber oral tablet 0.15-30 mg-mcg 1 MO

kaitlib fe oral tablet chewable 0.8-25 mg-mcg 1 MO

kimidess oral tablet 0.15-0.02/0.01 mg (21/5) 1 MO

larissia oral tablet 0.1-20 mg-mcg 1 MO








116

?


levonorg-eth estrad triphasic oral tablet 1 MO

low-ogestrel oral tablet 0.3-30 mg-mcg 1 MO

lyza oral tablet 0.35 mg 1 MO

medroxyprogesterone acetate intramuscular

suspension 150 mg/ml 1

norethindrone acet-ethinyl est oral tablet 1-20

mg-mcg 1 MO

norethindrone oral tablet 0.35 mg 1 MO

norgestimate-eth estradiol oral tablet 0.25-35 mg-

mcg 1 MO

norgestim-eth estrad triphasic oral tablet

0.18/0.215/0.25 mg-25 mcg, 0.18/0.215/0.25 mg-

35 mcg

1 MO

pirmella 1/35 oral tablet 1-35 mg-mcg 1 MO

setlakin oral tablet 0.15-0.03 mg 1 MO; QL (91 EA per 91 days)

tri-lo-estarylla oral tablet 0.18/0.215/0.25 mg-25

mcg 1 MO

tri-lo-sprintec oral tablet 0.18/0.215/0.25 mg-25

mcg 1 MO

trinessa (28) oral tablet 0.18/0.215/0.25 mg-35

mcg 1 MO

tri-previfem oral tablet 0.18/0.215/0.25 mg-35

mcg 1 MO

tri-sprintec oral tablet 0.18/0.215/0.25 mg-35

mcg 1

vienva oral tablet 0.1-20 mg-mcg 1 MO

vyfemla oral tablet 0.4-35 mg-mcg 1 MO

BLEEDING FROM THE





2.5 mg, 5 mg 1 MO









117

?







BREAST DISEASE

adrucil intravenous solution 500 mg/10ml 1 BD


MG, 7.5 MG 2

exemestane oral tablet 25 mg 1 MO

fluorouracil intravenous solution 2.5 gm/50ml 1 BD

letrozole oral tablet 2.5 mg 1 MO

raloxifene hcl oral tablet 60 mg 1 MO

SOLTAMOX ORAL SOLUTION 10 MG/5ML 2 MO

tamoxifen citrate oral tablet 10 mg, 20 mg 1 MO

DEFECTIVE INTERNAL

SECRETION OF OVARIES

alendronate sodium oral tablet 10 mg, 35 mg, 5

mg, 70 mg 1 MO

calcitonin (salmon) nasal solution 200 unit/act 1 BD; MO



1250 (500 ca) mg 3


600-200 mg-unit 3

FORTEO SUBCUTANEOUS SOLUTION 600

MCG/2.4ML 2 MO

FOSAMAX PLUS D ORAL TABLET 70-2800

MG-UNIT 2 MO; QL (4 EA per 28 days)


MG-UNIT 2 MO









118

?


ibandronate sodium oral tablet 150 mg 1 MO


600-400 mg-unit 3

MENEST ORAL TABLET 0.3 MG, 0.625 MG,

1.25 MG 2 PA; HR; MO

MIACALCIN INJECTION SOLUTION 200

UNIT/ML 2


MG-UNIT 3




0.625 MG, 0.9 MG, 1.25 MG 2 PA; HR; MO




1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO

PROLIA SUBCUTANEOUS SOLUTION 60

MG/ML 2


risedronate sodium oral tablet 150 mg, 35 mg, 5

mg 1 MO

risedronate sodium oral tablet delayed release 35

mg 1 MO




zoledronic acid intravenous solution 5 mg/100ml 1 BD

DEFICIENT ACTIVITY OF THE

TESTIS

ANDRODERM TRANSDERMAL PATCH 24

HOUR 2 MG/24HR, 4 MG/24HR 2 MO

methyltestosterone oral capsule 10 mg 1 MO








119

?


testosterone cypionate intramuscular solution 100

mg/ml, 200 mg/ml 1

testosterone enanthate intramuscular solution 200

mg/ml 1

ENDOMETRIOSIS

danazol oral capsule 100 mg, 200 mg, 50 mg 1






SYNAREL NASAL SOLUTION 2 MG/ML 2

INFLAMMATION OR INFECTION

OF VAGINA










1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO
















120

?








1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO




MASS OF UTERINE ADNEXA

LYNPARZA ORAL CAPSULE 50 MG 2 PA

RUBRACA ORAL TABLET 200 MG, 300 MG 2 PA

NEOPLASM OF FEMALE GENITAL

ORGAN


MG, 7.5 MG 2




GARDASIL 9 INTRAMUSCULAR

SUSPENSION 2


SUSPENSION PREFILLED SYRINGE 2

GARDASIL INTRAMUSCULAR

SUSPENSION 2















121

?






OVERGROWTH OF THE UTERINE

LINING


2.5 mg, 5 mg 1 MO

PAIN IN THE VULVA


PREMENSTRUAL SYNDROME


mg 1 MO

PROBLEM WITH PERIODS




2.5 mg, 5 mg 1 MO



PROBLEMS GETTING PREGNANT


mg, 70 mg 1 MO






1250 (500 ca) mg 3


600-200 mg-unit 3








122

?



MCG/2.4ML 2 MO




MG-UNIT 2 MO




600-400 mg-unit 3





UNIT/ML 2


MG-UNIT 3




0.625 MG, 0.9 MG, 1.25 MG 2 PA; HR; MO




1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO


MG/ML 2



mg 1 MO


mg 1 MO










123

?



mg/ml, 200 mg/ml 1


mg/ml 1



STIMULATION OF OVARIAN

FUNCTION

chorionic gonadotropin intramuscular solution

reconstituted 10000 unit 1 PA

WASTING OF TISSUES OF THE

VULVA




1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO


DISORDER OF RESPIRATORY

SYSTEM

ALLERGIES AFFECTING THE

SINUSES, NOSE OR THROAT


5-120 mg oral 5-120 mg 3




MG 3




1-2.5 mg/5ml 3









124

?








% 1 MO


MG 3




10-240 mg oral 10-240 mg 3





mg 1 MO


MG ORAL 4-60 MG 3


MG/5ML 3



AN INCREASE IN THE THICKNESS

OF LUNG SECRETIONS

acetylcysteine inhalation solution 10 % 1 BD

BREATHING CHANGES


CHRONIC LUNG OR BREATHING

PASSAGE PROBLEM









125

?



MG, 2 MG, 2.5 MG 2 MO




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO




(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO










2 MO













2 MO








126

?





mcg/act 1





2 MO



% 1 MO


(3) mg/3ml 1 BD; MO









mg 1 MO








125 MG 2 PA; MO












127

?





2 MO




MG/ML 2 BD; MO



50 MCG/DOSE

2 MO


mg/12.5ml 1 PA



CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO


mg/5ml 1 BD
















128

?







DECREASED OXYGEN IN THE

TISSUES OR BLOOD


DRYNESS OF THE NOSE


0.65 % 3

HICCUPS

chlorpromazine hcl oral tablet 10 mg 1 BD; MO

chlorpromazine hcl oral tablet 100 mg, 200 mg,

25 mg, 50 mg 1 MO


RESPIRATORY TRACT

ADACEL INTRAMUSCULAR SUSPENSION

5-2-15.5 LF-MCG/0.5 2




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO


5-120 mg oral 5-120 mg 3




MG 3









129

?




BOOSTRIX INTRAMUSCULAR

SUSPENSION 5-2.5-18.5 2




2 MO




1-2.5 mg/5ml 3

clotrimazole mouth/throat troche 10 mg 1


2.5-1-5 mg/5ml 3


400 MG 3






DAPTACEL INTRAMUSCULAR

SUSPENSION 10-15-5 2




0.05 % 3



ORAL 2.5-1-5 MG/5ML 3




2 MO








130

?






mcg/act 1





2 MO


INFANRIX INTRAMUSCULAR SUSPENSION

25-58-10 2


% 1 MO


1-5 mg/5ml 3

KINRIX INTRAMUSCULAR SUSPENSION 2


MG 3




10-240 mg oral 10-240 mg 3





mg 1 MO


oral 5-100 mg/5ml 3












131

?



mg/5ml 3


mg 3





RELEASE 100 MG 2 MO




0.65 % 3

ORAVIG BUCCAL TABLET 50 MG 2

PASER ORAL PACKET 4 GM 2

PEDIARIX INTRAMUSCULAR SUSPENSION 2




PRIFTIN ORAL TABLET 150 MG 2




2 MO



QUADRACEL INTRAMUSCULAR

SUSPENSION 2

RIFATER ORAL TABLET 50-120-300 MG 2





50 MCG/DOSE

2 MO

SIRTURO ORAL TABLET 100 MG 2








132

?



CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




MG ORAL 4-60 MG 3


SYNAGIS INTRAMUSCULAR SOLUTION 50

MG/0.5ML 2


hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO


mg/5ml 1 BD


oral 100 mg/5ml 3


MG/5ML 3











LUNG DISEASE









133

?




5-2-15.5 LF-MCG/0.5 2



MG, 2 MG, 2.5 MG 2 MO




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO




(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO







MG/4ML, 400 MG/16ML 2








2 MO











134

?



25 mg, 50 mg 1 MO















2 MO







2 MO



25-58-10 2



(3) mg/3ml 1 BD; MO














135

?


lidocaine external ointment 5 % 1








mg 1 MO


oral 5-100 mg/5ml 3








RELEASE 100 MG 2 MO






125 MG 2 PA; MO
















136

?





2 MO




MG/ML 2 BD; MO


SUSPENSION 2







50 MCG/DOSE

2 MO


mg/12.5ml 1 PA





CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




MG/0.5ML 2


hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO








137

?



mg/5ml 1 BD



oral 100 mg/5ml 3






MG 2 MO











RESPIRATORY OBSTRUCTION


5-2-15.5 LF-MCG/0.5 2




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO










138

?



(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO











2 MO










2 MO







2 MO


25-58-10 2



(3) mg/3ml 1 BD; MO









139

?







mg 1 MO









2 MO




SUSPENSION 2



50 MCG/DOSE

2 MO


CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO










140

?










DISORDER OF THE DIGESTIVE

SYSTEM

BILIARY AND GALLBLADDER

PROBLEM

ursodiol oral tablet 250 mg, 500 mg 1 MO

BLEEDING OF THE STOMACH OR

INTESTINES









CANCER OF THE STOMACH OR

INTESTINES



MG, 7.5 MG 2


MG/4ML, 400 MG/16ML 2











141

?








RECONSTITUTED 50 MG

2 BD

LONSURF ORAL TABLET 15-6.14 MG, 20-

8.19 MG 2


MG/ML 2 MO

ZANOSAR INTRAVENOUS SOLUTION


CONSTIPATION

AMITIZA ORAL CAPSULE 24 MCG, 8 MCG 2 MO

docusate sodium liquid 50 mg/5ml oral 50

mg/5ml 3

DOCUSIL CAPSULE 100 MG ORAL 100 MG 3

DOK TABLET 100 MG ORAL 100 MG 3

ENEMEEZ MINI ENEMA 283 MG RECTAL

283 MG 3


fiber laxative tablet 625 mg oral 625 mg 3


KONSYL POWDER 30.9 % ORAL 30.9 % 3


LINZESS ORAL CAPSULE 145 MCG, 290

MCG, 72 MCG 2 MO

milk of magnesia suspension 1200 mg/15ml oral

1200 mg/15ml 3

MOVANTIK ORAL TABLET 12.5 MG, 25 MG 2

polyethylene glycol 3350 oral powder 1

RELISTOR ORAL TABLET 150 MG 2








142

?


RELISTOR SUBCUTANEOUS SOLUTION 12

MG/0.6ML, 8 MG/0.4ML 2

SOLUBLE FIBER THERAPY POWDER ORAL 3

DIARRHEA

alosetron hcl oral tablet 0.5 mg, 1 mg 1 MO

anti-diarrheal tablet 2 mg oral 2 mg 3

diphenoxylate-atropine oral liquid 2.5-0.025

mg/5ml 1

diphenoxylate-atropine oral tablet 2.5-0.025 mg 1

loperamide hcl oral capsule 2 mg 1


RELEASE 125 MG 2 MO



mcg/ml

1 MO

paromomycin sulfate oral capsule 250 mg 1



MG

2

sb bismuth suspension 262 mg/15ml oral 262

mg/15ml 3


DISORDER OF COLON



APRISO ORAL CAPSULE EXTENDED

RELEASE 24 HOUR 0.375 GM 2 MO

balsalazide disodium oral capsule 750 mg 1

dicyclomine hcl intramuscular solution 10 mg/ml 1

dicyclomine hcl oral capsule 10 mg 1

dicyclomine hcl oral solution 10 mg/5ml 1

dicyclomine hcl oral tablet 20 mg 1

DIFICID ORAL TABLET 200 MG 2 ST








143

?


DIPENTUM ORAL CAPSULE 250 MG 2 MO

docusate sodium liquid 50 mg/5ml oral 50

mg/5ml 3


DOK TABLET 100 MG ORAL 100 MG 3

ENEMEEZ MINI ENEMA 283 MG RECTAL

283 MG 3


fiber laxative tablet 625 mg oral 625 mg 3




LIALDA ORAL TABLET DELAYED

RELEASE 1.2 GM 2


MCG, 72 MCG 2 MO

MESALAMINE ORAL TABLET DELAYED

RELEASE 800 MG 2

mesalamine-cleanser rectal kit 4 gm 1


1200 mg/15ml 3


polyethylene glycol 3350 oral powder 1



MG/0.6ML, 8 MG/0.4ML 2

SOLUBLE FIBER THERAPY POWDER ORAL 3

sulfasalazine oral tablet 500 mg 1 MO


UCERIS ORAL TABLET EXTENDED

RELEASE 24 HOUR 9 MG 2 ST

UCERIS RECTAL FOAM 2 MG/ACT 2 ST









144

?


DISORDER OF THE ESOPHAGUS

OR STOMACH

ABREVA CREAM 10 % EXTERNAL 10 % 3 QL (2 GM per 30 days)

acid reducer tablet 10 mg oral 10 mg 3 QL (60 EA per 30 days)

ALKA-SELTZER GOLD TABLET

EFFERVESCENT 832-312-958 MG ORAL 832-

312-958 MG

3

ALMACONE TABLET CHEWABLE 200-200-

25 MG ORAL 200-200-25 MG 3

antacid plus anti-gas relief suspension 200-200-

20 mg/5ml oral 200-200-20 mg/5ml 3



calcium antacid tablet chewable 500 mg oral 500

mg 3

calcium antacid ultra max st tablet chewable

1000 mg oral 1000 mg 3

CARAFATE ORAL SUSPENSION 1 GM/10ML 2 MO

chlorhexidine gluconate mouth/throat solution

0.12 % 1

cvs lansoprazole capsule delayed release 15 mg

oral 15 mg 3 MO



famotidine intravenous solution 20 mg/2ml 1

famotidine oral tablet 20 mg, 40 mg 1 MO

FAMOTIDINE PREMIXED INTRAVENOUS

SOLUTION 20-0.9 MG/50ML-% 2




2 BD

gnp foaming antacid suspension 95-358 mg/15ml

oral 95-358 mg/15ml 3








145

?


lansoprazole oral capsule delayed release 15 mg,

30 mg 1 MO

MAALOX MAX SUSPENSION 400-400-40

MG/5ML ORAL 400-400-40 MG/5ML 3

methscopolamine bromide oral tablet 2.5 mg 1




omeprazole oral capsule delayed release 10 mg,

20 mg, 40 mg 1 MO

omeprazole tablet delayed release 20 mg oral 20







ROTARIX ORAL SUSPENSION

RECONSTITUTED 2

ROTATEQ ORAL SOLUTION 2


mg/15ml 3

sodium bicarbonate oral tablet 650 mg 3

sucralfate oral tablet 1 gm 1 MO

triamcinolone acetonide mouth/throat paste 0.1 % 1

TYPHIM VI INTRAMUSCULAR SOLUTION

25 MCG/0.5ML 2



EMPTYING OF THE BOWEL

peg 3350-kcl-na bicarb-nacl oral solution

reconstituted 420 gm 1








146

?


PREPOPIK ORAL PACKET 10-3.5-12 MG-GM-

GM 2

EXOCRINE PANCREATIC

INSUFFICIENCY

CREON ORAL CAPSULE DELAYED

RELEASE PARTICLES 12000 UNIT, 24000

UNIT, 3000-9500 UNIT, 36000 UNIT, 6000

UNIT

2 MO

ZENPEP ORAL CAPSULE DELAYED

RELEASE PARTICLES 10000 UNIT, 15000

UNIT, 20000 UNIT, 25000 UNIT, 3000-10000

UNIT, 5000 UNIT

2 MO

GAS


25 MG ORAL 200-200-25 MG 3


20 mg/5ml oral 200-200-20 mg/5ml 3


MG/5ML ORAL 400-400-40 MG/5ML 3

HUNTER SYNDROME


MG/3ML 2 BD

INFLAMMATION OF THE LINING

OF THE STOMACH AND

INTESTINES


RECONSTITUTED 2



25 MCG/0.5ML 2

INFLAMMATORY BOWEL DISEASE











147

?


budesonide oral capsule delayed release particles

3 mg 1






oral 15 mg 3 MO







40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO


30 mg 1 MO


RELEASE 1.2 GM 2


RELEASE 800 MG 2



20 mg, 40 mg 1 MO








148

?





RECONSTITUTED 2


STELARA SUBCUTANEOUS SOLUTION


MG/ML

2 ST; MO





25 MCG/0.5ML 2


300 MG/15ML 2 PA





DIGESTIVE SYSTEM

adefovir dipivoxil oral tablet 10 mg 1 MO




BARACLUDE ORAL SOLUTION 0.05 MG/ML 2 MO


3 mg 1






oral 15 mg 3 MO








149

?


DAKLINZA ORAL TABLET 30 MG, 60 MG,

90 MG 2 PA



ENGERIX-B INJECTION SUSPENSION 10

MCG/0.5ML, 20 MCG/ML 2 BD

entecavir oral tablet 0.5 mg, 1 mg 1 MO

EPCLUSA ORAL TABLET 400-100 MG 2 PA

EPIVIR HBV ORAL SOLUTION 5 MG/ML 2 MO



GAMASTAN S/D INTRAMUSCULAR

INJECTABLE 2 BD

HARVONI ORAL TABLET 90-400 MG 2 PA

HAVRIX INTRAMUSCULAR SUSPENSION

1440 EL U/ML, 720 EL U/0.5ML 2



40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO

INTRON A INJECTION SOLUTION 10000000

UNIT/ML, 6000000 UNIT/ML 2 MO

INTRON A INJECTION SOLUTION

RECONSTITUTED 10000000 UNIT, 18000000

UNIT, 50000000 UNIT

2 MO








150

?


lamivudine oral tablet 100 mg 1 MO


30 mg 1 MO


RELEASE 1.2 GM 2


RELEASE 800 MG 2



20 mg, 40 mg 1 MO




PEGASYS PROCLICK SUBCUTANEOUS

SOLUTION 135 MCG/0.5ML, 180 MCG/0.5ML 2

PEGASYS SUBCUTANEOUS SOLUTION 180

MCG/0.5ML, 180 MCG/ML 2

PEG-INTRON REDIPEN SUBCUTANEOUS

KIT 120 MCG/0.5ML 2

PEGINTRON SUBCUTANEOUS KIT 50

MCG/0.5ML 2


50 MG, 75 MG 2 MO





RECOMBIVAX HB INJECTION SUSPENSION

10 MCG/ML, 40 MCG/ML, 5 MCG/0.5ML 2 BD

RIBASPHERE ORAL TABLET 400 MG 2

ribasphere ribapak oral tablet 200 & 400 mg, 400

& 600 mg, 400 mg 1

ribavirin oral capsule 200 mg 1

ribavirin oral tablet 200 mg 1








151

?



RECONSTITUTED 2


SOVALDI ORAL TABLET 400 MG 2 PA



MG/ML

2 ST; MO




TWINRIX INTRAMUSCULAR SUSPENSION

720-20 2


25 MCG/0.5ML 2


300 MG/15ML 2 PA




VAQTA INTRAMUSCULAR SUSPENSION 25

UNIT/0.5ML, 50 UNIT/ML 2

VEMLIDY ORAL TABLET 25 MG 2 PA; MO



250 MG, 300 MG 2 MO



ZEPATIER ORAL TABLET 50-100 MG 2 PA

INTESTINAL PARASITIC

INFECTION

ALINIA ORAL SUSPENSION

RECONSTITUTED 100 MG/5ML 2

ALINIA ORAL TABLET 500 MG 2








152

?


ivermectin oral tablet 3 mg 1


IRRITABLE COLON



dicyclomine hcl intramuscular solution 10 mg/ml 1

dicyclomine hcl oral capsule 10 mg 1


dicyclomine hcl oral tablet 20 mg 1


MCG, 72 MCG 2 MO


IRRITATION OF THE STOMACH

OR INTESTINES



oral 15 mg 3 MO




30 mg 1 MO


20 mg, 40 mg 1 MO




RECONSTITUTED 2




25 MCG/0.5ML 2

LIVER PROBLEMS








153

?






mg, 50 mg 1 BD; MO




90 MG 2 PA









INJECTABLE 2 BD







1440 EL U/ML, 720 EL U/0.5ML 2





UNIT, 50000000 UNIT

2 MO










154

?














KIT 120 MCG/0.5ML 2


MCG/0.5ML 2


MG/ML 2 BD


50 MG, 75 MG 2 MO





& 600 mg, 400 mg 1




MG 2 BD; MO


MG/ML 2 BD; MO












155

?



720-20 2

ursodiol oral tablet 250 mg, 500 mg 1 MO






250 MG, 300 MG 2 MO




0.75 MG 2 BD; MO

MALABSORPTION

GATTEX SUBCUTANEOUS KIT 5 MG 2 MO

NAUSEA AND VOMITING

APREPITANT ORAL CAPSULE 125 MG, 40

MG, 80 & 125 MG, 80 MG 2 BD

compro rectal suppository 25 mg 1


EMEND INTRAVENOUS SOLUTION


EMEND ORAL SUSPENSION


granisetron hcl intravenous solution 0.1 mg/ml, 1

mg/ml 1 BD; QL (60 ML per 30 days)

granisetron hcl oral tablet 1 mg 1 BD; QL (60 EA per 30 days)

hydroxyzine hcl intramuscular solution 25 mg/ml,

50 mg/ml 1 PA; HR



metoclopramide hcl injection solution 5 mg/ml 1

motion sickness tablet 50 mg oral 50 mg 3








156

?


ondansetron hcl injection solution 4 mg/2ml 1 BD; QL (160 ML per 30 days)

ondansetron hcl oral solution 4 mg/5ml 1 BD

ondansetron hcl oral tablet 24 mg 1 BD; QL (30 EA per 30 days)

ondansetron hcl oral tablet 4 mg, 8 mg 1 BD; QL (60 EA per 30 days)

ondansetron oral tablet dispersible 4 mg, 8 mg 1 BD; QL (60 EA per 30 days)

prochlorperazine edisylate injection solution 5

mg/ml 1

prochlorperazine maleate oral tablet 10 mg, 5 mg 1 MO

prochlorperazine rectal suppository 25 mg 1

promethazine hcl oral tablet 12.5 mg 1

SANCUSO TRANSDERMAL PATCH 3.1

MG/24HR 2 QL (4 EA per 28 days)

TRANSDERM-SCOP (1.5 MG)

TRANSDERMAL PATCH 72 HOUR 1

MG/3DAYS

2

RECTAL DISORDER




ARTHRITIS


STOMACH OR INTESTINAL TRACT

OPERATION


neomycin sulfate oral tablet 500 mg 1

STOMACH OR INTESTINAL ULCER






oral 15 mg 3 MO








157

?










30 mg 1 MO


RELEASE 1.2 GM 2


RELEASE 800 MG 2


methscopolamine bromide oral tablet 2.5 mg 1

misoprostol oral tablet 100 mcg, 200 mcg 1 MO


20 mg, 40 mg 1 MO






















158

?


DISORDER OF THE ENDOCRINE

GLANDS

ACROMEGALY



mcg/ml

1 MO



MG

2



MG/0.3ML

2



ADRENAL GLAND PROBLEMS

dexamethasone oral elixir 0.5 mg/5ml 1

dexamethasone oral tablet 0.5 mg, 0.75 mg, 1 mg,

1.5 mg, 2 mg, 4 mg, 6 mg 1

dexamethasone sodium phosphate injection

solution 10 mg/ml, 120 mg/30ml 1

fludrocortisone acetate oral tablet 0.1 mg 1 MO



LYSODREN ORAL TABLET 500 MG 2




mg, 8 mg 1













159

?




SIGNIFOR SUBCUTANEOUS SOLUTION 0.3

MG/ML, 0.6 MG/ML, 0.9 MG/ML 2 MO

DEFECTIVE INTERNAL

SECRETION OF OVARIES


mg, 70 mg 1 MO




1250 (500 ca) mg 3


600-200 mg-unit 3


MCG/2.4ML 2 MO




MG-UNIT 2 MO




600-400 mg-unit 3




UNIT/ML 2


MG-UNIT 3




0.625 MG, 0.9 MG, 1.25 MG 2 PA; HR; MO








160

?





1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO


MG/ML 2



mg 1 MO


mg 1 MO





DEFICIENCY OF GONADOTROPIN

RELEASING FACTOR





mg/ml, 200 mg/ml 1

DEFICIENCY OF THE HORMONE

ESTROGEN



DEFICIENT ACTIVITY OF THE

TESTIS





mg/ml, 200 mg/ml 1








161

?



mg/ml 1

DIABETES

acarbose oral tablet 100 mg, 25 mg, 50 mg 1 MO

AVANDIA ORAL TABLET 2 MG, 4 MG 2 MO

BYDUREON SUBCUTANEOUS PEN-

INJECTOR 2 MG 2 MO

BYDUREON SUBCUTANEOUS SUSPENSION

RECONSTITUTED ER 2 MG 2 MO






mg 1 MO

chlorpropamide oral tablet 100 mg, 250 mg 1 PA; HR; MO

CYCLOSET ORAL TABLET 0.8 MG 2 MO

glimepiride oral tablet 1 mg, 2 mg, 4 mg 1 MO

glipizide er oral tablet extended release 24 hour

10 mg, 2.5 mg, 5 mg 1 MO

glipizide oral tablet 10 mg, 5 mg 1 MO

glipizide-metformin hcl oral tablet 2.5-250 mg,

2.5-500 mg, 5-500 mg 1 MO

glyburide micronized oral tablet 1.5 mg, 3 mg, 6

mg 1 PA; HR; MO

glyburide oral tablet 1.25 mg, 2.5 mg, 5 mg 1 PA; HR; MO

glyburide-metformin oral tablet 1.25-250 mg, 2.5-

500 mg, 5-500 mg 1 PA; HR; MO

INVOKAMET ORAL TABLET 150-1000 MG,

150-500 MG, 50-1000 MG, 50-500 MG 2 MO

INVOKAMET XR ORAL TABLET

EXTENDED RELEASE 24 HOUR 150-1000

MG, 150-500 MG, 50-1000 MG, 50-500 MG

2 MO

INVOKANA ORAL TABLET 100 MG, 300 MG 2 MO








162

?


JANUMET ORAL TABLET 50-1000 MG, 50-

500 MG 2 MO

JANUMET XR ORAL TABLET EXTENDED

RELEASE 24 HOUR 100-1000 MG, 50-1000

MG, 50-500 MG

2 MO

JANUVIA ORAL TABLET 100 MG, 25 MG, 50

MG 2 MO

JARDIANCE ORAL TABLET 10 MG, 25 MG 2 MO

JENTADUETO ORAL TABLET 2.5-1000 MG,

2.5-500 MG, 2.5-850 MG 2 MO

JENTADUETO XR ORAL TABLET

EXTENDED RELEASE 24 HOUR 2.5-1000

MG, 5-1000 MG

2 MO



200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75

MG

2 MO


metformin hcl er (osm) oral tablet extended


metformin hcl er oral tablet extended release 24


metformin hcl oral tablet 1000 mg, 500 mg, 850

mg 1 MO





nateglinide oral tablet 120 mg, 60 mg 1 MO

pioglitazone hcl oral tablet 15 mg, 30 mg, 45 mg 1 MO

pioglitazone hcl-glimepiride oral tablet 30-2 mg,

30-4 mg 1 MO

pioglitazone hcl-metformin hcl oral tablet 15-500

mg, 15-850 mg 1 MO








163

?





2-500 mg 1 MO

RIOMET ORAL SOLUTION 500 MG/5ML 2 MO





SYNJARDY ORAL TABLET 12.5-1000 MG,

12.5-500 MG, 5-1000 MG, 5-500 MG 2 MO

tolazamide oral tablet 250 mg, 500 mg 1 MO

tolbutamide oral tablet 500 mg 1 MO

TRADJENTA ORAL TABLET 5 MG 2 MO

VICTOZA SUBCUTANEOUS SOLUTION

PEN-INJECTOR 18 MG/3ML 2 MO

DISORDER OF PARATHYROID

GLAND


mg 1 MO



25 MCG 2 MO


2 MCG/ML 2


5 MCG/ML 2 BD





MG 2 MO

FAILURE TO GROW








164

?


ALDURAZYME INTRAVENOUS SOLUTION

2.9 MG/5ML 2 BD; LA


MG/3ML 2 BD


MG/4ML 2 LA; MO

NAGLAZYME INTRAVENOUS SOLUTION 1

MG/ML 2 BD



MG/3ML, 5 MG/1.5ML

2 PA; MO





FEMALE HORMONE

DISTURBANCE




2.5 mg, 5 mg 1 MO


INCREASED GROWTH OF ISLET

CELLS OF PANCREAS


MG/ML 2 MO

INCREASED PROLACTIN IN THE

BLOOD



cabergoline oral tablet 0.5 mg 1

INSULINOMA








165

?



MG/ML 2 MO

LOW BLOOD SUGAR

GLUCAGEN HYPOKIT INJECTION


GLUCAGON EMERGENCY INJECTION KIT 1

MG 2


MG/ML 2 MO

PITUITARY HORMONE

DEFICIENCY

desmopressin ace rhinal tube nasal solution 0.01

% 1 MO

desmopressin ace spray refrig nasal solution 0.01

% 1 MO

desmopressin acetate injection solution 4 mcg/ml 1



MG/4ML 2 LA; MO


mg/ml 1

PUBERTY AT AN EARLIER AGE

THAN WOULD BE EXPECTED


LUPRON DEPOT-PED (1-MONTH)

INTRAMUSCULAR KIT 11.25 MG, 15 MG 2

SYNAREL NASAL SOLUTION 2 MG/ML 2

SYNDROME OF INAPPROPRIATE

ANTIDIURETIC HORMONE

SECRETION

SAMSCA ORAL TABLET 15 MG, 30 MG 2 PA

THYROID PROBLEMS








166

?


levothyroxine sodium oral tablet 100 mcg, 112

mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200

mcg, 25 mcg, 300 mcg, 50 mcg, 75 mcg, 88 mcg

1 MO

levoxyl oral tablet 100 mcg, 112 mcg, 125 mcg,

137 mcg, 150 mcg, 175 mcg, 200 mcg, 25 mcg, 50

mcg, 75 mcg, 88 mcg

1 MO

liothyronine sodium oral tablet 25 mcg, 5 mcg, 50

mcg 1 MO

methimazole oral tablet 10 mg, 5 mg 1 MO

propylthiouracil oral tablet 50 mg 1 MO

SYNTHROID ORAL TABLET 100 MCG, 112

MCG, 125 MCG, 137 MCG, 150 MCG, 175

MCG, 200 MCG, 25 MCG, 300 MCG, 50 MCG,

75 MCG, 88 MCG

2 MO

unithroid oral tablet 100 mcg, 112 mcg, 125 mcg,

150 mcg, 175 mcg, 200 mcg, 25 mcg, 300 mcg, 50

mcg, 75 mcg, 88 mcg

1 MO

EAR PROBLEM

EAR INFLAMMATION

acetic acid otic solution 2 % 1

CIPRODEX OTIC SUSPENSION 0.3-0.1 % 2

dexamethasone sodium phosphate ophthalmic

solution 0.1 % 1

fluocinolone acetonide otic oil 0.01 % 1

neomycin-polymyxin-hc otic solution 1 % 1

neomycin-polymyxin-hc otic suspension 3.5-

10000-1 1

ofloxacin otic solution 0.3 % 1

HEARING DISORDER





INFECTION OF EAR








167

?



EYE DISORDER

ABNORMALITIES OF THE LINING

OF THE EYE

AZASITE OPHTHALMIC SOLUTION 1 % 2

azelastine hcl ophthalmic solution 0.05 % 1

cromolyn sodium ophthalmic solution 4 % 1




2 BD

olopatadine hcl ophthalmic solution 0.1 % 1

PATADAY OPHTHALMIC SOLUTION 0.2 % 2

PAZEO OPHTHALMIC SOLUTION 0.7 % 2

polymyxin b-trimethoprim ophthalmic solution

10000-0.1 unit/ml-% 1

RESTASIS OPHTHALMIC EMULSION 0.05 % 2 MO

sulfacetamide sodium ophthalmic solution 10 % 1

trifluridine ophthalmic solution 1 % 1

DISEASE OF THE CORNEA OF THE

EYE


MURO 128 OPHTHALMIC OINTMENT 5 % 3

MURO 128 SOLUTION 5 % OPHTHALMIC 5

% 3



ZIRGAN OPHTHALMIC GEL 0.15 % 2

DISEASE OF THE RETINA OF THE

EYE



DRY EYE








168

?


artificial tears ophthalmic ointment 83-15 % 3

artificial tears solution 0.4 % ophthalmic 0.4 % 3


gnp artificial tears solution 5-6 mg/ml ophthalmic

5-6 mg/ml 3

REFRESH P.M. OINTMENT OPHTHALMIC 3

REFRESH PLUS SOLUTION 0.5 %

OPHTHALMIC 0.5 % 3


EYE INFECTION


BACITRACIN OPHTHALMIC OINTMENT 500

UNIT/GM 2

bacitracin-polymyxin b ophthalmic ointment 500-

10000 unit/gm 1

erythromycin ophthalmic ointment 5 mg/gm 1



neomycin-bacitracin zn-polymyx ophthalmic

ointment 5-400-10000 1

neomycin-polymyxin-gramicidin ophthalmic

solution 1.75-10000-.025 1

neomycin-polymyxin-hc ophthalmic suspension

3.5-10000-1 1


10000-0.1 unit/ml-% 1


TOBRADEX OPHTHALMIC OINTMENT 0.3-

0.1 % 2

TOBRADEX OPHTHALMIC SUSPENSION

0.3-0.1 % 2

TOBRADEX ST OPHTHALMIC SUSPENSION

0.3-0.05 % 2








169

?


tobramycin-dexamethasone ophthalmic

suspension 0.3-0.1 % 1



EYE SURGERY

flurbiprofen sodium ophthalmic solution 0.03 % 1

INCREASED PRESSURE IN EYES


ALPHAGAN P OPHTHALMIC SOLUTION 0.1

%, 0.15 % 2 MO

apraclonidine hcl ophthalmic solution 0.5 % 1

AZOPT OPHTHALMIC SUSPENSION 1 % 2 MO

betaxolol hcl ophthalmic solution 0.5 % 1 MO

BIMATOPROST OPHTHALMIC SOLUTION

0.03 % 2 MO

brimonidine tartrate ophthalmic solution 0.15 %,

0.2 % 1 MO

carteolol hcl ophthalmic solution 1 % 1 MO

COMBIGAN OPHTHALMIC SOLUTION 0.2-

0.5 % 2 MO

dorzolamide hcl ophthalmic solution 2 % 1 MO

dorzolamide hcl-timolol mal ophthalmic solution

22.3-6.8 mg/ml 1 MO

latanoprost ophthalmic solution 0.005 % 1 MO

levobunolol hcl ophthalmic solution 0.5 % 1 MO

LUMIGAN OPHTHALMIC SOLUTION 0.01 % 2 MO

METHAZOLAMIDE ORAL TABLET 25 MG,

50 MG 2 MO

metipranolol ophthalmic solution 0.3 % 1 MO

PHOSPHOLINE IODIDE OPHTHALMIC

SOLUTION RECONSTITUTED 0.125 % 2 MO

SIMBRINZA OPHTHALMIC SUSPENSION 1-

0.2 % 2 MO








170

?


timolol maleate ophthalmic gel forming solution

0.25 %, 0.5 % 1 MO

timolol maleate ophthalmic solution 0.25 %, 0.5

% 1 MO

TRAVATAN Z OPHTHALMIC SOLUTION

0.004 % 2 MO

INCREASED PRESSURE IN THE

EYE



INFLAMMATION OF THE EYE



BLEPHAMIDE OPHTHALMIC SUSPENSION

10-0.2 % 2

BLEPHAMIDE S.O.P. OPHTHALMIC

OINTMENT 10-0.2 % 2



solution 0.1 % 1

diclofenac sodium ophthalmic solution 0.1 % 1

DUREZOL OPHTHALMIC EMULSION 0.05 % 2




2 BD

ILEVRO OPHTHALMIC SUSPENSION 0.3 % 2

ketorolac tromethamine ophthalmic solution 0.4

%, 0.5 % 1

LOTEMAX OPHTHALMIC GEL 0.5 % 2

LOTEMAX OPHTHALMIC OINTMENT 0.5 % 2

LOTEMAX OPHTHALMIC SUSPENSION 0.5

% 2









171

?





10000-0.1 unit/ml-% 1

prednisolone acetate ophthalmic suspension 1 % 1

prednisolone sodium phosphate ophthalmic

solution 1 % 1



sulfacetamide-prednisolone ophthalmic solution

10-0.23 % 1


0.1 % 2


0.3-0.1 % 2


0.3-0.05 % 2





PAIN IN THE EYE





%, 0.5 % 1

PROBLEMS WITH EYESIGHT


ALPHAGAN P OPHTHALMIC SOLUTION 0.1

%, 0.15 % 2 MO

apraclonidine hcl ophthalmic solution 0.5 % 1









172

?


AZOPT OPHTHALMIC SUSPENSION 1 % 2 MO



0.03 % 2 MO

brimonidine tartrate ophthalmic solution 0.15 %,

0.2 % 1 MO

carteolol hcl ophthalmic solution 1 % 1 MO

COMBIGAN OPHTHALMIC SOLUTION 0.2-

0.5 % 2 MO


dorzolamide hcl ophthalmic solution 2 % 1 MO

dorzolamide hcl-timolol mal ophthalmic solution

22.3-6.8 mg/ml 1 MO

latanoprost ophthalmic solution 0.005 % 1 MO


LUMIGAN OPHTHALMIC SOLUTION 0.01 % 2 MO

METHAZOLAMIDE ORAL TABLET 25 MG,

50 MG 2 MO

metipranolol ophthalmic solution 0.3 % 1 MO

PHOSPHOLINE IODIDE OPHTHALMIC

SOLUTION RECONSTITUTED 0.125 % 2 MO

SIMBRINZA OPHTHALMIC SUSPENSION 1-

0.2 % 2 MO

timolol maleate ophthalmic gel forming solution

0.25 %, 0.5 % 1 MO

timolol maleate ophthalmic solution 0.25 %, 0.5

% 1 MO

TRAVATAN Z OPHTHALMIC SOLUTION

0.004 % 2 MO

PUPIL ABNORMALITIES










173

?




ARTHRITIS


FEVER

FEVER

ACEPHEN SUPPOSITORY 120 MG RECTAL

120 MG 3 QL (200 EA per 30 days)











childrens acetaminophen tablet dispersible 80 mg

oral 80 mg 3 QL (200 EA per 30 days)

childrens non-aspirin tablet chewable 80 mg oral

80 mg 3

goodsense pain relief extra st tablet 500 mg oral


goodsense pain relief tablet extended release 650

mg oral 650 mg 3 QL (200 EA per 30 days)

mapap tablet 325 mg oral 325 mg 3

pain relief childrens suspension 160 mg/5ml oral

160 mg/5ml 3

q-pap infants solution 80 mg/0.8ml oral 80

mg/0.8ml 3

KAWASAKI DISEASE








174

?





2 BD

INFECTION

ACUTE INFECTION OF THE NOSE,

THROAT OR SINUS


5-120 mg oral 5-120 mg 3




MG 3







1-2.5 mg/5ml 3



2.5-1-5 mg/5ml 3


400 MG 3






0.05 % 3



ORAL 2.5-1-5 MG/5ML 3








175

?




mcg/act 1



% 1 MO


1-5 mg/5ml 3


MG 3




10-240 mg oral 10-240 mg 3





mg 1 MO


oral 5-100 mg/5ml 3






mg/5ml 3


mg 3



0.65 % 3









176

?






MG ORAL 4-60 MG 3



MG/0.5ML 2


oral 100 mg/5ml 3


MG/5ML 3



CLOSTRIDIUM DIFFICILE

INFECTION


DISEASES OF CHILDHOOD

ACTHIB INTRAMUSCULAR SOLUTION

RECONSTITUTED 2


5-2-15.5 LF-MCG/0.5 2





DIPHTHERIA-TETANUS TOXOIDS DT

INTRAMUSCULAR SUSPENSION 25-5

LFU/0.5ML

2

HIBERIX INJECTION SOLUTION

RECONSTITUTED 10 MCG 2


25-58-10 2

IPOL INJECTION INJECTABLE 2








177

?



MENHIBRIX INTRAMUSCULAR SOLUTION

RECONSTITUTED 5-5-2.5 MCG 2

M-M-R II SUBCUTANEOUS INJECTABLE 2


PEDVAX HIB INTRAMUSCULAR

SUSPENSION 7.5 MCG/0.5ML 2

PROQUAD SUBCUTANEOUS INJECTABLE 2


SUSPENSION 2


MG/0.5ML 2

TENIVAC INTRAMUSCULAR INJECTABLE

5-2 LFU 2

TETANUS-DIPHTHERIA TOXOIDS TD


LF/0.5ML

2 BD

VARIVAX SUBCUTANEOUS INJECTABLE

1350 PFU/0.5ML 2

EYE INFECTION


BACITRACIN OPHTHALMIC OINTMENT 500

UNIT/GM 2

bacitracin-polymyxin b ophthalmic ointment 500-

10000 unit/gm 1

erythromycin ophthalmic ointment 5 mg/gm 1



neomycin-bacitracin zn-polymyx ophthalmic

ointment 5-400-10000 1

neomycin-polymyxin-gramicidin ophthalmic

solution 1.75-10000-.025 1

neomycin-polymyxin-hc ophthalmic suspension

3.5-10000-1 1








178

?



10000-0.1 unit/ml-% 1



0.1 % 2


0.3-0.1 % 2


0.3-0.05 % 2





INFECTION AFFECTING THE

ENTIRE BODY

BEXSERO INTRAMUSCULAR SUSPENSION

PREFILLED SYRINGE 2

MENACTRA INTRAMUSCULAR

INJECTABLE 2



MENVEO INTRAMUSCULAR SOLUTION

RECONSTITUTED 2

TRUMENBA INTRAMUSCULAR


INFECTION AROUND A TOOTH


0.12 % 1

INFECTION CAUSED BY A FUNGUS

ciclopirox external solution 8 % 1










179

?


ERAXIS INTRAVENOUS SOLUTION

RECONSTITUTED 100 MG, 50 MG 2

griseofulvin microsize oral suspension 125

mg/5ml 1

griseofulvin microsize oral tablet 500 mg 1

griseofulvin ultramicrosize oral tablet 125 mg,

250 mg 1








RELEASE 100 MG 2 MO

nystatin external cream 100000 unit/gm 1

nystatin external ointment 100000 unit/gm 1

nystatin external powder 100000 unit/gm 1

nystatin mouth/throat suspension 100000 unit/ml 1

nystatin oral tablet 500000 unit 1

nystatin-triamcinolone external cream 100000-

0.1 unit/gm-% 1

nystatin-triamcinolone external ointment 100000-

0.1 unit/gm-% 1






INFECTION CAUSED BY A VIRUS

abacavir sulfate oral tablet 300 mg 1 MO










180

?



150-300 mg 1 MO






APTIVUS ORAL CAPSULE 250 MG 2 MO

APTIVUS ORAL SOLUTION 100 MG/ML 2 MO

ATRIPLA ORAL TABLET 600-200-300 MG 2 MO


COMPLERA ORAL TABLET 200-25-300 MG 2 MO

CONDYLOX EXTERNAL GEL 0.5 % 2

CRIXIVAN ORAL CAPSULE 200 MG, 400 MG 2 MO


90 MG 2 PA


DESCOVY ORAL TABLET 200-25 MG 2 MO

didanosine oral capsule delayed release 125 mg,

200 mg, 250 mg, 400 mg 1 MO


EDURANT ORAL TABLET 25 MG 2 MO

EMTRIVA ORAL CAPSULE 200 MG 2 MO

EMTRIVA ORAL SOLUTION 10 MG/ML 2 MO






EVOTAZ ORAL TABLET 300-150 MG 2 MO

FUZEON SUBCUTANEOUS SOLUTION









181

?






INJECTABLE 2 BD




SUSPENSION 2




SUSPENSION 2

GENVOYA ORAL TABLET 150-150-200-10

MG 2 MO



1440 EL U/ML, 720 EL U/0.5ML 2



imiquimod external cream 5 % 1



INTELENCE ORAL TABLET 100 MG, 200

MG, 25 MG 2 MO





UNIT, 50000000 UNIT

2 MO

INVIRASE ORAL CAPSULE 200 MG 2 MO

INVIRASE ORAL TABLET 500 MG 2 MO


ISENTRESS ORAL PACKET 100 MG 2 MO








182

?


ISENTRESS ORAL TABLET 400 MG 2 MO

ISENTRESS ORAL TABLET CHEWABLE 100

MG, 25 MG 2 MO


KALETRA ORAL TABLET 100-25 MG, 200-50

MG 2 MO



lamivudine oral tablet 100 mg, 150 mg, 300 mg 1 MO

lamivudine-zidovudine oral tablet 150-300 mg 1 MO

LEXIVA ORAL SUSPENSION 50 MG/ML 2 MO

LEXIVA ORAL TABLET 700 MG 2 MO



400-100 MG/5ML 2 MO


MG/5ML 2 PA; HR; MO



M-M-R II SUBCUTANEOUS INJECTABLE 2


RELEASE 125 MG 2 MO


100 mg, 400 mg 1 MO

NEVIRAPINE ORAL SUSPENSION 50

MG/5ML 2 MO

nevirapine oral tablet 200 mg 1 MO



MG/3ML, 5 MG/1.5ML

2 PA; MO

NORVIR ORAL CAPSULE 100 MG 2 MO

NORVIR ORAL SOLUTION 80 MG/ML 2 MO

NORVIR ORAL TABLET 100 MG 2 MO








183

?






ODEFSEY ORAL TABLET 200-25-25 MG 2 MO

OSELTAMIVIR PHOSPHATE ORAL

CAPSULE 30 MG, 45 MG, 75 MG 2







KIT 120 MCG/0.5ML 2


MCG/0.5ML 2

podofilox external solution 0.5 % 1

PREZCOBIX ORAL TABLET 800-150 MG 2 MO

PREZISTA ORAL SUSPENSION 100 MG/ML 2 MO

PREZISTA ORAL TABLET 150 MG, 600 MG,

75 MG, 800 MG 2 MO


50 MG, 75 MG 2 MO

PROQUAD SUBCUTANEOUS INJECTABLE 2


SUSPENSION 2





RELENZA DISKHALER INHALATION

AEROSOL POWDER BREATH ACTIVATED 5

MG/BLISTER

2








184

?


RESCRIPTOR ORAL TABLET 100 MG, 200

MG 2 MO

RETROVIR INTRAVENOUS SOLUTION 10

MG/ML 2

REYATAZ ORAL CAPSULE 150 MG, 200 MG,

300 MG 2 MO

REYATAZ ORAL PACKET 50 MG 2 MO



& 600 mg, 400 mg 1



rimantadine hcl oral tablet 100 mg 1


RECONSTITUTED 2


SELZENTRY ORAL TABLET 150 MG, 300

MG 2 MO

SELZENTRY ORAL TABLET 25 MG, 75 MG 2 MO


stavudine oral capsule 15 mg, 20 mg, 30 mg, 40

mg 1 MO

STRIBILD ORAL TABLET 150-150-200-300

MG 2 MO

SUSTIVA ORAL CAPSULE 200 MG, 50 MG 2 MO

SUSTIVA ORAL TABLET 600 MG 2 MO


MG/0.5ML 2

TAMIFLU ORAL SUSPENSION

RECONSTITUTED 6 MG/ML 2

TIVICAY ORAL TABLET 10 MG, 25 MG, 50

MG 2 MO









185

?


TRIUMEQ ORAL TABLET 600-50-300 MG 2 MO

TRUVADA ORAL TABLET 100-150 MG, 133-

200 MG, 167-250 MG, 200-300 MG 2 MO


720-20 2

TYBOST ORAL TABLET 150 MG 2 MO



VARIVAX SUBCUTANEOUS INJECTABLE

1350 PFU/0.5ML 2


VIDEX ORAL SOLUTION RECONSTITUTED

2 GM 2 MO

VIRACEPT ORAL TABLET 250 MG, 625 MG 2 MO



250 MG, 300 MG 2 MO

YF-VAX SUBCUTANEOUS INJECTABLE 2


ZERIT ORAL SOLUTION RECONSTITUTED

1 MG/ML 2 MO

ZIAGEN ORAL SOLUTION 20 MG/ML 2 MO

zidovudine oral capsule 100 mg 1 MO

zidovudine oral syrup 50 mg/5ml 1 MO

zidovudine oral tablet 300 mg 1 MO


ZOSTAVAX SUBCUTANEOUS SUSPENSION

RECONSTITUTED 19400 UNT/0.65ML 2

INFECTION CAUSED BY BACTERIA

ACTHIB INTRAMUSCULAR SOLUTION

RECONSTITUTED 2


5-2-15.5 LF-MCG/0.5 2








186

?



bacitracin ointment 500 unit/gm external 500

unit/gm 3

bacitracin zinc ointment 500 unit/gm external 500

unit/gm 3

BEXSERO INTRAMUSCULAR SUSPENSION

PREFILLED SYRINGE 2





dapsone oral tablet 100 mg, 25 mg 1 MO





LFU/0.5ML

2

gentamicin sulfate external cream 0.1 % 1

gentamicin sulfate external ointment 0.1 % 1

HIBERIX INJECTION SOLUTION



25-58-10 2



INJECTABLE 2



MENVEO INTRAMUSCULAR SOLUTION

RECONSTITUTED 2

methocarbamol injection solution 1000 mg/10ml 1 PA; HR


MUPIROCIN CALCIUM EXTERNAL CREAM

2 % 2








187

?


mupirocin external ointment 2 % 1


200000 1


PEDVAX HIB INTRAMUSCULAR

SUSPENSION 7.5 MCG/0.5ML 2


10000-0.1 unit/ml-% 1


SUSPENSION 2

ra antibiotic plus cream 3.5-10000-10 external

3.5-10000-10 3



5-2 LFU 2



LF/0.5ML

2 BD


mg/5ml 1 BD


triple antibiotic ointment 3.5-400-5000 external

3.5-400-5000 3

TRUMENBA INTRAMUSCULAR



25 MCG/0.5ML 2


INFECTION CAUSED BY

MYCOBACTERIA

BCG VACCINE INJECTION INJECTABLE 2

CAPASTAT SULFATE INJECTION

SOLUTION RECONSTITUTED 1 GM 2









188

?


ethambutol hcl oral tablet 100 mg, 400 mg 1

isoniazid injection solution 100 mg/ml 1

isoniazid oral syrup 50 mg/5ml 1 MO

isoniazid oral tablet 100 mg, 300 mg 1 MO



pyrazinamide oral tablet 500 mg 1

rifabutin oral capsule 150 mg 1

rifampin intravenous solution reconstituted 600

mg 1

rifampin oral capsule 150 mg, 300 mg 1



TRECATOR ORAL TABLET 250 MG 2

INFECTION DUE TO A PARASITE

ALINIA ORAL SUSPENSION

RECONSTITUTED 100 MG/5ML 2

ALINIA ORAL TABLET 500 MG 2

atovaquone-proguanil hcl oral tablet 250-100 mg 1

chloroquine phosphate oral tablet 250 mg, 500

mg 1 MO

COARTEM ORAL TABLET 20-120 MG 2


EURAX EXTERNAL CREAM 10 % 2

hm lice treatment lotion 1 % external 1 % 3


lindane external shampoo 1 % 1

mefloquine hcl oral tablet 250 mg 1 MO


permethrin external cream 5 % 1








189

?


PRIMAQUINE PHOSPHATE ORAL TABLET

26.3 MG 2

INFECTION OF A WOUND

FOLLOWING INJURY

silver sulfadiazine external cream 1 % 1

INFECTION OF EAR


INFECTION OF GENITALS OR

URINARY TRACT








200000 1




INFECTION OF THE STOMACH

AND INTESTINES


RECONSTITUTED 2



25 MCG/0.5ML 2

INFECTION THAT LASTS A LONG

TIME










190

?



90 MG 2 PA









UNIT, 50000000 UNIT

2 MO







KIT 120 MCG/0.5ML 2


MCG/0.5ML 2


50 MG, 75 MG 2 MO



& 600 mg, 400 mg 1







250 MG, 300 MG 2 MO









191

?


INFECTIOUS DIARRHEA



LOWER RESPIRATORY TRACT

INFECTION


5-2-15.5 LF-MCG/0.5 2






25-58-10 2






RELEASE 100 MG 2 MO







SUSPENSION 2




MG/0.5ML 2


mg/5ml 1 BD








192

?


NERVOUS SYSTEM INFECTION OF

BRAIN AND SPINAL CORD









SKIN INFECTION



unit/gm 3


unit/gm 3

ciclopirox external gel 0.77 % 1

ciclopirox olamine external cream 0.77 % 1

ciclopirox olamine external suspension 0.77 % 1

clotrimazole external cream 1 % 1

clotrimazole external solution 1 % 1

clotrimazole-betamethasone external cream 1-

0.05 % 1

clotrimazole-betamethasone external lotion 1-

0.05 % 1



econazole nitrate external cream 1 % 1


SUSPENSION 2










193

?



SUSPENSION 2





ketoconazole external cream 2 % 1

ketoconazole external shampoo 2 % 1


2 % 2






0.1 unit/gm-% 1


0.1 unit/gm-% 1


qc tolnaftate cream 1 % external 1 % 3


3.5-10000-10 3

th clotrimazole cream 1 % external 1 % 3


3.5-400-5000 3

INFLAMMATION OF THE SEROUS

MEMBRANES IN THE BODY

ASCITES


INFLAMMATORY DISORDER








194

?


DISEASE IN WHICH BODY HAS

IMMUNE RESPONSE AGAINST

ITSELF


MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST






125 MG/125ML 2 BD












50 mg 1 MO






INJECTOR 150 MG/ML

2 ST; MO




24 hour 100 mg 1 MO








195

?




MG/ML

2 MO






400 mg, 500 mg, 600 mg 1 MO





2 BD


GM/10ML 2 BD


10 GM/100ML, 10 GM/200ML, 20 GM/200ML,

5 GM/50ML

2 BD


GM/10ML 2 BD




40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO








196

?







hour 200 mg 1 MO




MG/50ML 2 PA








mg, 8 mg 1






















197

?







GM/200ML 2 BD


50 MG, 75 MG 2 MO



MG/50ML 2


50 MG/4ML 2 ST; MO





MG/0.5ML

2 ST; MO





MG, 7.5 MG 2 BD




INFLAMMATION OF THE EYE



BLEPHAMIDE OPHTHALMIC SUSPENSION

10-0.2 % 2

BLEPHAMIDE S.O.P. OPHTHALMIC

OINTMENT 10-0.2 % 2









198

?



solution 0.1 % 1






2 BD



%, 0.5 % 1

LOTEMAX OPHTHALMIC GEL 0.5 % 2

LOTEMAX OPHTHALMIC OINTMENT 0.5 % 2

LOTEMAX OPHTHALMIC SUSPENSION 0.5

% 2





10000-0.1 unit/ml-% 1

prednisolone acetate ophthalmic suspension 1 % 1

prednisolone sodium phosphate ophthalmic

solution 1 % 1



sulfacetamide-prednisolone ophthalmic solution

10-0.23 % 1


0.1 % 2


0.3-0.1 % 2


0.3-0.05 % 2










199

?





CARDIOVASCULAR SYSTEM




2 BD


DIGESTIVE SYSTEM







3 mg 1






oral 15 mg 3 MO


90 MG 2 PA

















200

?



INJECTABLE 2 BD



1440 EL U/ML, 720 EL U/0.5ML 2



40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO





UNIT, 50000000 UNIT

2 MO



30 mg 1 MO


RELEASE 1.2 GM 2


RELEASE 800 MG 2



20 mg, 40 mg 1 MO








201

?










KIT 120 MCG/0.5ML 2


MCG/0.5ML 2


50 MG, 75 MG 2 MO









& 600 mg, 400 mg 1




RECONSTITUTED 2





MG/ML

2 ST; MO










202

?




720-20 2


25 MCG/0.5ML 2


300 MG/15ML 2 PA









250 MG, 300 MG 2 MO





MUSCULOSKELETAL SYSTEM


MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST








50 mg 1 MO











203

?






INJECTOR 150 MG/ML

2 ST; MO



diclofenac potassium oral tablet 50 mg 1 MO


24 hour 100 mg 1 MO

diclofenac sodium transdermal gel 1 % 1



MG/ML

2 MO






400 mg, 500 mg, 600 mg 1 MO

etodolac oral capsule 200 mg, 300 mg 1 MO

etodolac oral tablet 400 mg, 500 mg 1 MO


hm ibuprofen tablet 200 mg oral 200 mg 3 QL (200 EA per 30 days)



40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO








204

?




40 MG/0.8ML

2 MO


ibuprofen oral suspension 100 mg/5ml 1

ibuprofen oral tablet 400 mg, 600 mg, 800 mg 1 MO




mg 1 PA; HR; MO



hour 200 mg 1 MO

ketoprofen oral capsule 50 mg, 75 mg 1 MO




meclofenamate sodium oral capsule 100 mg, 50

mg 1 MO




naproxen dr oral tablet delayed release 375 mg,

500 mg 1 MO

naproxen oral suspension 125 mg/5ml 1 MO

naproxen oral tablet 250 mg, 375 mg, 500 mg 1 MO

naproxen sodium oral tablet 275 mg, 550 mg 1 MO














205

?






MG/50ML 2

SAVELLA ORAL TABLET 100 MG, 12.5 MG,

25 MG, 50 MG 2 MO

SAVELLA TITRATION PACK ORAL 12.5 &

25 & 50 MG 2


50 MG/4ML 2 ST; MO





MG/0.5ML

2 ST; MO



MG/ML

2 ST; MO


sulindac oral tablet 150 mg, 200 mg 1 MO




MG, 7.5 MG 2 BD





RESPIRATORY TRACT


5-2-15.5 LF-MCG/0.5 2








206

?





MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO


5-120 mg oral 5-120 mg 3




MG 3









2 MO




1-2.5 mg/5ml 3



2.5-1-5 mg/5ml 3


400 MG 3












207

?








0.05 % 3



ORAL 2.5-1-5 MG/5ML 3




2 MO





mcg/act 1





2 MO



25-58-10 2


% 1 MO


1-5 mg/5ml 3



MG 3










208

?



10-240 mg oral 10-240 mg 3





mg 1 MO


oral 5-100 mg/5ml 3






mg/5ml 3


mg 3





RELEASE 100 MG 2 MO




0.65 % 3















209

?





2 MO




SUSPENSION 2






50 MCG/DOSE

2 MO



CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




MG ORAL 4-60 MG 3



MG/0.5ML 2


hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO


mg/5ml 1 BD


oral 100 mg/5ml 3








210

?



MG/5ML 3












THE NERVOUS SYSTEM



GM/25ML 2 BD








SKIN INFLAMMATION

amcinonide external cream 0.1 % 1

amcinonide external lotion 0.1 % 1

amcinonide external ointment 0.1 % 1

betamethasone dipropionate aug external lotion

0.05 % 1

betamethasone dipropionate external cream 0.05

% 1








211

?


betamethasone dipropionate external ointment

0.05 % 1

betamethasone valerate external cream 0.1 % 1

betamethasone valerate external lotion 0.1 % 1

betamethasone valerate external ointment 0.1 % 1




clobetasol propionate e external cream 0.05 % 1

clobetasol propionate external gel 0.05 % 1

clobetasol propionate external ointment 0.05 % 1




0.05 % 1


0.05 % 1


desonide external cream 0.05 % 1

desonide external lotion 0.05 % 1

desonide external ointment 0.05 % 1

desoximetasone external cream 0.05 %, 0.25 % 1

desoximetasone external gel 0.05 % 1

desoximetasone external ointment 0.25 % 1

diflorasone diacetate external cream 0.05 % 1

DIFLORASONE DIACETATE EXTERNAL

OINTMENT 0.05 % 2


ELIDEL EXTERNAL CREAM 1 % 2

fluocinolone acetonide body external oil 0.01 % 1

fluocinolone acetonide external cream 0.01 %,

0.025 % 1








212

?


fluocinolone acetonide external ointment 0.025 % 1

fluocinolone acetonide external solution 0.01 % 1


fluocinonide external cream 0.05 % 1

fluocinonide external gel 0.05 % 1

fluocinonide external ointment 0.05 % 1

fluocinonide external solution 0.05 % 1

fluocinonide-e external cream 0.05 % 1

fluticasone propionate external cream 0.05 % 1

fluticasone propionate external ointment 0.005 % 1




2 BD


SUSPENSION 2




SUSPENSION 2

halobetasol propionate external cream 0.05 % 1

halobetasol propionate external ointment 0.05 % 1

hydrocortisone external cream 1 %, 2.5 % 1

hydrocortisone external lotion 2.5 % 1

hydrocortisone external ointment 1 %, 2.5 % 1

hydrocortisone valerate external cream 0.2 % 1

hydrocortisone valerate external ointment 0.2 % 1

HYDROSKIN LOTION 1 % EXTERNAL 1 % 3




metronidazole external cream 0.75 % 1

metronidazole external gel 0.75 % 1








213

?


metronidazole external lotion 0.75 % 1

mometasone furoate external cream 0.1 % 1

mometasone furoate external ointment 0.1 % 1


2 % 2






0.1 unit/gm-% 1


0.1 unit/gm-% 1


prednicarbate external cream 0.1 % 1

prednicarbate external ointment 0.1 % 1

procto-med hc rectal cream 2.5 % 1

procto-pak rectal cream 1 % 1

proctozone-hc rectal cream 2.5 % 1


ra hydrocortisone plus cream 1 % external 1 % 3

selenium sulfide external lotion 2.5 % 1


triamcinolone acetonide external cream 0.025 %,

0.1 %, 0.5 % 1

triamcinolone acetonide external lotion 0.025 %,

0.1 % 1

triamcinolone acetonide external ointment 0.025

%, 0.1 %, 0.5 % 1

zinc oxide ointment 20 % external 20 % 3

INJURY TO A MUCOUS

MEMBRANE








214

?


ABNORMALITIES OF THE LINING

OF THE EYE







2 BD





10000-0.1 unit/ml-% 1




DRYNESS OF THE NOSE


0.65 % 3

INFLAMMATION OF THE TISSUES

SURROUNDING A TOOTH


0.12 % 1

doxycycline hyclate oral tablet 20 mg 1

PAINFUL, RED OR SWOLLEN

MOUTH





2 BD

KEPIVANCE INTRAVENOUS SOLUTION

RECONSTITUTED 6.25 MG 2 BD








215

?



nystatin mouth/throat suspension 100000 unit/ml 1

nystatin oral tablet 500000 unit 1


VAGINAL INFLAMMATION DUE

TO LOSS OF HORMONE

STIMULATION




1.5 MG, 0.625-2.5 MG, 0.625-5 MG 2 PA; HR; MO


INJURY

BURN

SANTYL EXTERNAL OINTMENT 250

UNIT/GM 2


HEAD INJURY


TETANUS


5-2-15.5 LF-MCG/0.5 2







LFU/0.5ML

2


25-58-10 2









216

?





SUSPENSION 2


5-2 LFU 2



LF/0.5ML

2 BD

WOUND


3.5-10000-10 3


LUNG DISEASE

AN INCREASE IN THE THICKNESS

OF LUNG SECRETIONS


BREATHING CHANGES


BRONCHITIS


5-2-15.5 LF-MCG/0.5 2



MCG/DOSE

2 MO







25-58-10 2









217

?




SUSPENSION 2



50 MCG/DOSE

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO


mg/5ml 1 BD

CHRONIC LUNG DISEASE



MG, 2 MG, 2.5 MG 2 MO




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO






2 MO












218

?










2 MO







2 MO



(3) mg/3ml 1 BD; MO







mg 1 MO








125 MG 2 PA; MO










219

?







2 MO




MG/ML 2 BD; MO



50 MCG/DOSE

2 MO


mg/12.5ml 1 PA



CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO


mg/5ml 1 BD














220

?







COUGH





oral 5-100 mg/5ml 3








oral 100 mg/5ml 3

DECREASED LUNG FUNCTION


DECREASED OXYGEN IN THE

TISSUES OR BLOOD


FLUID IN THE LUNGS


HEART AND LUNG DISEASE



HICCUPS









221

?



25 mg, 50 mg 1 MO

INCREASED PRESSURE OF

PULMONARY CIRCULATION



MG, 2 MG, 2.5 MG 2 MO




mg/12.5ml 1 PA





LOWER RESPIRATORY TRACT

INFECTION


5-2-15.5 LF-MCG/0.5 2






25-58-10 2






RELEASE 100 MG 2 MO










222

?






SUSPENSION 2




MG/0.5ML 2


mg/5ml 1 BD

LUNG CANCER


MG/4ML, 400 MG/16ML 2

LUNG EMBOLISM


MG, 2 MG, 2.5 MG 2 MO



MG 2 MO



LUNG FIBROSIS








LUNG INFECTION










223

?




RELEASE 100 MG 2 MO








MG/0.5ML 2


mg/5ml 1 BD

LUNG TISSUE PROBLEMS





LYMPHANGIOLEIOMYOMATOSIS



MECHANICAL VENTILATION



OBSTRUCTIVE PULMONARY

DISEASE


5-2-15.5 LF-MCG/0.5 2




MCG/DOSE

2 MO








224

?



21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO




(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO











2 MO










2 MO







2 MO


25-58-10 2








225

?




(3) mg/3ml 1 BD; MO







mg 1 MO









2 MO




SUSPENSION 2



50 MCG/DOSE

2 MO


CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO








226

?



hour 600 mg 1 MO











RESPIRATORY OBSTRUCTION


5-2-15.5 LF-MCG/0.5 2




MCG/DOSE

2 MO


21 MCG/ACT, 230-21 MCG/ACT, 45-21

MCG/ACT

2 MO




(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63

mg/3ml, 1.25 mg/3ml

1 BD; MO















227

?





2 MO










2 MO







2 MO


25-58-10 2



(3) mg/3ml 1 BD; MO







mg 1 MO













228

?





2 MO




SUSPENSION 2



50 MCG/DOSE

2 MO


CAPSULE 18 MCG 2 MO



MCG/ACT

2 MO




hour 100 mg, 200 mg, 300 mg, 450 mg 1 MO


hour 600 mg 1 MO











MARGINAL ZONE LYMPHOMA

INDOLENT B-CELL NON-HODGKIN

LYMPHOMA








229

?



MUSCLE OR BONE DISORDER

ABNORMAL INCREASE IN MUSCLE

TONE










VESICARE ORAL TABLET 10 MG, 5 MG 2 MO

ABNORMAL MANNER OF

WALKING





mg 1 MO

ARTHRITIS


MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST








50 mg 1 MO








230

?









INJECTOR 150 MG/ML

2 ST; MO





24 hour 100 mg 1 MO




MG/ML

2 MO






400 mg, 500 mg, 600 mg 1 MO







40 MG/0.8ML

2 MO










231

?




MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO







mg 1 PA; HR; MO



hour 200 mg 1 MO






mg 1 MO





500 mg 1 MO











232

?












MG/50ML 2


50 MG/4ML 2 ST; MO





MG/0.5ML

2 ST; MO



MG/ML

2 ST; MO






MG, 7.5 MG 2 BD




BONE DISEASE


2000000 UNIT/0.5ML 2 LA; MO








233

?



mg, 70 mg 1 MO

alendronate sodium oral tablet 40 mg 1




mg 1 MO



1250 (500 ca) mg 3


600-200 mg-unit 3


MCG/2.4ML 2 MO




MG-UNIT 2 MO




600-400 mg-unit 3


UNIT/ML 2



mcg/ml

1 MO


MG-UNIT 3




MG/ML 2









234

?





mg 1 MO



mg 1 MO



MG

2





MG/0.3ML

2




MG/1.7ML 2




MG/100ML 2 BD

CHRONIC MUSCLE OR BONE PAIN

duloxetine hcl oral capsule delayed release

particles 20 mg, 30 mg, 60 mg 1 MO

DULOXETINE HCL ORAL CAPSULE

DELAYED RELEASE PARTICLES 40 MG 2 MO

INFLAMMATION OF THE SAC

SURROUNDING THE JOINT -

BURSITIS


INFLAMMATION OF THE TENDON








235

?




MUSCULOSKELETAL SYSTEM


MG/10ML, 400 MG/20ML, 80 MG/4ML 2 ST








50 mg 1 MO








INJECTOR 150 MG/ML

2 ST; MO





24 hour 100 mg 1 MO




MG/ML

2 MO












236

?



400 mg, 500 mg, 600 mg 1 MO







40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO







mg 1 PA; HR; MO



hour 200 mg 1 MO












237

?



mg 1 MO





500 mg 1 MO














MG/50ML 2


25 MG, 50 MG 2 MO


25 & 50 MG 2


50 MG/4ML 2 ST; MO





MG/0.5ML

2 ST; MO








238

?




MG/ML

2 ST; MO






MG, 7.5 MG 2 BD




INVOLUNTARY MUSCLE

MOVEMENTS






mg, 0.5 mg, 1 mg, 2 mg 1 MO







25 (42)-100 (7) MG, 25 (84)-100(14) MG 2


25 mg 1 MO



mg, 25 mg, 50 mg 1 MO








239

?




MG/100ML, 500 MG/100ML

2




mg, 750 mg 1 MO




mg/5ml 1 MO


60 mg, 80 mg 1 MO










MINOR MUSCULOSKELETAL

INJURY


MUSCLE OR BONE PAIN







25 MG, 50 MG 2 MO








240

?



25 & 50 MG 2

MUSCLE PROBLEMS








25 MG, 35 MG

2 MO




mg 1 MO


GM/25ML 2 BD










release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO








241

?



2.5 mg, 5 mg 1 MO




25 MG, 50 MG 2 MO


25 & 50 MG 2


MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO


MUSCLE SPASM


5-2-15.5 LF-MCG/0.5 2




cyclobenzaprine hcl oral tablet 10 mg, 5 mg 1 PA; HR










LFU/0.5ML

2


25-58-10 2



methocarbamol oral tablet 500 mg, 750 mg 1 PA; HR








242

?


orphenadrine citrate er oral tablet extended

release 12 hour 100 mg 1 PA; HR

orphenadrine citrate injection solution 30 mg/ml 1 PA; HR



SUSPENSION 2


5-2 LFU 2



LF/0.5ML

2 BD

tizanidine hcl oral tablet 2 mg, 4 mg 1 MO

NEUROPSYCHIATRIC DISORDER

MENTAL DISTURBANCE

ABILIFY MAINTENA INTRAMUSCULAR

SUSPENSION RECONSTITUTED 300 MG, 400

MG

2 MO

acamprosate calcium oral tablet delayed release

333 mg 1 MO

alprazolam er oral tablet extended release 24

hour 0.5 mg, 1 mg, 3 mg 1 QL (120 EA per 30 days)

alprazolam er oral tablet extended release 24

hour 2 mg 1

ALPRAZOLAM INTENSOL ORAL

CONCENTRATE 1 MG/ML 2

alprazolam oral tablet 0.25 mg, 0.5 mg, 1 mg, 2

mg 1

alprazolam oral tablet dispersible 0.25 mg 1 QL (720 EA per 30 days)

alprazolam oral tablet dispersible 0.5 mg 1 QL (180 EA per 30 days)

alprazolam oral tablet dispersible 1 mg 1 QL (360 EA per 30 days)

alprazolam oral tablet dispersible 2 mg 1

alprazolam xr oral tablet extended release 24

hour 0.5 mg 1 QL (120 EA per 30 days)








243

?


amoxapine oral tablet 100 mg, 150 mg, 25 mg, 50

mg 1 MO



APLENZIN ORAL TABLET EXTENDED


aripiprazole oral tablet 10 mg, 15 mg, 2 mg, 20


ARIPIPRAZOLE ORAL TABLET

DISPERSIBLE 10 MG, 15 MG 2 MO

ARISTADA INTRAMUSCULAR PREFILLED

SYRINGE 441 MG/1.6ML, 662 MG/2.4ML, 882

MG/3.2ML

2 ST; MO

buprenorphine hcl sublingual tablet sublingual 2

mg, 8 mg 1

buprenorphine hcl-naloxone hcl sublingual tablet

sublingual 2-0.5 mg, 8-2 mg 1

bupropion hcl er (smoking det) oral tablet

extended release 12 hour 150 mg 1

bupropion hcl er (sr) oral tablet extended release

12 hour 100 mg, 150 mg, 200 mg 1 MO

bupropion hcl er (xl) oral tablet extended release

24 hour 150 mg, 300 mg 1 MO

bupropion hcl oral tablet 100 mg, 75 mg 1 MO

buspirone hcl oral tablet 10 mg, 15 mg, 30 mg, 5

mg, 7.5 mg 1


12 hour 100 mg, 200 mg, 300 mg 1 MO


hour 100 mg, 200 mg, 400 mg 1 MO


CHANTIX CONTINUING MONTH PAK ORAL

TABLET 1 MG 2 QL (56 EA per 28 days)

CHANTIX ORAL TABLET 0.5 MG 2 QL (11 EA per 30 days)

CHANTIX ORAL TABLET 1 MG 2 QL (180 EA per 90 days)








244

?


CHANTIX STARTING MONTH PAK ORAL

TABLET 0.5 MG X 11 & 1 MG X 42 2 QL (53 EA per 30 days)



chlordiazepoxide-amitriptyline oral tablet 10-25

mg, 5-12.5 mg 1 PA; HR; MO



25 mg, 50 mg 1 MO

citalopram hydrobromide oral solution 10

mg/5ml 1 MO

citalopram hydrobromide oral tablet 10 mg, 20

mg, 40 mg 1 MO

clomipramine hcl oral capsule 25 mg, 50 mg, 75

mg 1 PA; HR; MO



mg, 0.5 mg, 1 mg, 2 mg 1 MO



clozapine oral tablet 100 mg, 200 mg, 25 mg, 50

mg 1

CLOZAPINE ORAL TABLET DISPERSIBLE

100 MG, 12.5 MG, 25 MG 2

clozapine oral tablet dispersible 150 mg, 200 mg 1

desipramine hcl oral tablet 10 mg, 100 mg, 150

mg, 25 mg, 50 mg, 75 mg 1 MO

desvenlafaxine er oral tablet extended release 24


desvenlafaxine succinate er oral tablet extended




25 MG, 35 MG

2 MO








245

?





mg 1 MO






disulfiram oral tablet 250 mg, 500 mg 1 MO


24 hour 250 mg, 500 mg 1 MO




mg, 250 mg, 500 mg 1 MO

doxepin hcl oral capsule 10 mg, 100 mg, 150 mg,

25 mg, 50 mg, 75 mg 1 PA; HR; MO

doxepin hcl oral concentrate 10 mg/ml 1 PA; HR; MO


mg 1 MO





EMSAM TRANSDERMAL PATCH 24 HOUR

12 MG/24HR, 6 MG/24HR, 9 MG/24HR 2 MO



escitalopram oxalate oral solution 5 mg/5ml 1 MO

escitalopram oxalate oral tablet 10 mg, 20 mg, 5

mg 1 MO

FANAPT ORAL TABLET 1 MG, 10 MG, 12

MG, 2 MG, 4 MG, 6 MG, 8 MG 2








246

?


FANAPT TITRATION PACK ORAL TABLET

1 & 2 & 4 & 6 MG 2

FETZIMA ORAL CAPSULE EXTENDED


80 MG

2 MO

FETZIMA TITRATION ORAL CAPSULE ER

24 HOUR THERAPY PACK 20 & 40 MG 2

fluoxetine hcl oral capsule 10 mg, 20 mg, 40 mg 1 MO

fluoxetine hcl oral capsule delayed release 90 mg 1 MO

fluoxetine hcl oral solution 20 mg/5ml 1 MO

fluoxetine hcl oral tablet 10 mg, 20 mg 1 MO

FLUOXETINE HCL ORAL TABLET 60 MG 2 MO

fluphenazine decanoate injection solution 25

mg/ml 1

fluphenazine hcl injection solution 2.5 mg/ml 1

fluphenazine hcl oral concentrate 5 mg/ml 1 MO

fluphenazine hcl oral elixir 2.5 mg/5ml 1 MO

fluphenazine hcl oral tablet 1 mg, 10 mg, 2.5 mg,

5 mg 1 MO

fluvoxamine maleate er oral capsule extended


fluvoxamine maleate oral tablet 100 mg, 25 mg,

50 mg 1 MO

FORFIVO XL ORAL TABLET EXTENDED


GEODON INTRAMUSCULAR SOLUTION




haloperidol decanoate intramuscular solution 100

mg/ml, 50 mg/ml 1

haloperidol lactate injection solution 5 mg/ml 1

haloperidol lactate oral concentrate 2 mg/ml 1 MO








247

?


haloperidol oral tablet 0.5 mg, 1 mg, 10 mg, 2





mg, 50 mg 1 PA; HR

imipramine hcl oral tablet 10 mg, 25 mg, 50 mg 1 PA; HR; MO

imipramine pamoate oral capsule 100 mg, 125

mg, 150 mg, 75 mg 1 PA; HR; MO

INVEGA SUSTENNA INTRAMUSCULAR

SUSPENSION 117 MG/0.75ML, 156 MG/ML,

234 MG/1.5ML, 39 MG/0.25ML, 78 MG/0.5ML

2

INVEGA TRINZA INTRAMUSCULAR

SUSPENSION 273 MG/0.875ML, 410

MG/1.315ML, 546 MG/1.75ML, 819

MG/2.625ML

2 MO


25 (42)-100 (7) MG, 25 (84)-100(14) MG 2


25 mg 1 MO



mg, 25 mg, 50 mg 1 MO

LATUDA ORAL TABLET 120 MG, 20 MG, 40

MG, 60 MG, 80 MG 2 MO

lithium carbonate er oral tablet extended release

300 mg, 450 mg 1 MO

lithium carbonate oral capsule 150 mg, 300 mg,

600 mg 1 MO

lithium carbonate oral tablet 300 mg 1 MO

lithium oral solution 8 meq/5ml 1 MO

lorazepam intensol oral concentrate 2 mg/ml 1

lorazepam oral tablet 0.5 mg, 1 mg, 2 mg 1 QL (150 EA per 30 days)








248

?


loxapine succinate oral capsule 10 mg, 25 mg, 5

mg, 50 mg 1 MO

maprotiline hcl oral tablet 25 mg, 50 mg, 75 mg 1 MO

MARPLAN ORAL TABLET 10 MG 2 MO

meprobamate oral tablet 200 mg, 400 mg 1 PA; HR

METHADONE HCL INJECTION SOLUTION

10 MG/ML 2

methadone hcl oral solution 10 mg/5ml, 5 mg/5ml 1

methadone hcl oral tablet 10 mg, 5 mg 1






release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO

mirtazapine oral tablet 15 mg, 30 mg, 45 mg, 7.5

mg 1 MO

mirtazapine oral tablet dispersible 15 mg, 30 mg,

45 mg 1 MO

MOLINDONE HCL ORAL TABLET 10 MG, 25

MG, 5 MG 2 MO

naltrexone hcl oral tablet 50 mg 1

nefazodone hcl oral tablet 100 mg, 150 mg, 200

mg, 250 mg, 50 mg 1 MO








249

?


NICORETTE GUM 2 MG MOUTH/THROAT 2

MG 3

NICORETTE MINI LOZENGE 2 MG

MOUTH/THROAT 2 MG 3


MOUTH/THROAT 4 MG 3

nicotine patch 24 hour 14 mg/24hr transdermal

(otc) 14 mg/24hr 3


(otc) 21 mg/24hr 3


(otc) 7 mg/24hr 3

nicotine polacrilex gum 4 mg mouth/throat 4 mg 3

NICOTROL INHALATION INHALER 10 MG 2

nortriptyline hcl oral capsule 10 mg, 25 mg, 50

mg, 75 mg 1 MO

NORTRIPTYLINE HCL ORAL SOLUTION 10

MG/5ML 2 MO

NUEDEXTA ORAL CAPSULE 20-10 MG 2 MO


olanzapine intramuscular solution reconstituted

10 mg 1

olanzapine oral tablet 10 mg, 15 mg, 2.5 mg, 20

mg, 5 mg, 7.5 mg 1 MO

olanzapine oral tablet dispersible 10 mg, 15 mg,

20 mg, 5 mg 1 MO

olanzapine-fluoxetine hcl oral capsule 12-25 mg,

12-50 mg, 3-25 mg, 6-25 mg, 6-50 mg 1 MO


paliperidone er oral tablet extended release 24

hour 1.5 mg, 3 mg, 6 mg, 9 mg 1 MO

paroxetine hcl er oral tablet extended release 24

hour 12.5 mg, 25 mg, 37.5 mg 1 MO








250

?


paroxetine hcl oral tablet 10 mg, 20 mg, 30 mg,

40 mg 1 MO

PAXIL ORAL SUSPENSION 10 MG/5ML 2 MO

perphenazine oral tablet 16 mg, 2 mg, 4 mg, 8 mg 1 MO

perphenazine-amitriptyline oral tablet 2-10 mg,

2-25 mg, 4-10 mg, 4-25 mg, 4-50 mg 1 PA; HR; MO

PEXEVA ORAL TABLET 10 MG, 20 MG, 30

MG 2 MO

phenelzine sulfate oral tablet 15 mg 1 MO


protriptyline hcl oral tablet 10 mg, 5 mg 1 MO

QUETIAPINE FUMARATE ER ORAL


MG, 200 MG, 300 MG, 400 MG, 50 MG

2 MO

quetiapine fumarate oral tablet 100 mg, 200 mg,

25 mg, 300 mg, 400 mg, 50 mg 1 MO

REXULTI ORAL TABLET 0.25 MG, 0.5 MG, 1

MG, 2 MG, 3 MG, 4 MG 2 PA; MO

RISPERDAL CONSTA INTRAMUSCULAR

SUSPENSION RECONSTITUTED 12.5 MG, 25

MG, 37.5 MG, 50 MG

2

risperidone oral solution 1 mg/ml 1 MO

risperidone oral tablet 0.25 mg, 0.5 mg, 1 mg, 2

mg, 3 mg, 4 mg 1 MO

risperidone oral tablet dispersible 0.25 mg, 0.5

mg, 1 mg, 2 mg, 3 mg, 4 mg 1 MO

SAPHRIS SUBLINGUAL TABLET

SUBLINGUAL 10 MG, 2.5 MG, 5 MG 2 MO

sertraline hcl oral concentrate 20 mg/ml 1 MO

sertraline hcl oral tablet 100 mg, 25 mg, 50 mg 1 MO

sm nicotine patch 24 hour 21 mg/24hr

transdermal 21 mg/24hr 3


MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO








251

?


SUBOXONE SUBLINGUAL FILM 12-3 MG, 2-

0.5 MG, 4-1 MG, 8-2 MG 2




mg/ml 3

thioridazine hcl oral tablet 10 mg, 100 mg, 25 mg,

50 mg 1 PA; HR; MO

thiothixene oral capsule 1 mg, 10 mg, 2 mg, 5 mg 1 MO

tranylcypromine sulfate oral tablet 10 mg 1 MO

trazodone hcl oral tablet 100 mg, 150 mg, 300

mg, 50 mg 1 MO

trifluoperazine hcl oral tablet 1 mg, 10 mg, 2 mg,

5 mg 1 MO

trimipramine maleate oral capsule 100 mg, 25

mg, 50 mg 1 PA; HR; MO

TRINTELLIX ORAL TABLET 10 MG, 20 MG,

5 MG 2 ST; MO

venlafaxine hcl er oral capsule extended release

24 hour 150 mg, 37.5 mg, 75 mg 1 MO

venlafaxine hcl er oral tablet extended release 24

hour 150 mg, 225 mg, 37.5 mg, 75 mg 1 MO

venlafaxine hcl oral tablet 100 mg, 25 mg, 37.5

mg, 50 mg, 75 mg 1 MO

VERSACLOZ ORAL SUSPENSION 50 MG/ML 2

VIIBRYD ORAL TABLET 10 MG, 20 MG, 40

MG 2 MO

VIIBRYD STARTER PACK ORAL KIT 10 &

20 MG 2


VRAYLAR ORAL CAPSULE 1.5 MG 2 ST; MO; QL (120 EA per 30 days)

VRAYLAR ORAL CAPSULE 3 MG 2 ST; MO; QL (60 EA per 30 days)

VRAYLAR ORAL CAPSULE 4.5 MG, 6 MG 2 ST; MO; QL (30 EA per 30 days)








252

?


VRAYLAR ORAL CAPSULE THERAPY

PACK 1.5 & 3 MG 2 ST

ziprasidone hcl oral capsule 20 mg, 40 mg, 60

mg, 80 mg 1 MO

ZYPREXA RELPREVV INTRAMUSCULAR

SUSPENSION RECONSTITUTED 210 MG 2

MOOD CHANGES

APLENZIN ORAL TABLET EXTENDED


ascomp-codeine oral capsule 50-325-40-30 mg 1 PA; HR

bupropion hcl er (xl) oral tablet extended release

24 hour 150 mg, 300 mg 1 MO

butalbital-acetaminophen oral tablet 50-325 mg 1

butalbital-apap-caff-cod oral capsule 50-325-40-

30 mg 1 PA; HR; QL (370 EA per 30 days)

butalbital-asa-caff-codeine oral capsule 50-325-

40-30 mg 1 PA; HR; QL (180 EA per 30 days)


mg 1 MO

FORFIVO XL ORAL TABLET EXTENDED


GEODON INTRAMUSCULAR SOLUTION


olanzapine intramuscular solution reconstituted

10 mg 1

zebutal oral capsule 50-325-40 mg 1

NEUROCOGNITIVE DISORDER







25 MG, 35 MG

2 MO








253

?





mg 1 MO









mg, 8 mg 1 MO











release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO








254

?




MG

2 MO



& 14 & 21 &28 MG

2


THERAPY PACK 7 & 14 & 21 &28 -10 MG 2







4.5 mg, 6 mg 1 MO


HOUR 13.3 MG/24HR, 4.6 MG/24HR, 9.5

MG/24HR

2 MO


MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO



mg/ml 3


NEURODEVELOPMENTAL

DISORDER





25 MG, 35 MG

2 MO




mg 1 MO








255

?









release 20 mg 1 MO



MG

2 PA; HR; MO


mg/5ml 1 MO


mg 1 MO


2.5 mg, 5 mg 1 MO



MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG 2 MO

NOT FEELING WELL

FLU-LIKE SYMPTOMS

gnp cold multi-symptom night tablet 5-2-10-325

mg oral 5-2-10-325 mg 3

OTHER OVER-THE-COUNTER

DRUGS

OTHER OVER-THE-COUNTER

DRUGS



312-958 MG

3











256

?


ASSURE ID INSULIN SAFETY SYR 29G X

1/2" 1 ML 2


1000 mg oral 1000 mg 3

CENTRUM SILVER TABLET ORAL 3




1-2.5 mg/5ml 3


2.5-1-5 mg/5ml 3

COMFORT ASSIST INSULIN SYRINGE 29G

X 1/2" 1 ML 2

CUTTER SKINSATIONS EXTERNAL LIQUID

7 % 3

CVS GAUZE STERILE PAD 2"X2" 2


mg 3


ecee plus tablet oral 3

eq nicotine patch 24 hour 7 mg/24hr transdermal

7 mg/24hr 3

EXEL COMFORT POINT PEN NEEDLE 29G X

12MM 2

EX-LAX ULTRA TABLET DELAYED

RELEASE 5 MG ORAL 5 MG 3

GLOBAL ALCOHOL PREP EASE PAD 70 % 2

gnp artificial tears solution 5-6 mg/ml ophthalmic

5-6 mg/ml 3

gnp cold multi-symptom night tablet 5-2-10-325

mg oral 5-2-10-325 mg 3


oral 95-358 mg/15ml 3









257

?




lice killing maximum strength shampoo 0.33-4 %

external 0.33-4 % 3


MG/5ML ORAL 400-400-40 MG/5ML 3



1200 mg/15ml 3


NOVOLIN 70/30 SUBCUTANEOUS

SUSPENSION (70-30) 100 UNIT/ML 2 MO

NOVOLIN N SUBCUTANEOUS SUSPENSION

100 UNIT/ML 2 MO

NOVOLIN R INJECTION SOLUTION 100

UNIT/ML 2 MO

OFF ACTIVE EXTERNAL AEROSOL 15 % 3

PEDIALYTE SOLUTION ORAL 3

POLY-VI-SOL/IRON SOLUTION ORAL 3

PREFERRED PLUS INSULIN SYRINGE 28G X

1/2" 0.5 ML 2


3.5-10000-10 3

RELI-ON INSULIN SYRINGE 29G 0.3 ML 2

REPEL TICK DEFENSE EXTERNAL

AEROSOL 15 % 3

SAWYER INSECT REPELLENT EXTERNAL

LIQUID 20 % 3


3.5-400-5000 3


oral 100 mg/5ml 3

vitamin a-beta carotene oral capsule 25000 unit 3








258

?



MG/5ML 3





OTHER PRESCRIPTION DRUGS

OTHER PRESCRIPTION DRUGS




150-300 mg 1 MO

ABELCET INTRAVENOUS SUSPENSION 5

MG/ML 2 BD

ABILIFY MAINTENA INTRAMUSCULAR

SUSPENSION RECONSTITUTED 300 MG

(1.5ML SYRINGE)

2 MO

ABRAXANE INTRAVENOUS SUSPENSION


acamprosate calcium oral tablet delayed release

333 mg 1 MO

acitretin oral capsule 10 mg, 17.5 mg, 25 mg 1



acyclovir oral capsule 200 mg 1

acyclovir oral suspension 200 mg/5ml 1

acyclovir oral tablet 400 mg, 800 mg 1

acyclovir sodium intravenous solution 50 mg/ml 1 BD



MG, 2 MG, 2.5 MG 2 MO

adriamycin intravenous solution 2 mg/ml 1 BD

AFRIN SALINE NASAL MIST SOLUTION

0.65 % NASAL 0.65 % 3








259

?


ALBENZA ORAL TABLET 200 MG 2

ALECENSA ORAL CAPSULE 150 MG 2

ALIMTA INTRAVENOUS SOLUTION


alosetron hcl oral tablet 0.5 mg 1 MO

ALUNBRIG ORAL TABLET 30 MG 2 PA

AMBISOME INTRAVENOUS SUSPENSION


AMINOSYN II INTRAVENOUS SOLUTION 10

%, 8.5 % 2 BD

aminosyn ii/electrolytes intravenous solution 8.5

% 1 BD

AMINOSYN/ELECTROLYTES

INTRAVENOUS SOLUTION 7 % 2 BD

aminosyn/electrolytes intravenous solution 8.5 % 1 BD

AMINOSYN-HBC INTRAVENOUS

SOLUTION 7 % 2 BD

AMINOSYN-PF INTRAVENOUS SOLUTION

10 %, 7 % 2 BD

AMINOSYN-RF INTRAVENOUS SOLUTION

5.2 % 2 BD

amiodarone hcl oral tablet 100 mg 1 MO

amitriptyline hcl oral tablet 10 mg, 100 mg, 150

mg, 25 mg, 50 mg, 75 mg 1 PA; HR; MO


mg, 10-320 mg, 5-160 mg, 5-320 mg 1 MO


40 mg, 5-20 mg, 5-40 mg 1 MO


mg, 10-160-25 mg, 10-320-25 mg, 5-160-12.5 mg,

5-160-25 mg

1 MO

amoxicillin oral capsule 250 mg, 500 mg 1

amoxicillin oral suspension reconstituted 125

mg/5ml, 200 mg/5ml, 250 mg/5ml, 400 mg/5ml 1








260

?


amoxicillin oral tablet 500 mg, 875 mg 1

amoxicillin oral tablet chewable 125 mg, 250 mg 1

amoxicillin-pot clavulanate oral suspension

reconstituted 200-28.5 mg/5ml, 400-57 mg/5ml,

600-42.9 mg/5ml

1

amoxicillin-pot clavulanate oral tablet 250-125

mg, 500-125 mg, 875-125 mg 1

amoxicillin-pot clavulanate oral tablet chewable

200-28.5 mg, 400-57 mg 1

amphetamine-dextroamphetamine oral tablet 12.5

mg, 15 mg, 7.5 mg 1 MO

amphotericin b injection solution reconstituted 50

mg 1 BD

ampicillin oral capsule 250 mg, 500 mg 1

ampicillin oral suspension reconstituted 125

mg/5ml, 250 mg/5ml 1

ampicillin sodium injection solution reconstituted

1 gm, 125 mg 1

ampicillin sodium intravenous solution


ampicillin-sulbactam sodium injection solution

reconstituted 1.5 (1-0.5) gm 1

ampicillin-sulbactam sodium intravenous solution

reconstituted 1.5 (1-0.5) gm, 15 (10-5) gm 1

anastrozole oral tablet 1 mg 1 MO

anti-diarrheal liquid 1 mg/5ml oral 1 mg/5ml 3


MG, 80 MG 2 BD


600 MG, 800 MG 2 MO

aripiprazole oral tablet 2 mg 1 MO

ARIPIPRAZOLE ORAL TABLET

DISPERSIBLE 10 MG, 15 MG 2 MO








261

?


ARRANON INTRAVENOUS SOLUTION 5

MG/ML 2 BD



25-200 MG

2 MO



atovaquone oral suspension 750 mg/5ml 1

azacitidine injection suspension reconstituted 100

mg 1

AZACTAM IN DEXTROSE INTRAVENOUS

SOLUTION 2 GM 2

azelastine hcl nasal solution 0.15 % 1

azithromycin intravenous solution reconstituted

500 mg 1

azithromycin oral packet 1 gm 1

azithromycin oral suspension reconstituted 100


azithromycin oral tablet 250 mg, 250 mg (6 pack),

500 mg, 500 mg (3 pack), 600 mg 1

aztreonam injection solution reconstituted 1 gm 1

bacitracin intramuscular solution reconstituted

50000 unit 1

bacitra-neomycin-polymyxin-hc ophthalmic

ointment 1 % 1

BANZEL ORAL SUSPENSION 40 MG/ML 2 MO

BANZEL ORAL TABLET 200 MG, 400 MG 2 MO

BAVENCIO INTRAVENOUS SOLUTION 200

MG/10ML 2 BD

BELEODAQ INTRAVENOUS SOLUTION


bexarotene oral capsule 75 mg 1 PA

bicalutamide oral tablet 50 mg 1








262

?


BICILLIN L-A INTRAMUSCULAR

SUSPENSION 600000 UNIT/ML 2

BICNU INTRAVENOUS SOLUTION



0.03 % 2 MO

bleomycin sulfate injection solution reconstituted

30 unit 1 BD


SUSPENSION 5-2.5-18.5 (0.5ML SYRINGE) 2

BOSULIF ORAL TABLET 100 MG, 500 MG 2 PA

BRISDELLE ORAL CAPSULE 7.5 MG 2 MO

buprenorphine hcl injection solution 0.3 mg/ml

(cartridge) 1


MG/ML 2 BD

CABOMETYX ORAL TABLET 20 MG, 40 MG,

60 MG 2

CANCIDAS INTRAVENOUS SOLUTION


CAPRELSA ORAL TABLET 100 MG, 300 MG 2


hour 100 mg 1 MO

carboplatin intravenous solution 150 mg/15ml 1 BD

cefaclor er oral tablet extended release 12 hour

500 mg 1

cefaclor oral capsule 250 mg, 500 mg 1

cefazolin sodium injection solution reconstituted

1 gm, 10 gm, 500 mg 1

cefdinir oral capsule 300 mg 1

cefdinir oral suspension reconstituted 125


cefepime hcl injection solution reconstituted 1

gm, 2 gm 1








263

?


cefixime oral suspension reconstituted 200

mg/5ml 1

cefoxitin sodium injection solution reconstituted

10 gm 1

cefoxitin sodium intravenous solution

reconstituted 1 gm, 2 gm 1

cefpodoxime proxetil oral suspension

reconstituted 100 mg/5ml, 50 mg/5ml 1

cefpodoxime proxetil oral tablet 100 mg, 200 mg 1

cefprozil oral suspension reconstituted 125


cefprozil oral tablet 250 mg, 500 mg 1

ceftriaxone sodium injection solution

reconstituted 250 mg, 500 mg 1

ceftriaxone sodium intravenous solution

reconstituted 1 gm, 10 gm, 2 gm 1

cefuroxime axetil oral tablet 250 mg 1

cefuroxime sodium injection solution

reconstituted 1.5 gm, 7.5 gm, 750 mg 1


50 mg 1 MO

cephalexin oral capsule 250 mg, 500 mg 1

cephalexin oral suspension reconstituted 125


cephalexin oral tablet 250 mg, 500 mg 1


PE/10ML 2

chloramphenicol sod succinate intravenous

solution reconstituted 1 gm 1

chlorpromazine hcl injection solution 50 mg/2ml 1 BD

ciprofloxacin hcl ophthalmic solution 0.3 % 1

ciprofloxacin hcl oral tablet 100 mg, 250 mg, 500

mg, 750 mg 1








264

?


ciprofloxacin in d5w intravenous solution 200

mg/100ml 1

ciprofloxacin intravenous solution 400 mg/40ml 1

ciprofloxacin oral suspension reconstituted 250

mg/5ml (5%), 500 mg/5ml (10%) 1

ciprofloxacin-ciproflox hcl er oral tablet extended

release 24 hour 1000 mg, 500 mg 1

cisplatin intravenous solution 100 mg/100ml 1 BD

clarithromycin oral tablet 250 mg, 500 mg 1

clindamycin hcl oral capsule 150 mg, 300 mg, 75

mg 1

clindamycin palmitate hcl oral solution

reconstituted 75 mg/5ml 1

clindamycin phosphate in d5w intravenous

solution 300 mg/50ml, 600 mg/50ml, 900

mg/50ml

1

clindamycin phosphate injection solution 300

mg/2ml, 600 mg/4ml, 900 mg/6ml 1

CLINIMIX E/DEXTROSE (2.75/10)

INTRAVENOUS SOLUTION 2.75 % 2 BD









CLINIMIX E/DEXTROSE (5/15)













265

?


CLINIMIX/DEXTROSE (2.75/5)


clinimix/dextrose (4.25/10) intravenous solution

4.25 % 1 BD







CLINIMIX/DEXTROSE (5/15) INTRAVENOUS

SOLUTION 5 % 2 BD


SOLUTION 5 % 2 BD


SOLUTION 5 % 2 BD

clofarabine intravenous solution 1 mg/ml 1 BD

CLOLAR INTRAVENOUS SOLUTION 1

MG/ML 2 BD

clozapine oral tablet dispersible 150 mg, 200 mg 1

colistimethate sodium injection solution

reconstituted 150 mg 1

COMETRIQ (100 MG DAILY DOSE) ORAL

KIT 1 X 80 & 1 X 20 MG 2

COMETRIQ (140 MG DAILY DOSE) ORAL

KIT 1 X 80 & 3 X 20 MG 2

COMETRIQ (60 MG DAILY DOSE) ORAL KIT

20 MG 2



COSMEGEN INTRAVENOUS SOLUTION


COTELLIC ORAL TABLET 20 MG 2 LA

CYCLOPHOSPHAMIDE ORAL CAPSULE 25

MG, 50 MG 2 BD








266

?


CYRAMZA INTRAVENOUS SOLUTION 100

MG/10ML, 500 MG/50ML 2 BD

cytarabine (pf) injection solution 100 mg/ml 1 BD

cytarabine injection solution 20 mg/ml 1 BD

dacarbazine intravenous solution reconstituted

200 mg 1 BD

DAPTOMYCIN INTRAVENOUS SOLUTION




daunorubicin hcl intravenous injectable 5 mg/ml 1 BD

decitabine intravenous solution reconstituted 50

mg 1

desvenlafaxine succinate er oral tablet extended




25 MG, 35 MG

2 MO

dextrose in lactated ringers intravenous solution

5 % 1

dextrose intravenous solution 10 %, 5 % 1 BD

DEXTROSE-NACL INTRAVENOUS

SOLUTION 10-0.2 % 2

dextrose-nacl intravenous solution 2.5-0.45 %, 5-

0.2 %, 5-0.33 %, 5-0.45 %, 5-0.9 % 1

diclofenac sodium oral tablet delayed release 25

mg, 50 mg, 75 mg 1 MO

diclofenac sodium transdermal gel 1 %, 3 % 1

dicloxacillin sodium oral capsule 250 mg, 500 mg 1


DOCETAXEL INTRAVENOUS

CONCENTRATE 80 MG/4ML 2

DOCETAXEL INTRAVENOUS SOLUTION 80

MG/8ML 2








267

?



mcg 1 MO

donepezil hcl oral tablet 23 mg 1 MO

DOXIL INTRAVENOUS INJECTABLE 2

MG/ML 2 BD

doxorubicin hcl intravenous solution 2 mg/ml 1 BD

doxorubicin hcl liposomal intravenous injectable

2 mg/ml 1 BD

doxycycline hyclate oral capsule 100 mg, 50 mg 1

doxycycline hyclate oral tablet 100 mg 1

doxycycline hyclate oral tablet delayed release 50

mg 1

doxycycline monohydrate oral capsule 100 mg,

50 mg 1

doxycycline monohydrate oral suspension

reconstituted 25 mg/5ml 1

doxycycline monohydrate oral tablet 100 mg, 50

mg, 75 mg 1


mg 1 MO





mg 1 MO

EMPLICITI INTRAVENOUS SOLUTION


EMPLICITI INTRAVENOUS SOLUTION


EMVERM ORAL TABLET CHEWABLE 100

MG 2


MCG/0.5ML (0.5ML SYRINGE) 2 BD









268

?


EPIRUBICIN HCL INTRAVENOUS

SOLUTION 200 MG/100ML 2 BD

ERBITUX INTRAVENOUS SOLUTION 100

MG/50ML 2 BD

erythrocin lactobionate intravenous solution

reconstituted 500 mg 1

erythrocin stearate oral tablet 250 mg 1

erythromycin base oral capsule delayed release

particles 250 mg 1

erythromycin ethylsuccinate oral tablet 400 mg 1



ethynodiol diac-eth estradiol oral tablet 1-50 mg-

mcg 1 MO

ETOPOPHOS INTRAVENOUS SOLUTION


etoposide intravenous solution 500 mg/25ml 1 BD

EZETIMIBE ORAL TABLET 10 MG 2 MO

famciclovir oral tablet 125 mg, 250 mg, 500 mg 1

FARESTON ORAL TABLET 60 MG 2 MO

FASLODEX INTRAMUSCULAR SOLUTION

250 MG/5ML 2 BD

felbamate oral suspension 600 mg/5ml 1 MO

felbamate oral tablet 400 mg, 600 mg 1 MO

fenofibrate oral capsule 150 mg, 50 mg 1 MO

FENOFIBRATE ORAL TABLET 40 MG 2 MO

FETZIMA ORAL CAPSULE EXTENDED


80 MG

2 MO

FETZIMA TITRATION ORAL CAPSULE ER

24 HOUR THERAPY PACK 20 & 40 MG 2

FIRMAGON SUBCUTANEOUS SOLUTION









269

?


fluconazole in sodium chloride intravenous

solution 200-0.9 mg/100ml-%, 400-0.9 mg/200ml-

%

1 BD

fluconazole oral suspension reconstituted 10

mg/ml, 40 mg/ml 1

fluconazole oral tablet 100 mg, 150 mg, 200 mg,

50 mg 1

flucytosine oral capsule 250 mg, 500 mg 1

FLUDARABINE PHOSPHATE


RECONSTITUTED 50 MG

2

flutamide oral capsule 125 mg 1

fluvastatin sodium er oral tablet extended release

24 hour 80 mg 1 MO

FOLOTYN INTRAVENOUS SOLUTION 40

MG/2ML 2 BD

FREAMINE HBC INTRAVENOUS SOLUTION

6.9 % 2 BD





10 GM/200ML 2 BD

GEMCITABINE HCL INTRAVENOUS

SOLUTION RECONSTITUTED 1 GM 2

gentamicin in saline intravenous solution 1-0.9

mg/ml-%, 1.2-0.9 mg/ml-%, 1.6-0.9 mg/ml-% 1

gentamicin sulfate injection solution 40 mg/ml 1

gentamicin sulfate intravenous solution 10 mg/ml 1

gentamicin sulfate ophthalmic ointment 0.3 % 1

gentamicin sulfate ophthalmic solution 0.3 % 1

GILOTRIF ORAL TABLET 20 MG, 30 MG, 40

MG 2 PA

GLEEVEC ORAL TABLET 100 MG, 400 MG 2








270

?


GLEOSTINE ORAL CAPSULE 5 MG 2

HALAVEN INTRAVENOUS SOLUTION 1

MG/2ML 2

hepatamine intravenous solution 8 % 1 BD

HERCEPTIN INTRAVENOUS SOLUTION


HEXALEN ORAL CAPSULE 50 MG 2



40 MG/0.8ML (6 PACK)

2 MO

hydrocodone-acetaminophen oral solution 7.5-

325 mg/15ml 1 QL (5500 ML per 30 days)

hydrocortisone external ointment 1 % 1

HYDROMORPHONE HCL INJECTION

SOLUTION 2 MG/ML 2


INJECTABLE 150 UNIT/ML (10ML) 2

IBRANCE ORAL CAPSULE 100 MG, 125 MG,

75 MG 2 PA

ICLUSIG ORAL TABLET 15 MG, 45 MG 2 PA

idarubicin hcl intravenous solution 10 mg/10ml 1 BD

ifosfamide intravenous solution reconstituted 1

gm 1 BD


IMFINZI INTRAVENOUS SOLUTION 120

MG/2.4ML, 500 MG/10ML 2 PA

imipenem-cilastatin intravenous solution

reconstituted 250 mg, 500 mg 1

INLYTA ORAL TABLET 1 MG, 5 MG 2

INVANZ INJECTION SOLUTION

RECONSTITUTED 1 GM 2


IRESSA ORAL TABLET 250 MG 2

irinotecan hcl intravenous solution 100 mg/5ml 1 BD








271

?


ISOLYTE-P IN D5W INTRAVENOUS

SOLUTION 2

ISOLYTE-S INTRAVENOUS SOLUTION 2

itraconazole oral capsule 100 mg 1


JEVTANA INTRAVENOUS SOLUTION 60

MG/1.5ML 2 BD

KADCYLA INTRAVENOUS SOLUTION


ketoconazole oral tablet 200 mg 1

KEYTRUDA INTRAVENOUS SOLUTION 100

MG/4ML 2 PA

KEYTRUDA INTRAVENOUS SOLUTION


KINRIX INTRAMUSCULAR SUSPENSION

INJECTION 0.5 ML 2

KISQALI 200 DOSE ORAL TABLET 200 MG 2 PA



KISQALI FEMARA 200 DOSE ORAL TABLET

THERAPY PACK 200 & 2.5 MG 2 PA





KUVAN ORAL PACKET 100 MG 2 MO

lactated ringers intravenous solution 1

lactated ringers irrigation solution 1



LANTUS SOLOSTAR SUBCUTANEOUS

SOLUTION PEN-INJECTOR 100 UNIT/ML 2 MO








272

?


LANTUS SUBCUTANEOUS SOLUTION 100

UNIT/ML 2 MO

LATUDA ORAL TABLET 60 MG 2 MO

LENVIMA 10 MG DAILY DOSE ORAL

CAPSULE THERAPY PACK 10 MG 2


CAPSULE THERAPY PACK 10 & 4 MG 2


CAPSULE THERAPY PACK 10 & 4 (2) MG 2


CAPSULE THERAPY PACK 10 (2) MG 2


CAPSULE THERAPY PACK 10 (2) & 4 MG 2


CAPSULE THERAPY PACK 4 (2) MG 2

LEUKINE INTRAVENOUS SOLUTION


LEVEMIR FLEXTOUCH SUBCUTANEOUS


LEVEMIR SUBCUTANEOUS SOLUTION 100

UNIT/ML 2 MO

levofloxacin in d5w intravenous solution 500

mg/100ml, 750 mg/150ml 1

levofloxacin intravenous solution 25 mg/ml 1

levofloxacin oral solution 25 mg/ml 1

levofloxacin oral tablet 250 mg, 500 mg, 750 mg 1



RECONSTITUTED 50 MG

2 BD

levonorg-eth estrad triphasic oral tablet 1 MO


lidocaine hcl external gel 2 % (10ml applicator) 1

lincomycin hcl injection solution 300 mg/ml 1 BD

linezolid intravenous solution 600 mg/300ml 1








273

?


linezolid oral suspension reconstituted 100

mg/5ml 1

linezolid oral tablet 600 mg 1


400-100 MG/5ML 2 MO

lyza oral tablet 0.35 mg 1 MO

magnesium sulfate injection solution 50 % (10ml

syringe) 1

MATULANE ORAL CAPSULE 50 MG 2


megestrol acetate oral tablet 20 mg, 40 mg 1 PA; HR

MEKINIST ORAL TABLET 0.5 MG, 2 MG 2 LA

melphalan hcl intravenous solution reconstituted

50 mg 1 BD





INJECTABLE 2



mercaptopurine oral tablet 50 mg 1

meropenem intravenous solution reconstituted

500 mg 1


RELEASE 800 MG 2

methotrexate sodium (pf) injection solution 1

gm/40ml 1 BD

methotrexate sodium injection solution 50 mg/2ml 1 BD

methotrexate sodium injection solution

reconstituted 1 gm 1 BD

methoxsalen rapid oral capsule 10 mg 1








274

?



2.5 mg, 5 mg 1 MO


METRONIDAZOLE IN NACL

INTRAVENOUS SOLUTION 500-0.79

MG/100ML-%

2 BD

metronidazole oral capsule 375 mg 1

metronidazole oral tablet 250 mg, 500 mg 1


minocycline hcl oral capsule 100 mg, 50 mg, 75

mg 1

minocycline hcl oral tablet 100 mg, 50 mg, 75 mg 1

mitomycin intravenous solution reconstituted 20

mg, 40 mg 1 BD

MITOMYCIN INTRAVENOUS SOLUTION


MOLINDONE HCL ORAL TABLET 10 MG, 25

MG, 5 MG 2 MO


morphine sulfate er beads oral capsule extended

release 24 hour 120 mg, 30 mg, 45 mg, 60 mg, 75

mg, 90 mg

1

morphine sulfate er oral capsule extended release

24 hour 10 mg 1

MOXEZA OPHTHALMIC SOLUTION 0.5 % 2

MOXIFLOXACIN HCL INTRAVENOUS

SOLUTION 400 MG/250ML 2


MG/1.2ML 2

MUSTARGEN INJECTION SOLUTION


MYCAMINE INTRAVENOUS SOLUTION









275

?







180 mg, 360 mg 1 BD; MO

NAFCILLIN SODIUM INJECTION SOLUTION

RECONSTITUTED 1 GM 2

nafcillin sodium injection solution reconstituted

10 gm 1

nalbuphine hcl injection solution 10 mg/ml, 20

mg/ml 1

neomycin-polymyxin-dexameth ophthalmic

ointment 3.5-10000-0.1 1

neomycin-polymyxin-dexameth ophthalmic

suspension 3.5-10000-0.1 1

neomycin-polymyxin-hc otic solution 1 % 1

NEPHRAMINE INTRAVENOUS SOLUTION

5.4 % 2 BD


400 mg 1 MO

NEXAVAR ORAL TABLET 200 MG 2 LA

niacin er (antihyperlipidemic) oral tablet

extended release 1000 mg, 500 mg, 750 mg 1 MO

nilutamide oral tablet 150 mg 1

NIPENT INTRAVENOUS SOLUTION


nitrofurantoin macrocrystal oral capsule 100 mg,

25 mg, 50 mg 1 PA; HR

nitrofurantoin monohyd macro oral capsule 100

mg 1 PA; HR

norethindrone acet-ethinyl est oral tablet 1-20

mg-mcg 1 MO

norgestim-eth estrad triphasic oral tablet

0.18/0.215/0.25 mg-25 mcg 1 MO








276

?


normosol-m in d5w intravenous solution 1

NORMOSOL-R IN D5W INTRAVENOUS

SOLUTION 2

NORMOSOL-R PH 7.4 INTRAVENOUS

SOLUTION 2

NOVOLOG FLEXPEN SUBCUTANEOUS


NOVOLOG MIX 70/30 FLEXPEN

SUBCUTANEOUS SUSPENSION PEN-

INJECTOR (70-30) 100 UNIT/ML

2 MO

NOVOLOG MIX 70/30 SUBCUTANEOUS

SUSPENSION (70-30) 100 UNIT/ML 2 MO

NOVOLOG PENFILL SUBCUTANEOUS

SOLUTION CARTRIDGE 100 UNIT/ML 2 MO

NOVOLOG SUBCUTANEOUS SOLUTION

100 UNIT/ML 2 MO


RELEASE 100 MG 2 MO

ofloxacin ophthalmic solution 0.3 % 1

ofloxacin oral tablet 300 mg, 400 mg 1




TABLET 20-12.5 MG, 40-12.5 MG, 40-25 MG 2 MO


TABLET 20-5-12.5 MG, 40-10-12.5 MG, 40-10-

25 MG, 40-5-12.5 MG, 40-5-25 MG

2 MO


omega-3-acid ethyl esters oral capsule 1 gm 1 MO

ondansetron hcl injection solution 4 mg/2ml (2ml

syringe) 1 BD










277

?


OPDIVO INTRAVENOUS SOLUTION 40

MG/4ML 2 PA


OSELTAMIVIR PHOSPHATE ORAL

CAPSULE 30 MG, 45 MG, 75 MG 2

oxaliplatin intravenous solution 100 mg/20ml 1 BD

oxycodone-acetaminophen oral solution 5-325

mg/5ml 1 QL (1800 ML per 30 days)

OXYCONTIN ORAL TABLET ER 12 HOUR

ABUSE-DETERRENT 15 MG 2

paclitaxel intravenous concentrate 300 mg/50ml 1 BD

paliperidone er oral tablet extended release 24

hour 1.5 mg, 3 mg, 6 mg, 9 mg 1 MO

PANTOPRAZOLE SODIUM INTRAVENOUS


pantoprazole sodium oral tablet delayed release

20 mg, 40 mg 1 MO


2 MCG/ML 2


5 MCG/ML 2 BD



penicillin g pot in dextrose intravenous solution

40000 unit/ml, 60000 unit/ml 1

penicillin g potassium injection solution

reconstituted 5000000 unit 1

penicillin g sodium injection solution

reconstituted 5000000 unit 1

penicillin v potassium oral solution reconstituted

125 mg/5ml, 250 mg/5ml 1

penicillin v potassium oral tablet 250 mg, 500 mg 1

PERJETA INTRAVENOUS SOLUTION 420

MG/14ML 2








278

?


PEXEVA ORAL TABLET 40 MG 2 MO

phenobarbital oral elixir 20 mg/5ml 1 PA; HR; MO

phenobarbital oral tablet 100 mg, 15 mg, 16.2

mg, 30 mg, 32.4 mg, 60 mg, 64.8 mg, 97.2 mg 1 PA; HR; MO

physiolyte irrigation solution 1

physiosol irrigation irrigation solution 1

pimozide oral tablet 2 mg 1 MO

piperacillin sod-tazobactam so intravenous

solution reconstituted 3.375 (3-0.375) gm, 4.5 (4-

0.5) gm

1

PLASMA-LYTE 148 INTRAVENOUS

SOLUTION 2

plenamine intravenous solution 15 % 1 BD

potassium chloride er oral tablet extended release

20 meq 1 MO

potassium citrate er oral tablet extended release

10 meq (1080 mg), 15 meq (1620 mg), 5 meq (540

mg)

1





prednisone oral solution 5 mg/5ml 1

prednisone oral tablet 1 mg, 10 mg, 2.5 mg, 20

mg, 5 mg, 50 mg 1

prednisone oral tablet therapy pack 10 mg (21),

10 mg (48), 5 mg (21), 5 mg (48) 1

premasol intravenous solution 6 % 1 BD

PRENATAL ORAL TABLET 27-1 MG 2

primidone oral tablet 250 mg, 50 mg 1 MO

PRIMSOL ORAL SOLUTION 50 MG/5ML 2

PROCALAMINE INTRAVENOUS SOLUTION

3 % 2 BD









279

?


PROLEUKIN INTRAVENOUS SOLUTION

RECONSTITUTED 22000000 UNIT 2 BD

PROSOL INTRAVENOUS SOLUTION 20 % 2 BD

PURIXAN ORAL SUSPENSION 2000

MG/100ML 2

QUETIAPINE FUMARATE ER ORAL


MG, 200 MG, 300 MG, 400 MG, 50 MG

2 MO

quinine sulfate oral capsule 324 mg 1



MG, 1 MG 2 MO


10 MCG/ML (1ML SYRINGE) 2 BD



MG/0.6ML (0.6ML SYRINGE) 2



2-500 mg 1 MO

REVLIMID ORAL CAPSULE 10 MG, 15 MG,

25 MG, 5 MG 2 LA

REVLIMID ORAL CAPSULE 2.5 MG, 20 MG 2

rifabutin oral capsule 150 mg 1

ringers intravenous solution 1

ringers irrigation irrigation solution 1


mg (12 pack), 5 mg 1 MO



mg 1 MO


HOUR 4.6 MG/24HR, 9.5 MG/24HR 2 MO

ROBINUL-FORTE ORAL TABLET 2 MG 2








280

?


rosuvastatin calcium oral tablet 10 mg, 20 mg, 40

mg, 5 mg 1 MO

RYDAPT ORAL CAPSULE 25 MG 2 PA



mg/12.5ml 1 PA


50 MG/4ML 2 ST; MO


sodium chloride intravenous solution 0.45 %, 0.9

%, 3 %, 5 % 1

sodium chloride irrigation solution 0.9 % 1

SODIUM FLUORIDE ORAL TABLET 2.2 (1 F)

MG 2

SODIUM LACTATE INTRAVENOUS

SOLUTION 5 MEQ/ML 2


SPRYCEL ORAL TABLET 100 MG, 140 MG,

20 MG, 50 MG, 70 MG, 80 MG 2

STIVARGA ORAL TABLET 40 MG 2 PA

streptomycin sulfate intramuscular solution


sulfadiazine oral tablet 500 mg 1

sulfamethoxazole-trimethoprim intravenous

solution 400-80 mg/5ml 1

sulfamethoxazole-trimethoprim oral suspension

200-40 mg/5ml 1

sulfamethoxazole-trimethoprim oral tablet 400-80

mg, 800-160 mg 1


SUPRAX ORAL CAPSULE 400 MG 2

SUTENT ORAL CAPSULE 12.5 MG, 25 MG,

37.5 MG, 50 MG 2








281

?


SYNERCID INTRAVENOUS SOLUTION

RECONSTITUTED 150-350 MG 2

TAFINLAR ORAL CAPSULE 50 MG, 75 MG 2 LA

TAGRISSO ORAL TABLET 40 MG, 80 MG 2 LA

TARCEVA ORAL TABLET 100 MG, 150 MG,

25 MG 2

TASIGNA ORAL CAPSULE 150 MG, 200 MG 2

tazicef injection solution reconstituted 2 gm 1 BD

TECENTRIQ INTRAVENOUS SOLUTION

1200 MG/20ML 2 BD

TEFLARO INTRAVENOUS SOLUTION




5 mg, 80-10 mg, 80-5 mg 1 MO


mg, 80-25 mg 1 MO

terbutaline sulfate injection solution 1 mg/ml 1


THIOTEPA INJECTION SOLUTION


TIVICAY ORAL TABLET 50 MG 2 MO


mg/5ml 1 BD

tobramycin ophthalmic solution 0.3 % 1

tobramycin sulfate injection solution 10 mg/ml,

80 mg/2ml 1

toposar intravenous solution 1 gm/50ml 1 BD

TOPOTECAN HCL INTRAVENOUS


TOUJEO SOLOSTAR SUBCUTANEOUS


tpn electrolytes intravenous solution 1








282

?


tranexamic acid intravenous solution 1000

mg/10ml 1

TRAVASOL INTRAVENOUS SOLUTION 10

% 2 BD

TREANDA INTRAVENOUS SOLUTION


tretinoin external gel 0.05 % 1

tretinoin oral capsule 10 mg 1

tri-lo-sprintec oral tablet 0.18/0.215/0.25 mg-25

mcg 1 MO



50 MG

2 MO

TYGACIL INTRAVENOUS SOLUTION


TYKERB ORAL TABLET 250 MG 2


25 MCG/0.5ML (0.5ML SYRINGE) 2

valacyclovir hcl oral tablet 1 gm, 500 mg 1

VALCHLOR EXTERNAL GEL 0.016 % 2

VALGANCICLOVIR HCL ORAL SOLUTION

RECONSTITUTED 50 MG/ML 2 MO

valganciclovir hcl oral tablet 450 mg 1 MO


mg 1 MO

vancomycin hcl intravenous solution reconstituted

10 gm, 1000 mg 1

VANCOMYCIN HCL INTRAVENOUS


vancomycin hcl oral capsule 125 mg, 250 mg 1

VECTIBIX INTRAVENOUS SOLUTION 100

MG/5ML 2 BD

VELCADE INJECTION SOLUTION









283

?


VERSACLOZ ORAL SUSPENSION 50 MG/ML 2

VIGAMOX OPHTHALMIC SOLUTION 0.5 % 2

vinblastine sulfate intravenous solution 1 mg/ml 1 BD

vincasar pfs intravenous solution 1 mg/ml 1 BD

vincristine sulfate intravenous solution 1 mg/ml 1 BD

vinorelbine tartrate intravenous solution 50

mg/5ml 1 BD

voriconazole intravenous solution reconstituted

200 mg 1

voriconazole oral suspension reconstituted 40

mg/ml 1

voriconazole oral tablet 200 mg 1

VOTRIENT ORAL TABLET 200 MG 2

vyfemla oral tablet 0.4-35 mg-mcg 1 MO

XALKORI ORAL CAPSULE 200 MG, 250 MG 2 PA

XTANDI ORAL CAPSULE 40 MG 2 PA; ST

YERVOY INTRAVENOUS SOLUTION 50

MG/10ML 2

ZALTRAP INTRAVENOUS SOLUTION 100

MG/4ML 2

zazole vaginal cream 0.8 % 1


ZEJULA ORAL CAPSULE 100 MG 2 PA




ZYKADIA ORAL CAPSULE 150 MG 2

ZYTIGA ORAL TABLET 250 MG 2

OVERDOSE

HIGH BLOOD LEVELS OF

METHOTREXATE








284

?







mg, 5 mg 1





RECONSTITUTED 50 MG

2 BD

OVERDOSE OF THE DRUG

ACETAMINOPHEN


POISONING BY HEAVY METALS

EXJADE ORAL TABLET SOLUBLE 125 MG,

250 MG, 500 MG 2 MO

FERRIPROX ORAL SOLUTION 100 MG/ML 2 MO

FERRIPROX ORAL TABLET 500 MG 2 MO

PYRIMETHAMINE POISONING


mg, 5 mg 1

TOXIC AMOUNT OF NARCOTICS

IN THE BODY



naloxone hcl injection solution 0.4 mg/ml 1

NALOXONE HCL INJECTION SOLUTION

PREFILLED SYRINGE 2 MG/2ML 2



MG/0.6ML, 8 MG/0.4ML 2

PAIN








285

?


ACUTE PAIN FOLLOWING AN

OPERATION

ketorolac tromethamine injection solution 15

mg/ml, 30 mg/ml 1 PA; HR

ketorolac tromethamine intramuscular solution

60 mg/2ml 1 PA; HR

ketorolac tromethamine oral tablet 10 mg 1 PA; HR

oxycodone-ibuprofen oral tablet 5-400 mg 1

ACUTE PAIN




60 mg/2ml 1 PA; HR



ADDITIONAL MEDICATIONS TO

TREAT PAIN

hydroxyzine hcl intramuscular solution 25 mg/ml,

50 mg/ml 1 PA; HR


BACKACHE


CHEST PAIN


30 mg, 60 mg 1 MO


mg 1 MO












286

?







120 mg, 180 mg, 240 mg, 300 mg 1 MO







mg

1 MO




90 mg 1 MO


mg, 180 mg, 240 mg 1 MO




40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1



10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2



release 40 mg 1 MO


mg, 5 mg 1 MO








287

?









5 mg/5ml 1 BD


mg 1 MO


0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr 1 MO




30 mg, 60 mg, 90 mg 1 MO






0.4 mg, 0.6 mg 1 MO






mg 1 MO




120 mg, 180 mg, 240 mg, 300 mg, 360 mg 1 MO










288

?




CHRONIC PAIN

diflunisal oral tablet 500 mg 1 MO





EMBEDA ORAL CAPSULE EXTENDED

RELEASE 100-4 MG, 20-0.8 MG, 30-1.2 MG,

50-2 MG, 60-2.4 MG, 80-3.2 MG

2 QL (60 EA per 30 days)

fentanyl transdermal patch 72 hour 100 mcg/hr,

12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr 1 ST; QL (10 EA per 30 days)

FENTANYL TRANSDERMAL PATCH 72

HOUR 37.5 MCG/HR, 62.5 MCG/HR, 87.5

MCG/HR

2

FENTORA BUCCAL TABLET 200 MCG, 400

MCG, 600 MCG, 800 MCG 2 PA

hydromorphone hcl pf injection solution 10

mg/ml, 50 mg/5ml 1

LAZANDA NASAL SOLUTION 100

MCG/ACT, 300 MCG/ACT, 400 MCG/ACT 2 PA


10 MG/ML 2



morphine sulfate (concentrate) oral solution 100

mg/5ml 1



mg, 90 mg

1


24 hour 10 mg, 100 mg, 20 mg, 30 mg, 50 mg, 60

mg, 80 mg

1








289

?


morphine sulfate er oral tablet extended release

100 mg, 15 mg, 30 mg, 60 mg 1

OPANA ER ORAL TABLET ER 12 HOUR

ABUSE-DETERRENT 10 MG, 15 MG, 20 MG,

30 MG, 40 MG, 5 MG, 7.5 MG

2

OXYCODONE HCL ER ORAL TABLET ER 12

HOUR ABUSE-DETERRENT 15 MG, 30 MG,

60 MG

2



30 MG, 40 MG, 60 MG, 80 MG

2

oxymorphone hcl er oral tablet extended release

12 hour 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 5

mg, 7.5 mg

1

HEAD PAIN







ascomp-codeine oral capsule 50-325-40-30 mg 1 PA; HR

butalbital-acetaminophen oral tablet 50-325 mg 1

butalbital-apap-caff-cod oral capsule 50-325-40-

30 mg 1 PA; HR; QL (370 EA per 30 days)

butalbital-asa-caff-codeine oral capsule 50-325-

40-30 mg 1 PA; HR; QL (180 EA per 30 days)




80 mg 3


mg/ml 1


24 hour 250 mg, 500 mg 1 MO








290

?





mg, 250 mg, 500 mg 1 MO












160 mg/5ml 3


24 hour 120 mg, 160 mg, 60 mg, 80 mg 1 MO



60 mg, 80 mg 1 MO


mg/0.8ml 3

















291

?




25 MG, 50 MG

2 MO



mg 1 MO



50 MG

2 MO


INDIGESTION




312-958 MG

3


25 MG ORAL 200-200-25 MG 3


20 mg/5ml oral 200-200-20 mg/5ml 3


mg 3


1000 mg oral 1000 mg 3






oral 95-358 mg/15ml 3


MG/5ML ORAL 400-400-40 MG/5ML 3


mg/15ml 3

sodium bicarbonate oral tablet 650 mg 3








292

?


KIDNEY PAIN


MINOR SKIN WOUND PAIN


3.5-10000-10 3

MUSCLE OR BONE PAIN







25 MG, 50 MG 2 MO


25 & 50 MG 2

MUSCLE PAIN


25 MG, 50 MG 2 MO


25 & 50 MG 2

NERVE PAIN





PAIN IN A CANCER PATIENT

WHEN ON PAIN MEDICATION





PAIN IN ARMS OR LEGS








293

?




mg 1 MO

PAIN IN THE EYE





%, 0.5 % 1

PAIN IN THE VULVA


PAIN OF THE ESOPHAGUS




312-958 MG

3


25 MG ORAL 200-200-25 MG 3


20 mg/5ml oral 200-200-20 mg/5ml 3


mg 3


1000 mg oral 1000 mg 3


oral 95-358 mg/15ml 3


MG/5ML ORAL 400-400-40 MG/5ML 3

PAIN












294

?




acetaminophen-codeine #2 oral tablet 300-15 mg 1 QL (400 EA per 30 days)



acetaminophen-codeine oral solution 120-12











80 mg 3




fenoprofen calcium oral tablet 600 mg 1 MO






hydrocodone-acetaminophen oral solution 7.5-

325 mg/15ml 1 QL (5500 ML per 30 days)

hydrocodone-acetaminophen oral tablet 10-325

mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg 1 QL (370 EA per 30 days)

hydrocodone-ibuprofen oral tablet 10-200 mg, 5-


hydrocodone-ibuprofen oral tablet 7.5-200 mg 1








295

?


HYDROMORPHONE HCL INJECTION

SOLUTION 2 MG/ML 2

hydromorphone hcl oral liquid 1 mg/ml 1

hydromorphone hcl oral tablet 2 mg, 4 mg, 8 mg 1






mg 1 MO

morphine sulfate oral solution 10 mg/5ml, 20

mg/5ml 1

MORPHINE SULFATE ORAL TABLET 15

MG, 30 MG 2




OPANA ORAL TABLET 10 MG, 5 MG 2

oxycodone hcl oral capsule 5 mg 1

oxycodone hcl oral tablet 10 mg, 15 mg, 20 mg,

30 mg, 5 mg 1

oxycodone-acetaminophen oral solution 5-325


oxycodone-acetaminophen oral tablet 10-325 mg,

2.5-325 mg, 5-325 mg, 7.5-325 mg 1 QL (370 EA per 30 days)

oxycodone-aspirin oral tablet 4.8355-325 mg 1

oxymorphone hcl oral tablet 10 mg, 5 mg 1


160 mg/5ml 3

pentazocine-naloxone hcl oral tablet 50-0.5 mg 1 PA; HR


mg/0.8ml 3

tramadol hcl oral tablet 50 mg 1 QL (240 EA per 30 days)








296

?


tramadol-acetaminophen oral tablet 37.5-325 mg 1 QL (370 EA per 30 days)

SEVERE PAIN

duramorph injection solution 0.5 mg/ml, 1 mg/ml 1

EMBEDA ORAL CAPSULE EXTENDED

RELEASE 100-4 MG 2 QL (60 EA per 30 days)

fentanyl transdermal patch 72 hour 100 mcg/hr,

12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr 1 ST; QL (10 EA per 30 days)

FENTANYL TRANSDERMAL PATCH 72

HOUR 37.5 MCG/HR, 62.5 MCG/HR, 87.5

MCG/HR

2

hydromorphone hcl oral liquid 1 mg/ml 1

hydromorphone hcl oral tablet 2 mg, 4 mg, 8 mg 1

hydromorphone hcl pf injection solution 10

mg/ml, 50 mg/5ml 1




60 mg/2ml 1 PA; HR



10 MG/ML 2



morphine sulfate (concentrate) oral solution 100

mg/5ml 1



mg, 90 mg

1


24 hour 100 mg 1

morphine sulfate er oral tablet extended release

100 mg 1

OPANA ER ORAL TABLET ER 12 HOUR

ABUSE-DETERRENT 30 MG, 40 MG 2








297

?


OXYCODONE HCL ER ORAL TABLET ER 12

HOUR ABUSE-DETERRENT 15 MG, 30 MG,

60 MG

2




30 MG, 40 MG, 60 MG, 80 MG

2

oxymorphone hcl er oral tablet extended release

12 hour 30 mg, 40 mg 1

URETERAL SPASM WITH PAIN


PATIENT DEMOGRAPHICS

TOBACCO SMOKING

bupropion hcl er (smoking det) oral tablet

extended release 12 hour 150 mg 1

CHANTIX CONTINUING MONTH PAK ORAL

TABLET 1 MG 2 QL (56 EA per 28 days)

CHANTIX ORAL TABLET 0.5 MG 2 QL (11 EA per 30 days)

CHANTIX ORAL TABLET 1 MG 2 QL (180 EA per 90 days)

CHANTIX STARTING MONTH PAK ORAL

TABLET 0.5 MG X 11 & 1 MG X 42 2 QL (53 EA per 30 days)

NICORETTE GUM 2 MG MOUTH/THROAT 2

MG 3


MOUTH/THROAT 2 MG 3


MOUTH/THROAT 4 MG 3


(otc) 14 mg/24hr 3


(otc) 21 mg/24hr 3


(otc) 7 mg/24hr 3

nicotine polacrilex gum 4 mg mouth/throat 4 mg 3








298

?


NICOTROL INHALATION INHALER 10 MG 2

sm nicotine patch 24 hour 21 mg/24hr

transdermal 21 mg/24hr 3

POOR NUTRITION

A LACK OF FATTY ACIDS

nutrilipid intravenous emulsion 20 % 1 BD

CARNITINE DEFICIENCY

levocarnitine oral solution 1 gm/10ml 1 MO

levocarnitine oral tablet 330 mg 1 MO

GENERAL ILL HEALTH AND

MALNUTRITION


MG/5ML 2 PA; HR; MO





MG/3ML, 5 MG/1.5ML

2 PA; MO





INCREASE OR DECREASE IN

VITAMIN D

CALCIFEROL SOLUTION 8000 UNIT/ML

ORAL 8000 UNIT/ML 3


mg 1 MO


d 5000 capsule 5000 unit oral 5000 unit 3










299

?


vitamin d (ergocalciferol) capsule 50000 unit oral

50000 unit 3 MO

vitamin d tablet 1000 unit oral 1000 unit 3


vitamin d3 tablet 400 unit oral 400 unit 3

LACK IN MINERALS


(38 fe) mg 3




(65 fe) mg 3


LACK IN VITAMINS

b complex tablet oral 3

balanced b-50 tablet oral 3

CALCIFEROL SOLUTION 8000 UNIT/ML

ORAL 8000 UNIT/ML 3


mg 1 MO


chewable vite childrens tablet chewable oral 3

chewable vite/iron childrens tablet chewable 15

mg oral 15 mg 3

cyanocobalamin solution 1000 mcg/ml injection

1000 mcg/ml 3

d 5000 capsule 5000 unit oral 5000 unit 3

daily-vite tablet oral 3

folic acid tablet 1 mg oral (otc) 1 mg 3 MO

folic acid tablet 400 mcg oral 400 mcg 3

geravim liquid oral 3










300

?





mg, 5 mg 1





RECONSTITUTED 50 MG

2 BD

MERIBIN CAPSULE 5 MG ORAL 5 MG 3

multi-delyn liquid oral 3

niacin oral tablet 50 mg 3

once daily/iron tablet oral 3

POLY-VI-SOL/IRON SOLUTION ORAL 3

pyridoxine hcl solution 100 mg/ml injection 100

mg/ml 3



sm vitamin c cr tablet extended release 500 mg

oral 500 mg 3


mg/ml 3

total b/c tablet oral 3

TRI-VI-SOL SOLUTION 750-400-35 UNIT-

MG/ML ORAL 750-400-35 UNIT-MG/ML 3

TRI-VITA SOLUTION 1500-400-35 UNIT-

MG/ML ORAL 1500-400-35 UNIT-MG/ML 3

tri-vitamin solution 1500-400-35 oral 1500-400-

35 3

vitamin a oral capsule 10000 unit 3



vitamin b-6 tablet 25 mg oral 25 mg 3








301

?


vitamin b-6 tablet 50 mg oral 50 mg 3

vitamin c oral tablet 250 mg 3

vitamin c tablet 500 mg oral 500 mg 3

vitamin d (ergocalciferol) capsule 50000 unit oral

50000 unit 3 MO



vitamin d3 tablet 400 unit oral 400 unit 3

PREGNANCY

EARLY LABOR

MAKENA INTRAMUSCULAR OIL 250

MG/ML 2

PREGNANCY

PRENATAL ORAL TABLET 27-1 MG 2

PROCEDURE

ADMINISTRATION OF LOCAL

ANESTHETIC DRUG


lidocaine hcl (pf) injection solution 0.5 % 1


lidocaine hcl external solution 4 % 1

lidocaine hcl injection solution 0.5 %, 2 % 1

lidocaine-prilocaine external cream 2.5-2.5 % 1

ATRIAL FIBRILLATION

ELECTRICALLY SHOCKED TO

NORMAL RHYTHM


mcg 1 MO


release 324 mg 1 MO









302

?


verapamil hcl intravenous solution 2.5 mg/ml 1

ATRIAL FLUTTER ELECTRICALLY

SHOCKED TO NORMAL RHYTHM


mcg 1 MO


release 324 mg 1 MO


EMPTYING OF THE BOWEL

peg 3350-kcl-na bicarb-nacl oral solution


PREPOPIK ORAL PACKET 10-3.5-12 MG-GM-

GM 2

GENERAL ANESTHESIA





mg, 50 mg 1 PA; HR

ROBINUL INJECTION SOLUTION 0.4

MG/2ML 2

INDUCING OF A RELAXED EASY

STATE





mg, 50 mg 1 PA; HR

MECHANICAL VENTILATION










303

?


METHOD OF REMOVING

WASTE/POISON FROM BLOOD

WITH DIALYSIS


MG 2 MO

PERIPHERAL BLOOD STEM CELL

THERAPY


MG/1.2ML 2

PREVENTION OF THROMBOSIS


125 MG/125ML 2 BD





25-200 MG

2 MO






40 mg/0.4ml, 60 mg/0.6ml, 80 mg/0.8ml

1


mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1


10000 UNIT/ML, 12500 UNIT/0.5ML, 15000

UNIT/0.6ML, 18000 UNT/0.72ML, 2500

UNIT/0.2ML, 5000 UNIT/0.2ML, 7500


2











304

?



100 unit/ml 1



unit/ml

1




MG 2 MO



RADIATION




RECENT OPERATION


MG, 80 & 125 MG, 80 MG 2 BD


125 MG/125ML 2 BD




MG/ML 2 BD







MG/ML 2 BD


MG/ML 2 BD









305

?




mg, 50 mg 1 BD; MO




solution 0.1 % 1







mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1








mg, 50 mg 1 PA; HR





60 mg/2ml 1 PA; HR


%, 0.5 % 1











306

?














180 mg, 360 mg 1 BD; MO








MG/ML 2 BD



3.5-10000-10 3



MG/2ML 2


MG 2 BD; MO


MG/ML 2 BD; MO









307

?









0.75 MG 2 BD; MO

SLOW DRUG ELIMINATION BY

KIDNEY


T3 SUPPRESSION FOR THYROID

FUNCTION TEST

liothyronine sodium oral tablet 25 mcg, 5 mcg, 50

mcg 1 MO

REACTION DUE TO AN ALLERGEN

ALLERGIC CONJUNCTIVITIS






ALLERGIES AFFECTING THE

SINUSES, NOSE OR THROAT


5-120 mg oral 5-120 mg 3




MG 3










308

?



1-2.5 mg/5ml 3








% 1 MO


MG 3




10-240 mg oral 10-240 mg 3





mg 1 MO


MG ORAL 4-60 MG 3


MG/5ML 3



CONTACT DERMATITIS


HIVES










309

?



MG/3ML 2


MG 3




MG/5ML 3



LIFE THREATENING ALLERGIC

REACTION

EPINEPHRINE INJECTION SOLUTION

AUTO-INJECTOR 0.15 MG/0.3ML, 0.3

MG/0.3ML

2

EPIPEN 2-PAK INJECTION SOLUTION

AUTO-INJECTOR 0.3 MG/0.3ML 2


MG/3ML 2

REACTION DUE TO AN ALLERGEN


mg 3


RECENT OPERATION

ADMINISTRATION OF LOCAL

ANESTHETIC DRUG














310

?


CARE IMMEDIATELY BEFORE,

DURING AND AFTER SURGERY


MG, 80 & 125 MG, 80 MG 2 BD


solution 0.1 % 1







60 mg/2ml 1 PA; HR


%, 0.5 % 1







DEEP VEIN THROMBOSIS

PREVENTION IN HIP SURGERY


mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1

DEEP VEIN THROMBOSIS

PREVENTION IN KNEE

REPLACEMENT


mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5

mg/0.6ml

1

EYE SURGERY








311

?



GENERAL ANESTHESIA





mg, 50 mg 1 PA; HR


MG/2ML 2

RECIPIENT OF ORGAN

TRANSPLANT




MG/ML 2 BD






MG/ML 2 BD


MG/ML 2 BD



mg, 50 mg 1 BD; MO















312

?









180 mg, 360 mg 1 BD; MO




MG/ML 2 BD



MG 2 BD; MO


MG/ML 2 BD; MO








0.75 MG 2 BD; MO

STOMACH OR INTESTINAL TRACT

OPERATION



SURGERY INVOLVING BLOOD

VESSELS


125 MG/125ML 2 BD








313

?



SURGICAL PROCEDURE IN THE

CHEST REGION


125 MG/125ML 2 BD


URINARY TRACT SURGERY




MG/ML 2 BD







mg, 50 mg 1 BD; MO















180 mg, 360 mg 1 BD; MO








314

?





MG/ML 2 BD



MG 2 BD; MO


MG/ML 2 BD; MO








0.75 MG 2 BD; MO

WOUND


3.5-10000-10 3


SKIN CONDITION

ABNORMAL PEELING OF SKIN


ACNE ROSACEA




ACNE

acne medication 10 lotion 10 % external 10 % 3

acne medication 5 lotion 5 % external 5 % 3

benzoyl peroxide-erythromycin external gel 5-3 % 1








315

?


claravis oral capsule 10 mg, 20 mg, 30 mg, 40 mg 1

clindamycin phos-benzoyl perox external gel 1-5

% 1

clindamycin phosphate external gel 1 % 1

clindamycin phosphate external lotion 1 % 1

clindamycin phosphate external solution 1 % 1

clindamycin phosphate external swab 1 % 1


mg 1 MO

erythromycin external gel 2 % 1

erythromycin external solution 2 % 1

kp benzoyl peroxide gel 10 % external 10 % 3

kp benzoyl peroxide gel 5 % external 5 % 3

myorisan oral capsule 30 mg 1

sulfacetamide sodium external suspension 10 % 1

TAZAROTENE EXTERNAL CREAM 0.1 % 2

TAZORAC EXTERNAL CREAM 0.1 % 2

TAZORAC EXTERNAL GEL 0.1 % 2

tretinoin external gel 0.05 % 1

DISORDER IN WHICH SKIN

CONVERTS TO HARD HORNY

MATERIAL


fluorouracil external cream 5 % 1

fluorouracil external solution 2 %, 5 % 1


PICATO EXTERNAL GEL 0.015 %, 0.05 % 2

TOLAK EXTERNAL CREAM 4 % 2

DRY SKIN

ammonium lactate external cream 12 % 1

ammonium lactate external lotion 12 % 1








316

?


ECZEMA




FABRY DISEASE



FINE WRINKLING

TAZAROTENE EXTERNAL CREAM 0.1 % 2


FINGERNAIL AND/OR TOENAIL

DISEASE

ciclopirox external solution 8 % 1

griseofulvin microsize oral suspension 125

mg/5ml 1

griseofulvin microsize oral tablet 500 mg 1

griseofulvin ultramicrosize oral tablet 125 mg,

250 mg 1

HIVES




MG/3ML 2


MG 3




MG/5ML 3



ITCHING








317

?







0.05 % 1


% 1


0.05 % 1













OINTMENT 0.05 % 2



0.025 % 1














318

?






















0.1 %, 0.5 % 1


0.1 % 1


%, 0.1 %, 0.5 % 1

PSORIASIS

acitretin oral capsule 10 mg, 17.5 mg, 25 mg 1

calcipotriene external solution 0.005 % 1











319

?







INJECTOR 150 MG/ML

2 ST; MO





MG/ML

2 MO







40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO


methoxsalen rapid oral capsule 10 mg 1












320

?






MG/ML

2 ST; MO


TAZORAC EXTERNAL GEL 0.05 %, 0.1 % 2


MG, 7.5 MG 2 BD

RASH










INJECTOR 150 MG/ML

2 ST; MO






MG/ML

2 MO














321

?




40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO



40 MG/0.8ML

2 MO













MG/ML

2 ST; MO


SCABIES

EURAX EXTERNAL CREAM 10 % 2

lindane external shampoo 1 % 1

permethrin external cream 5 % 1

SEBORRHEA









322

?


SKIN DISEASE OF THE SCALP

clobetasol propionate external solution 0.05 % 1


SKIN INFECTION



unit/gm 3


unit/gm 3







0.05 % 1


0.05 % 1





SUSPENSION 2




SUSPENSION 2













323

?




2 % 2






0.1 unit/gm-% 1


0.1 unit/gm-% 1




3.5-10000-10 3



3.5-400-5000 3

SKIN INFLAMMATION





0.05 % 1


% 1


0.05 % 1












324

?










0.05 % 1


0.05 % 1










OINTMENT 0.05 % 2





0.025 % 1














325

?









2 BD


SUSPENSION 2




SUSPENSION 2


















2 % 2









326

?






0.1 unit/gm-% 1


0.1 unit/gm-% 1












0.1 %, 0.5 % 1


0.1 % 1


%, 0.1 %, 0.5 % 1


SKIN IRRITATION



SKIN LESION












327

?








INJECTOR 150 MG/ML

2 ST; MO







MG/ML

2 MO





ERIVEDGE ORAL CAPSULE 150 MG 2




fluorouracil external solution 2 %, 5 % 1



40 MG/0.8ML

2 MO





MG/0.8ML

2 MO



MG/0.8ML

2 MO








328

?




40 MG/0.8ML

2 MO

hydroxyurea oral capsule 500 mg 1






UNIT, 50000000 UNIT

2 MO

ISTODAX (OVERFILL) INTRAVENOUS


ISTODAX INTRAVENOUS SOLUTION







2 % 2

ODOMZO ORAL CAPSULE 200 MG 2 LA








PICATO EXTERNAL GEL 0.015 %, 0.05 % 2



UNIT/GM 2









329

?




MG/ML

2 ST; MO

SYLATRON SUBCUTANEOUS KIT 200 MCG,

300 MCG, 600 MCG 2 MO

TARGRETIN EXTERNAL GEL 1 % 2

TOLAK EXTERNAL CREAM 4 % 2


ZELBORAF ORAL TABLET 240 MG 2


ZOLINZA ORAL CAPSULE 100 MG 2

SKIN ULCER



UNIT/GM 2

SYSTEMIC LUPUS

ERYTHEMATOSUS






TUMOR OF THE SKIN




fluorouracil external solution 5 % 1












330

?




UNIT, 50000000 UNIT

2 MO








300 MCG, 600 MCG 2 MO






KIDNEY


KIDNEY


TUMOR

A TUMOR FORMED OF BLOOD

VESSELS



BREAST TUMOR



MG, 7.5 MG 2











331

?





ENLARGED PROSTATE


8 mg 1 MO



mg 1 MO





mg 1 MO

INCREASED CALCIUM IN THE

BLOOD FROM CANCER




MG/1.7ML 2



MG/100ML 2 BD

MALIGNANT TUMOR OR CANCER



MG, 7.5 MG 2



MG, 80 & 125 MG, 80 MG 2 BD


MG/4ML, 400 MG/16ML 2









332

?


cladribine intravenous solution 10 mg/10ml 1 BD


MG/5ML 2 LA





MG, 45 MG, 7.5 MG 2 BD

ELITEK INTRAVENOUS SOLUTION

RECONSTITUTED 1.5 MG, 7.5 MG 2 BD


EMEND INTRAVENOUS SOLUTION


EMEND ORAL SUSPENSION



ERWINAZE INJECTION SOLUTION

RECONSTITUTED 10000 UNIT 2 PA



20 MG 2 PA







SUSPENSION 2




SUSPENSION 2

granisetron hcl intravenous solution 0.1 mg/ml, 1

mg/ml 1 BD; QL (60 ML per 30 days)








333

?


granisetron hcl oral tablet 1 mg 1 BD; QL (60 EA per 30 days)










UNIT, 50000000 UNIT

2 MO






MG, 25 MG, 5 MG 2






MG/50ML 2 PA








LEUKERAN ORAL TABLET 2 MG 2











334

?




RECONSTITUTED 50 MG

2 BD

LONSURF ORAL TABLET 15-6.14 MG, 20-

8.19 MG 2










LYSODREN ORAL TABLET 500 MG 2





mg/12.5ml 1


MG/1.2ML 2





MCG/0.8ML

2


MG 2



mcg/ml

1 MO










335

?


ondansetron hcl oral solution 4 mg/5ml 1 BD

ondansetron hcl oral tablet 24 mg 1 BD; QL (30 EA per 30 days)

ondansetron hcl oral tablet 4 mg, 8 mg 1 BD; QL (60 EA per 30 days)

ondansetron oral tablet dispersible 4 mg, 8 mg 1 BD; QL (60 EA per 30 days)






MG, 4 MG 2 LA










MG/ML 2 MO



MG/50ML 2


SANCUSO TRANSDERMAL PATCH 3.1

MG/24HR 2 QL (4 EA per 28 days)



MG

2




MG/0.3ML

2








336

?



300 MCG, 600 MCG 2 MO

SYNRIBO SUBCUTANEOUS SOLUTION


TABLOID ORAL TABLET 40 MG 2




MG, 200 MG, 50 MG 2 MO


MG/ML 2 BD



22.5 MG, 3.75 MG

2 BD

TRISENOX INTRAVENOUS SOLUTION 10

MG/10ML 2 BD


VENCLEXTA ORAL TABLET 10 MG, 100

MG, 50 MG 2 PA; LA

VENCLEXTA STARTING PACK ORAL

TABLET THERAPY PACK 10 & 50 & 100 MG 2 PA; LA



MG/1.7ML 2



ZANOSAR INTRAVENOUS SOLUTION














337

?



MG/100ML 2 BD


MYELOPROLIFERATIVE

NEOPLASM


NEOPLASM OF FEMALE GENITAL

ORGAN


MG, 7.5 MG 2





SUSPENSION 2




SUSPENSION 2












PHEOCHROMOCYTOMA


PLASMACYTOMA








338

?



MG/5ML 2 LA


20 MG 2 PA




MG 2


MG, 4 MG 2 LA


MG, 200 MG, 50 MG 2 MO



MG/100ML 2 BD

TUMOR OF THE BRAIN OR SPINAL

CORD



TUMOR OF THE SKIN











UNIT, 50000000 UNIT

2 MO










339

?







300 MCG, 600 MCG 2 MO






340

Index

INDEX \e " " \c "3" \h "A" \z "1033"

HPMS Approved Formulary File Submission ID 17397, Version Number 13

Il presente prontuario è aggiornato alla data 08/01/2017. Per ulteriori aggiornamenti o altre richieste, contatti il reparto Servizi per i Partecipanti (Participant Services) di AgeWell New York FIDA al numero 1-866-586-8044, non udenti 1-800-662-1220, disponibile 7 giorni su 7 dalle 8:00 alle 20:00, oppure visiti il sito www.agewellnewyork.com

Siamo sempre pronti per la Sua chiamata.Numero verde 1.866.586.8044 | Non udenti 1.800.662.1220 [email protected] | agewellnewyork.com


Documents

AgeWell New York · HPMS Approved Formulary File Submission ID 17397, Version Number 13 Il presente prontuario è aggiornato alla data 08/01/2017. Piano AgeWell New York (Medicare-Medicaid)